General Information of Drug (ID: DMDTVYC)

Drug Name
DNCB Drug Info
Synonyms 1-Chloro-2,4-dinitrobenzene
Indication
Disease Entry ICD 11 Status REF
Immune System disease 4A01-4B41 Phase 2 [1]
Cross-matching ID
PubChem CID
6
ChEBI ID
CHEBI:34718
CAS Number
CAS 97-00-7
TTD Drug ID
DMDTVYC
INTEDE Drug ID
DR1928

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DME
DOT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
Preclinical Drug(s)
Patented Agent(s)
Discontinued Drug(s)
Drug(s) Affected By Pirin (PIR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [11]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [13]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [13]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Sulfamethoxazole DMB08GE Acute otitis media AB00 Approved [15]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interleukin-1 beta (IL1B)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [16]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Gefitinib DM15F0X Colon adenocarcinoma Approved [18]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [19]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [20]
Lumiracoxib DM1S4AG Chronic renal failure GB61.Z Approved [19]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [21]
Selenium DM25CGV N. A. N. A. Approved [22]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [23]
Spironolactone DM2AQ5N Chronic heart failure BD1Z Approved [24]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [25]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [26]
Drug(s) Affected By Ferritin heavy chain (FTH1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [27]
TECFIDERA DM2OVDT Multiple sclerosis 8A40 Approved [28]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [29]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [33]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [34]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [35]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [13]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Annexin A1 (ANXA1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [36]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [37]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [40]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [35]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [42]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [37]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [44]
Selenium DM25CGV N. A. N. A. Approved [22]
Methotrexate DM2TEOL Anterior urethra cancer Approved [45]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [46]
Epinephrine DM3KJBC Acute asthma CA23 Approved [47]
Quercetin DM3NC4M Obesity 5B81 Approved [48]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [37]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [49]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [50]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [51]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Transcription factor Jun (JUN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Mitoxantrone DMM39BF Acute myelogenous leukaemia 2A41 Approved [52]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [53]
Fructose DM43AN2 Vomiting MD90 Approved [54]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [55]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [56]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [57]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [58]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [59]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [60]
Methotrexate DM2TEOL Anterior urethra cancer Approved [61]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Annexin A2 (ANXA2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [62]
Quercetin DM3NC4M Obesity 5B81 Approved [36]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [63]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [64]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [65]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [42]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [67]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cathepsin B (CTSB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [68]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [69]
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Omeprazole DM471KJ Cystic fibrosis CA25 Approved [71]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Pyrimethamine DM5X7VY Malaria 1F40-1F45 Approved [73]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [74]
Propylthiouracil DM6D7N8 Hyperthyroidism 5A02 Approved [75]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [76]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [77]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [79]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [80]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [35]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [81]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [82]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Heme oxygenase 1 (HMOX1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [84]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [85]
Pantothenic acid DM091H2 Vitamin deficiency 5B55-5B71 Approved [86]
Verapamil DMA7PEW Angina pectoris BA40 Approved [87]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [44]
Selenium DM25CGV N. A. N. A. Approved [88]
TECFIDERA DM2OVDT Multiple sclerosis 8A40 Approved [89]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [90]
Methotrexate DM2TEOL Anterior urethra cancer Approved [91]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [92]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [93]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Berberine DMC5Q8X N. A. N. A. Phase 4 [94]
Drug(s) Affected By NAD(P)H dehydrogenase 1 (NQO1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [13]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [95]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [27]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [20]
TECFIDERA DM2OVDT Multiple sclerosis 8A40 Approved [96]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [29]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [97]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [46]
Quercetin DM3NC4M Obesity 5B81 Approved [98]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [37]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [85]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [57]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [99]
Quercetin DM3NC4M Obesity 5B81 Approved [100]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [101]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [102]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [103]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [105]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [57]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [44]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [106]
Methotrexate DM2TEOL Anterior urethra cancer Approved [107]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [51]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [108]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [109]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [110]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [115]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Methotrexate DM2TEOL Anterior urethra cancer Approved [45]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [45]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [116]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [117]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [120]
Pentosan Polysulfate DM2HRKE Interstitial cystitis GC00.3 Approved [121]
Methotrexate DM2TEOL Anterior urethra cancer Approved [91]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [122]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [123]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [125]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [126]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [58]
Gefitinib DM15F0X Colon adenocarcinoma Approved [127]
Talazoparib DM1KS78 Breast cancer 2C60-2C65 Approved [128]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [99]
Etretinate DM2CZFA Keratosis ED56 Approved [129]
Prednisone DM2HG4X Acute asthma CA23 Approved [130]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [131]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [132]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein S100-A10 (S100A10)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [133]
Adenosine triphosphate DM79F6G Malnutrition 5B50-5B71 Approved [134]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Folic Acid DMEMBJC Colorectal carcinoma Approved [136]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [105]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [137]
Selenium DM25CGV N. A. N. A. Approved [70]
Methotrexate DM2TEOL Anterior urethra cancer Approved [138]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [140]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [51]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [141]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [13]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [13]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Ninjurin-1 (NINJ1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [144]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [145]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [144]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [13]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [13]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [13]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [49]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [146]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [147]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [147]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Perilipin-2 (PLIN2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [148]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [149]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [150]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [13]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [152]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [146]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Krueppel-like factor 6 (KLF6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [105]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [153]
Selenium DM25CGV N. A. N. A. Approved [70]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [132]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [154]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Semaphorin-4C (SEMA4C)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [159]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
SB-431542 DM0YOXQ Pulmonary fibrosis CB03.4 Preclinical [161]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [162]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [49]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [163]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [85]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Clozapine DMFC71L Schizophrenia 6A20 Approved [164]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [165]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [166]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [167]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [82]
Ampicillin DMHWE7P Acute epiglottitis Approved [8]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Antizyme inhibitor 1 (AZIN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [169]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [170]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [115]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [171]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [170]
Tamibarotene DM3G74J T-cell leukaemia 2A90 Phase 3 [168]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [172]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [173]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [137]
Methotrexate DM2TEOL Anterior urethra cancer Approved [138]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [174]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [175]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [6]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [171]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
Bortezomib DMNO38U Leukemia Approved [178]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Rigosertib DMOSTXF Myelodysplastic syndrome 2A37 Phase 3 [179]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [180]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [181]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [142]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [182]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Arsenic DMTL2Y1 N. A. N. A. Approved [183]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [184]
Bicalutamide DMZMSPF Prostate cancer 2C82.0 Approved [185]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Copine-3 (CPNE3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Haloperidol DM96SE0 Delirium Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Benzatropine DMF7EXL Parkinsonian disorder Approved [164]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [178]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [186]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [187]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [188]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Motexafin gadolinium DMEJKRF Brain cancer 2A00 Approved [187]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [170]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Syntaxin-11 (STX11)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Menthol DMG2KW7 Back pain ME84.Z Approved [189]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [190]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [115]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Menthol DMG2KW7 Back pain ME84.Z Approved [189]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [192]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [193]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [195]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [196]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cholecalciferol DMGU74E Adult acute monocytic leukemia Approved [197]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [198]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [199]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [200]
Spironolactone DM2AQ5N Chronic heart failure BD1Z Approved [201]
Etretinate DM2CZFA Keratosis ED56 Approved [202]
Prednisone DM2HG4X Acute asthma CA23 Approved [203]
Methotrexate DM2TEOL Anterior urethra cancer Approved [91]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [204]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [122]
Fructose DM43AN2 Vomiting MD90 Approved [205]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Carbonic anhydrase 2 (CA2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetazolamide DM1AF5U Absence epilepsy Approved [206]
Epinephrine DM3KJBC Acute asthma CA23 Approved [207]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [51]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [116]
Methazolamide DM7J2TA Glaucoma/ocular hypertension 9C61 Approved [208]
Topiramate DM82Z30 Alcohol dependence 6C40.2 Approved [209]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Voriconazole DMAOL2S Aspergillosis 1F20 Approved [210]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [211]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [57]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [212]
Gefitinib DM15F0X Colon adenocarcinoma Approved [213]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [11]
Selenium DM25CGV N. A. N. A. Approved [214]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [215]
Trametinib DM2JGQ3 Melanoma 2C30 Approved [216]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [217]
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [219]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [220]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Selenium DM25CGV N. A. N. A. Approved [70]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [221]
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [222]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein S100-B (S100B)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [196]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [223]
Norepinephrine DMOUC09 Alopecia ED70 Approved [224]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [225]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [158]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Myeloperoxidase (MPO)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dapsone DM4LT8A Acne vulgaris ED80 Approved [54]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [54]
Sulfamethoxazole DMB08GE Acute otitis media AB00 Approved [54]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [226]
Salicyclic acid DM2F8XZ Acne vulgaris ED80 Approved [227]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [228]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [229]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [230]
Propylthiouracil DM6D7N8 Hyperthyroidism 5A02 Approved [231]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Glycophorin-B (GYPB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [232]
EUGENOL DM7US1H Discovery agent N.A. Patented [5]
Drug(s) Affected By Procathepsin L (CTSL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [116]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [233]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Amodiaquine DME4RA8 Malaria 1F40-1F45 Approved [234]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [235]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [236]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [233]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [141]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [238]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [239]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Quercetin DM3NC4M Obesity 5B81 Approved [240]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [241]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [144]
Estrone DM5T6US Acne vulgaris ED80 Approved [239]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [242]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [243]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [244]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [178]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By C-C motif chemokine 2 (CCL2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [245]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [220]
Gefitinib DM15F0X Colon adenocarcinoma Approved [246]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [247]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [248]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [249]
TECFIDERA DM2OVDT Multiple sclerosis 8A40 Approved [89]
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [250]
Quercetin DM3NC4M Obesity 5B81 Approved [251]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Fos-related antigen 2 (FOSL2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [252]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [13]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [13]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Platelet glycoprotein 4 (CD36)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [253]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [254]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [255]
Tolcapone DM8MNVO Parkinson disease 8A00.0 Approved [256]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [257]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [258]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [146]
Asasantin DMCZIHT Cerebrovascular ischaemia 8B1Z Approved [259]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Selenium DM25CGV N. A. N. A. Approved [70]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [260]
Methotrexate DM2TEOL Anterior urethra cancer Approved [138]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [261]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [261]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Lumiracoxib DM1S4AG Chronic renal failure GB61.Z Approved [19]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [19]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [262]
Penbutolol DM4ES8F Hypertension BA00-BA04 Approved [19]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [19]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [19]
Nevirapine DM6HX9B Human immunodeficiency virus infection 1C62 Approved [19]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [263]
Etodolac DM6WJO9 Osteoarthritis FA00-FA05 Approved [19]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [150]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Arsenic DMTL2Y1 N. A. N. A. Approved [264]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [265]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [193]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Methotrexate DM2TEOL Anterior urethra cancer Approved [91]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [154]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [266]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [267]
Testosterone DM7HUNW Hot flushes GA30 Approved [268]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [169]
Menthol DMG2KW7 Back pain ME84.Z Approved [189]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [186]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [269]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Menthol DMG2KW7 Back pain ME84.Z Approved [189]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [270]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [62]
Quercetin DM3NC4M Obesity 5B81 Approved [271]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [272]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [273]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
Aminoglutethimide DMWFHMZ Cushing disease 5A70 Approved [274]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Syndecan-2 (SDC2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [275]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [169]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [276]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Paclitaxel DMLB81S Breast carcinoma Approved [277]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [278]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [279]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [174]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [258]
Ethanol DMDRQZU Chronic pain MG30 Approved [280]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [281]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [282]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [283]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [284]
Kanamycin DM2DMPO Bacteremia 1A73 Approved [285]
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [286]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [285]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [11]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [285]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [165]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [287]
Methotrexate DM2TEOL Anterior urethra cancer Approved [45]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [288]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [289]
Quercetin DM3NC4M Obesity 5B81 Approved [290]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [291]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [45]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [182]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [37]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [37]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [292]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [293]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [294]
Terbinafine DMI6HUW Fungal infection 1F29-1F2F Approved [295]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [293]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [25]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [296]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [297]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [252]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [13]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [13]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [105]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [298]
Selenium DM25CGV N. A. N. A. Approved [22]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [166]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [137]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [299]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [137]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [300]
Epigallocatechin gallate DMCGWBJ Hepatic fibrosis DB93.0 Phase 3 [301]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [302]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [303]
Gefitinib DM15F0X Colon adenocarcinoma Approved [304]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [305]
Selenium DM25CGV N. A. N. A. Approved [70]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [306]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [307]
Quercetin DM3NC4M Obesity 5B81 Approved [308]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [309]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [310]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [287]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [311]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [145]
Quizartinib DM8Y4JS Acute myeloid leukaemia 2A60 Approved [312]
Tofacitinib DMBS370 Rheumatoid arthritis FA20 Approved [313]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [314]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [170]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [315]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Ethanol DMDRQZU Chronic pain MG30 Approved [316]
Folic Acid DMEMBJC Colorectal carcinoma Approved [317]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [318]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [319]
Testosterone undecanoate DMZO10Y Hypogonadism 5A61.0 Approved [320]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Dipeptidyl peptidase 1 (CTSC)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [141]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [13]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [13]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [13]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [13]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [321]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [13]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cadherin-8 (CDH8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [141]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [322]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [159]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [39]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [323]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [196]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [182]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Folic Acid DMEMBJC Colorectal carcinoma Approved [136]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
Bortezomib DMNO38U Leukemia Approved [178]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [324]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein BTG1 (BTG1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Colchicine DM2POTE Acute gout flare FA25.0 Approved [132]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [144]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [325]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [145]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [35]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [144]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [326]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Mitoxantrone DMM39BF Acute myelogenous leukaemia 2A41 Approved [327]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [190]
Daunorubicin DMQUSBT Acute monocytic leukemia Approved [327]
Arsenic DMTL2Y1 N. A. N. A. Approved [328]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [329]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [171]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [200]
Selenium DM25CGV N. A. N. A. Approved [22]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [19]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [244]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [19]
Nevirapine DM6HX9B Human immunodeficiency virus infection 1C62 Approved [19]
Trihexyphenidyl DMB19L8 Dystonia 8A02 Approved [19]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [19]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [298]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [330]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [331]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [239]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [298]
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [150]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [332]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [333]
Estrone DM5T6US Acne vulgaris ED80 Approved [239]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [137]
Methotrexate DM2TEOL Anterior urethra cancer Approved [138]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Riboflavin DM8YMWE Acne vulgaris ED80 Approved [334]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [335]
Bortezomib DMNO38U Leukemia Approved [178]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [336]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [184]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [326]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Enzalutamide DMGL19D Prostate cancer 2C82.0 Approved [337]
Chloroquine DMSI5CB Malaria 1F40-1F45 Approved [338]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [324]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [147]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [147]
Arsenic DMTL2Y1 N. A. N. A. Approved [339]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [11]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Ergotidine DM78IME Osteoarthritis FA00-FA05 Approved [340]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [341]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [342]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Quercetin DM3NC4M Obesity 5B81 Approved [343]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [196]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Cholecalciferol DMGU74E Adult acute monocytic leukemia Approved [197]
Pioglitazone DMKJ485 Amyotrophic lateral sclerosis 8B60.0 Approved [344]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [345]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [342]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [346]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [346]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [347]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [348]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [235]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [346]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [326]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [349]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [40]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [350]
Capecitabine DMTS85L Adenocarcinoma 2D40 Approved [351]
Tegafur DM31ZQM Solid tumour/cancer 2A00-2F9Z Approved [352]
Flucytosine DM13VTW Cryptococcal meningitis Approved [54]
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [49]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [40]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [326]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [330]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Folic Acid DMEMBJC Colorectal carcinoma Approved [317]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [353]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [354]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [355]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [356]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [357]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [358]
Fluoxetine DM3PD2C Bipolar depression Approved [359]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [49]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [166]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Fibroleukin (FGL2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [343]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [244]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [276]
Arsenic DMTL2Y1 N. A. N. A. Approved [360]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [225]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [361]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [362]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [172]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [363]
Methotrexate DM2TEOL Anterior urethra cancer Approved [364]
Quercetin DM3NC4M Obesity 5B81 Approved [308]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Bleomycin DMNER5S Cervical cancer 2C77.0 Approved [363]
Bortezomib DMNO38U Leukemia Approved [178]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [45]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [365]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [39]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [366]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [45]
Prednisolone DMQ8FR2 Acute adrenal insufficiency Approved [45]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [45]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [137]
Methotrexate DM2TEOL Anterior urethra cancer Approved [138]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [13]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [13]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Homeobox protein TGIF1 (TGIF1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [367]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [145]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [368]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [318]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [162]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [158]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PMID27336223-Compound-5 DM6E50A N. A. N. A. Patented [162]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Pantothenic acid DM091H2 Vitamin deficiency 5B55-5B71 Approved [86]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [323]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [13]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [13]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [13]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [326]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
methyl p-hydroxybenzoate DMO58UW Discovery agent N.A. Investigative [369]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [370]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [365]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [341]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [170]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [330]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ethanol DMDRQZU Chronic pain MG30 Approved [371]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [341]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [159]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [372]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [373]
Drug(s) Affected By Embigin (EMB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [374]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
EUGENOL DM7US1H Discovery agent N.A. Patented [5]
Milchsaure DM462BT Pruritus EC90 Investigative [375]
methyl p-hydroxybenzoate DMO58UW Discovery agent N.A. Investigative [369]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [365]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [345]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [292]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [376]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [171]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [377]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [378]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [235]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [43]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [159]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [105]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [365]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [162]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [159]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [372]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
PMID27336223-Compound-5 DM6E50A N. A. N. A. Patented [162]
EUGENOL DM7US1H Discovery agent N.A. Patented [5]
3R14S-OCHRATOXIN A DM2KEW6 Discovery agent N.A. Investigative [379]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [326]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [149]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [380]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [84]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [8]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [381]
Tributylstannanyl DMHN7CB Discovery agent N.A. Investigative [382]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Splicing factor 45 (RBM17)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [164]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [383]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Mitoxantrone DMM39BF Acute myelogenous leukaemia 2A41 Approved [384]
Pemetrexed DMMX2E6 Central nervous system lymphoma 2B33.5 Approved [384]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [195]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [318]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Methotrexate DM2TEOL Anterior urethra cancer Approved [385]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [196]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Pioglitazone DMKJ485 Amyotrophic lateral sclerosis 8B60.0 Approved [344]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [362]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [386]
EUGENOL DM7US1H Discovery agent N.A. Patented [5]
MICROCYSTIN-LR DMTMLRN Discovery agent N.A. Investigative [387]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [170]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [353]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [335]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [171]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [302]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein C12orf4 (FERRY3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [115]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [70]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [386]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [193]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [388]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [195]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [389]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Ethanol DMDRQZU Chronic pain MG30 Approved [316]
Capsaicin DMGMF6V Back pain ME84.Z Approved [390]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [335]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [356]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [193]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [169]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [356]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [70]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
EUGENOL DM7US1H Discovery agent N.A. Patented [5]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [391]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [392]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [142]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By SLAM family member 8 (SLAMF8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [196]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [386]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [326]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [393]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [394]
EUGENOL DM7US1H Discovery agent N.A. Patented [5]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [26]
⏷ Show the Full List of 8 Drug(s)
Drug(s) Affected By F-box only protein 9 (FBXO9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [318]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [171]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [353]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Epigallocatechin gallate DMCGWBJ Hepatic fibrosis DB93.0 Phase 3 [397]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Sorting nexin-9 (SNX9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [193]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [171]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Peroxiredoxin-2 (PRDX2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [398]
Etretinate DM2CZFA Keratosis ED56 Approved [399]
Quercetin DM3NC4M Obesity 5B81 Approved [400]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [401]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [67]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Peroxiredoxin-1 (PRDX1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [402]
Etretinate DM2CZFA Keratosis ED56 Approved [399]
Methotrexate DM2TEOL Anterior urethra cancer Approved [91]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [49]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [266]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [144]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [34]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [144]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [403]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Gefitinib DM15F0X Colon adenocarcinoma Approved [404]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [137]
Selenium DM25CGV N. A. N. A. Approved [70]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [405]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [406]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [13]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [13]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [13]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [403]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [389]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
2-deoxyglucose DMIAHVU Solid tumour/cancer 2A00-2F9Z Approved [407]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [27]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [408]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [409]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [408]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [408]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Fluoxetine DM3PD2C Bipolar depression Approved [408]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [410]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Eicosapentaenoic acid/docosa-hexaenoic acid DMMUCG4 Hypertriglyceridemia 5C80.1 Approved [411]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [412]
Gamolenic acid DMQN30Z Allergy 4A80-4A85 Approved [413]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [414]
Flupentixol DM0DJ9O Schizophrenia 6A20 Approved [415]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [416]
Ibandronate DM0QZBN Hypercalcaemia 5B91.0 Approved [417]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [220]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [19]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [418]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [69]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Methotrexate DM2TEOL Anterior urethra cancer Approved [45]
Quercetin DM3NC4M Obesity 5B81 Approved [419]
Omeprazole DM471KJ Cystic fibrosis CA25 Approved [420]
Carfilzomib DM48K0X Multiple myeloma 2A83 Approved [421]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [45]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [422]
Etodolac DM6WJO9 Osteoarthritis FA00-FA05 Approved [423]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [424]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [126]
Dextropropoxyphene DM23HCX Pain MG30-MG3Z Approved [425]
Selenium DM25CGV N. A. N. A. Approved [70]
Naloxone DM3FXMA Narcotic depression 6A7Z Approved [426]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Tacrine DM51FY6 Alzheimer disease 8A20 Approved [427]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [428]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [429]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Gremlin-1 (GREM1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [200]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [244]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [430]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [220]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [431]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [432]
Quercetin DM3NC4M Obesity 5B81 Approved [433]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [434]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [435]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Aldosterone DM9S2JW Hypertension BA00-BA04 Approved [436]
Sanguinarine DMDINFS Dental plaque DA08.4 Approved [437]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein c-Fos (FOS)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [126]
Verapamil DMA7PEW Angina pectoris BA40 Approved [438]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [57]
Acebutolol DM0TI4U Hypertension BA00-BA04 Approved [438]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [212]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [298]
Methotrexate DM2TEOL Anterior urethra cancer Approved [439]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [440]
Quercetin DM3NC4M Obesity 5B81 Approved [441]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [442]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [443]
Quercetin DM3NC4M Obesity 5B81 Approved [444]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [80]
Nevirapine DM6HX9B Human immunodeficiency virus infection 1C62 Approved [445]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Calcitonin (CALCA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ranitidine DM0GUSX Gastric ulcer DA60 Approved [446]
Fructose DM43AN2 Vomiting MD90 Approved [205]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Folic Acid DMEMBJC Colorectal carcinoma Approved [317]
Nizatidine DMGFV3Z Acid-reflux disorder DA22 Approved [446]
Capsaicin DMGMF6V Back pain ME84.Z Approved [447]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [448]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [284]
Quercetin DM3NC4M Obesity 5B81 Approved [251]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [266]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [449]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [450]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [393]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Tofacitinib DMBS370 Rheumatoid arthritis FA20 Approved [451]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [172]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [452]
Etretinate DM2CZFA Keratosis ED56 Approved [453]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [454]
Methotrexate DM2TEOL Anterior urethra cancer Approved [91]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [455]
Quercetin DM3NC4M Obesity 5B81 Approved [456]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [122]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [457]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [11]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Stromelysin-1 (MMP3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [54]
Fluvastatin DM4MDJY Arteriosclerosis BD40 Approved [54]
Pravastatin DM6A0X7 Adult acute monocytic leukemia Approved [54]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [54]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [16]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [200]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [454]
Methotrexate DM2TEOL Anterior urethra cancer Approved [458]
Quercetin DM3NC4M Obesity 5B81 Approved [459]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [122]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [105]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [200]
Selenium DM25CGV N. A. N. A. Approved [22]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [37]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [45]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [9]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [460]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [91]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [145]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [35]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [169]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [105]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Selenium DM25CGV N. A. N. A. Approved [22]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [45]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [244]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [461]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [365]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tolbutamide DM02AWV Advanced cancer 2A00-2F9Z Approved [462]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [105]
Methotrexate DM2TEOL Anterior urethra cancer Approved [463]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [462]
Ethacrynic acid DM60QMR Edema MG29 Approved [464]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [167]
Trovafloxacin DM6AN32 Acute gonococcal cervicitis Approved [465]
Clonidine DM6RZ9Q Attention deficit hyperactivity disorder 6A05.Z Approved [462]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [466]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [276]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [366]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [324]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [467]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [154]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [275]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [468]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [365]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [27]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [44]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [469]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [470]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [471]
Quercetin DM3NC4M Obesity 5B81 Approved [472]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [473]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [188]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [27]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [59]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [470]
Quercetin DM3NC4M Obesity 5B81 Approved [474]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [187]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [333]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [323]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [475]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Selenium DM25CGV N. A. N. A. Approved [70]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [154]
Quercetin DM3NC4M Obesity 5B81 Approved [240]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [9]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [365]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [178]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [220]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [365]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [225]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [220]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [476]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [477]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [478]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [479]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [300]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [171]
Seocalcitol DMKL9QO Rickets 5B57 Phase 3 [477]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [62]
Selenium DM25CGV N. A. N. A. Approved [70]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [249]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [49]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [480]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [166]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [187]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [11]
Propylthiouracil DM6D7N8 Hyperthyroidism 5A02 Approved [249]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [137]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [323]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Metallothionein-2 (MT2A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [481]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [105]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [99]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [482]
Quercetin DM3NC4M Obesity 5B81 Approved [483]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [266]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [187]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [40]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [252]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [13]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 1A1 (CYP1A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amodiaquine DME4RA8 Malaria 1F40-1F45 Approved [484]
Riluzole DMECBWN Amyotrophic lateral sclerosis 8B60.0 Approved [485]
Flutamide DMK0O7U Prostate cancer 2C82.0 Approved [486]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [487]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [488]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [266]
Ethacrynic acid DM60QMR Edema MG29 Approved [489]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [103]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [490]
Clofibrate DMPC1J7 Dysbetalipoproteinemia 5C80.2 Approved [491]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Meclofenamic acid DM05FXR Ankylosing spondylitis FA92.0 Approved [492]
Diazepam DM08E9O Alcohol withdrawal Approved [493]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [99]
Salicyclic acid DM2F8XZ Acne vulgaris ED80 Approved [494]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [492]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [495]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [492]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [496]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [27]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [220]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Salicyclic acid DM2F8XZ Acne vulgaris ED80 Approved [494]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [49]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [174]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [27]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [99]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [174]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [13]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [6]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [137]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [470]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [149]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [497]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [450]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Reserpine DM6VM38 Hypertension BA00-BA04 Approved [498]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [365]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [6]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [499]
Ketoprofen DMRKXPT Bursitis Approved [54]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [500]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [501]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [470]
Quercetin DM3NC4M Obesity 5B81 Approved [502]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [49]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [503]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [187]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [163]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Superoxide dismutase (SOD1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [504]
Haloperidol DM96SE0 Delirium Approved [54]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [69]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [58]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [20]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [505]
SPI-1005 DM6XFHS Reperfusion injury ND56.Z Approved [506]
Methotrexate DM2TEOL Anterior urethra cancer Approved [507]
Epinephrine DM3KJBC Acute asthma CA23 Approved [47]
Quercetin DM3NC4M Obesity 5B81 Approved [508]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Ferritin light chain (FTL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [27]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [99]
Selenium DM25CGV N. A. N. A. Approved [70]
TECFIDERA DM2OVDT Multiple sclerosis 8A40 Approved [28]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [405]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [6]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Ethanol DMDRQZU Chronic pain MG30 Approved [509]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Catalase (CAT)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [20]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [510]
Haloperidol DM96SE0 Delirium Approved [54]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [500]
Selenium DM25CGV N. A. N. A. Approved [511]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [512]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [513]
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [514]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [91]
Quercetin DM3NC4M Obesity 5B81 Approved [400]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [515]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [196]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [6]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [499]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [516]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [469]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [34]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [6]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Bosentan DMIOGBU Pulmonary arterial hypertension BB01.0 Approved [517]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [54]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [164]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [220]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [501]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [470]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [518]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [167]
Glutathione DMAHMT9 Human immunodeficiency virus infection 1C62 Approved [519]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [6]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
Benzoic Acid DMKB9FI Alopecia areata ED70.2 Approved [6]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [27]
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [49]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [6]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [520]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [298]
Selenium DM25CGV N. A. N. A. Approved [70]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [521]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [13]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [13]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [6]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [13]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
Benzoic Acid DMKB9FI Alopecia areata ED70.2 Approved [6]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Meclofenamic acid DM05FXR Ankylosing spondylitis FA92.0 Approved [492]
Diazepam DM08E9O Alcohol withdrawal Approved [493]
Levonorgestrel DM1DP7T Atypical endometrial hyperplasia Approved [522]
Desogestrel DM27U4Y Contraception QA21 Approved [522]
Salicyclic acid DM2F8XZ Acne vulgaris ED80 Approved [492]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [492]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [523]
Quercetin DM3NC4M Obesity 5B81 Approved [524]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [27]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [99]
Selenium DM25CGV N. A. N. A. Approved [70]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [470]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [323]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [13]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [13]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [6]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [6]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Methylene blue DMJAPE7 Acquired methemoglobinemia 3A93 Approved [525]
Benzoic Acid DMKB9FI Alopecia areata ED70.2 Approved [6]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Metallothionein-1X (MT1X)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [85]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [99]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [526]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [187]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [40]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Progesterone DMUY35B Amenorrhea GA20.0 Approved [527]
Meclofenamic acid DM05FXR Ankylosing spondylitis FA92.0 Approved [492]
Diazepam DM08E9O Alcohol withdrawal Approved [493]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [489]
Salicyclic acid DM2F8XZ Acne vulgaris ED80 Approved [492]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [492]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [154]
Glimepiride DM5FSJA Diabetic complication 5A2Y Approved [528]
Ethacrynic acid DM60QMR Edema MG29 Approved [489]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [492]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [27]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [137]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [529]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [6]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Sulfiredoxin-1 (SRXN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [27]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [450]
Ethacrynic acid DM60QMR Edema MG29 Approved [464]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [166]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [13]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [13]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [364]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [145]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [35]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [182]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [345]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [530]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [35]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [82]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [531]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [532]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [531]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [147]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [533]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [534]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [535]
Dinoprostone DMTYOPD Medical abortion JA00.1Z Approved [536]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [537]
I3C DMIGFOR Breast cancer 2C60-2C65 Phase 3 [538]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [539]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [537]
EUGENOL DM7US1H Discovery agent N.A. Patented [534]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [142]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [99]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [225]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [372]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
EUGENOL DM7US1H Discovery agent N.A. Patented [345]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [142]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [85]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [137]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [540]
Methotrexate DM2TEOL Anterior urethra cancer Approved [541]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [542]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [543]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [101]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [144]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [187]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Bortezomib DMNO38U Leukemia Approved [178]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [184]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [195]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [544]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Affected By Toll-like receptor 4 (TLR4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [286]
Quercetin DM3NC4M Obesity 5B81 Approved [545]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Glutathione DMAHMT9 Human immunodeficiency virus infection 1C62 Approved [546]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [547]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [286]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [13]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Hyaluronan synthase 3 (HAS3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [141]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [365]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [478]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [115]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [39]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [195]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [150]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [405]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [321]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Epanova DMHEAGL Hypertriglyceridemia 5C80.1 Approved [548]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [190]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [549]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [550]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [403]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [169]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [551]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [552]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Paclitaxel DMLB81S Breast carcinoma Approved [385]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [70]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [195]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [195]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [553]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [394]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [195]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [326]
Selenium DM25CGV N. A. N. A. Approved [70]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [275]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [342]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [35]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Arsenic DMTL2Y1 N. A. N. A. Approved [339]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [554]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [555]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [296]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [117]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [556]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [555]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Importin-8 (IPO8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [557]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [549]
Geldanamycin DMS7TC5 Kidney cancer 2C90.0 Discontinued in Phase 2 [141]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [26]
Milchsaure DM462BT Pruritus EC90 Investigative [375]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [558]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Vitamin C DMXJ7O8 Adenocarcinoma 2D40 Approved [558]
Afimoxifene DMFORDT Breast cancer 2C60-2C65 Phase 2 [559]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [560]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [170]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [561]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [170]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [550]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [356]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [184]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
PEITC DMOMN31 Prostate cancer 2C82.0 Phase 2 [562]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
3R14S-OCHRATOXIN A DM2KEW6 Discovery agent N.A. Investigative [563]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [564]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Enzalutamide DMGL19D Prostate cancer 2C82.0 Approved [354]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [299]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Nardilysin (NRDC)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [169]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [565]
3R14S-OCHRATOXIN A DM2KEW6 Discovery agent N.A. Investigative [565]
Milchsaure DM462BT Pruritus EC90 Investigative [375]
GALLICACID DM6Y3A0 Discovery agent N.A. Investigative [566]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [567]
Tributylstannanyl DMHN7CB Discovery agent N.A. Investigative [565]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [126]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [353]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [354]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By RNA helicase aquarius (AQR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [170]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [170]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [386]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [326]
Milchsaure DM462BT Pruritus EC90 Investigative [375]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [568]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [319]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Periplakin (PPL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [8]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [235]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [569]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Fluoxetine DM3PD2C Bipolar depression Approved [359]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [49]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [401]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [146]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [244]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [318]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [115]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [329]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Sorting nexin-2 (SNX2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [198]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [335]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [389]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Filamin-B (FLNB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [37]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [570]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [117]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Ethanol DMDRQZU Chronic pain MG30 Approved [316]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [561]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Selenium DM25CGV N. A. N. A. Approved [70]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [8]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [571]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
Methotrexate DM2TEOL Anterior urethra cancer Approved [385]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [70]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [126]
Quercetin DM3NC4M Obesity 5B81 Approved [572]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [49]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [573]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [341]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [35]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [13]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [13]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [13]
Ibrutinib DMHZCPO Mantle cell lymphoma 2A85.5 Approved [574]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [335]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [115]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [269]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [195]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [26]
AHPN DM8G6O4 Discovery agent N.A. Investigative [575]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
Topotecan DMP6G8T Central nervous system neoplasm Approved [385]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [365]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Clozapine DMFC71L Schizophrenia 6A20 Approved [164]
Bortezomib DMNO38U Leukemia Approved [178]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [193]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [70]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [576]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Indomethacin DMSC4A7 Bursitis Approved [577]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [569]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [225]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Importin-7 (IPO7)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [252]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [557]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [335]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [318]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [232]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [9]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [9]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [578]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [199]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [579]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
all-trans-4-oxo-retinoic acid DMM2R1N Discovery agent N.A. Investigative [9]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [141]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [478]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [580]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Indomethacin DMSC4A7 Bursitis Approved [577]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Arsenic DMTL2Y1 N. A. N. A. Approved [581]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [544]
chloropicrin DMSGBQA Discovery agent N.A. Investigative [582]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Bortezomib DMNO38U Leukemia Approved [178]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
SB-431542 DM0YOXQ Pulmonary fibrosis CB03.4 Preclinical [161]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [388]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [169]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [556]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [195]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [544]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [583]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [326]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [540]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [584]
Quercetin DM3NC4M Obesity 5B81 Approved [585]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [586]
Clonidine DM6RZ9Q Attention deficit hyperactivity disorder 6A05.Z Approved [587]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [588]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [405]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [589]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [195]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Arsenic DMTL2Y1 N. A. N. A. Approved [590]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [115]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
Fenretinide DMRD5SP Macular degeneration 9B78.3 Phase 3 [591]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [592]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
BIBW 2992 DMTKD7Q Non-small-cell lung cancer 2C25.Y Approved [593]
Gefitinib DM15F0X Colon adenocarcinoma Approved [594]
Erlotinib DMCMBHA Adrenal gland neoplasm Approved [595]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [596]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [597]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [598]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [57]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Selenium DM25CGV N. A. N. A. Approved [120]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [599]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [144]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [564]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [144]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Complement C3 (C3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [220]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [200]
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [37]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [149]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [515]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [600]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [37]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tumor necrosis factor (TNF)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indomethacin DMSC4A7 Bursitis Approved [601]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [602]
Fructose DM43AN2 Vomiting MD90 Approved [54]
Ketoprofen DMRKXPT Bursitis Approved [54]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [370]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [603]
Baclofen DM0QV1J Multiple sclerosis 8A40 Approved [604]
Gefitinib DM15F0X Colon adenocarcinoma Approved [605]
Ganciclovir DM1MBYQ Cytomegalovirus infection 1D82 Approved [606]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [247]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interleukin-1 alpha (IL1A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [105]
Primidone DM0WX6I Epilepsy 8A60-8A68 Approved [19]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [19]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [247]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [19]
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Quercetin DM3NC4M Obesity 5B81 Approved [308]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [19]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [266]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [607]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [9]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [117]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [608]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Folic Acid DMEMBJC Colorectal carcinoma Approved [609]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [9]
Bexarotene DMOBIKY Cutaneous T-cell lymphoma 2B01 Approved [610]
Methamphetamine DMPM4SK Anxiety Approved [611]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [607]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [9]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [133]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [196]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [612]
Pioglitazone DMKJ485 Amyotrophic lateral sclerosis 8B60.0 Approved [344]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [9]
Arsenic DMTL2Y1 N. A. N. A. Approved [613]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [192]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Prelamin-A/C (LMNA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Methotrexate DM2TEOL Anterior urethra cancer Approved [91]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [614]
Quercetin DM3NC4M Obesity 5B81 Approved [615]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [616]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [429]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Albumin (ALB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Sulfamethoxazole DMB08GE Acute otitis media AB00 Approved [54]
Tolbutamide DM02AWV Advanced cancer 2A00-2F9Z Approved [617]
Diazepam DM08E9O Alcohol withdrawal Approved [618]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [619]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [620]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [621]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [622]
Methotrexate DM2TEOL Anterior urethra cancer Approved [623]
Quercetin DM3NC4M Obesity 5B81 Approved [624]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Estrogen receptor (ESR1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [625]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [626]
Gefitinib DM15F0X Colon adenocarcinoma Approved [627]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [628]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [596]
Liraglutide DM3FXPS Non-insulin dependent diabetes 5A11 Approved [629]
Quercetin DM3NC4M Obesity 5B81 Approved [630]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [631]
Procaine DM4LSNE Anaesthesia 9A78.6 Approved [628]
Estrone DM5T6US Acne vulgaris ED80 Approved [632]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [607]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [196]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [184]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [300]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [633]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [374]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PD-153035 DM7KJTI Psoriasis vulgaris EA90 Discontinued in Phase 1 [607]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [634]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [68]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [62]
Selenium DM25CGV N. A. N. A. Approved [70]
Methotrexate DM2TEOL Anterior urethra cancer Approved [107]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [187]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [564]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [635]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [158]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [636]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [200]
Spironolactone DM2AQ5N Chronic heart failure BD1Z Approved [201]
Methotrexate DM2TEOL Anterior urethra cancer Approved [637]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [638]
Quercetin DM3NC4M Obesity 5B81 Approved [639]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [49]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [640]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [174]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [123]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [571]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [273]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [356]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [54]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interleukin-6 (IL6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [45]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [641]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [105]
Pantothenic acid DM091H2 Vitamin deficiency 5B55-5B71 Approved [86]
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [245]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [247]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [21]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [469]
Methotrexate DM2TEOL Anterior urethra cancer Approved [45]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [642]
Dicloxacillin DM8EU0Z Bacterial infection 1A00-1C4Z Approved [642]
Ergonovine DM0VEC1 Postpartum haemorrhage JA43 Approved [54]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [643]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [644]
Mizolastine DM1FDN8 Allergic rhinitis CA08.0 Approved [645]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [646]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [647]
Salicyclic acid DM2F8XZ Acne vulgaris ED80 Approved [648]
TECFIDERA DM2OVDT Multiple sclerosis 8A40 Approved [89]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [649]
Quercetin DM3NC4M Obesity 5B81 Approved [615]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [323]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [614]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [649]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [13]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [13]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [292]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [358]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [40]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [403]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Benzatropine DMF7EXL Parkinsonian disorder Approved [164]
Clozapine DMFC71L Schizophrenia 6A20 Approved [164]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [169]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [236]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [54]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PP-242 DM2348V Discovery agent N.A. Investigative [650]
Deguelin DMXT7WG Esophageal squamous cell carcinoma 2E60.1 Investigative [651]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [253]
Etretinate DM2CZFA Keratosis ED56 Approved [399]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [253]
Quercetin DM3NC4M Obesity 5B81 Approved [36]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [49]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [253]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [187]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [253]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Involucrin (IVL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcipotriol DM03CP7 Psoriasis EA90 Approved [652]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [69]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [653]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [117]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [654]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [652]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [655]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [656]
Vitamin A DMJ2AH4 Night blindness 9D45 Approved [69]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Prosaposin (PSAP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [144]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [144]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Paclitaxel DMLB81S Breast carcinoma Approved [657]
Bortezomib DMNO38U Leukemia Approved [178]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [318]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [13]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [13]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [13]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [13]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Tetracaine DM9J6C2 Spinal anesthesia MB40.3 Approved [658]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Folic Acid DMEMBJC Colorectal carcinoma Approved [659]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcipotriol DM03CP7 Psoriasis EA90 Approved [652]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [607]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Tofacitinib DMBS370 Rheumatoid arthritis FA20 Approved [660]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [578]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Busulfan DMXYJ9C Chronic myelogenous leukaemia 2A20.0 Approved [661]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [662]
Chlorambucil DMRKE63 Chronic lymphocytic leukaemia 2A82.0 Approved [662]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [663]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [27]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [298]
Selenium DM25CGV N. A. N. A. Approved [70]
Etretinate DM2CZFA Keratosis ED56 Approved [399]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [664]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [665]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Poly polymerase 1 (PARP1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [105]
Gefitinib DM15F0X Colon adenocarcinoma Approved [666]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [667]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [540]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [668]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [131]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [668]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [669]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [670]
Methotrexate DM2TEOL Anterior urethra cancer Approved [671]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [672]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [85]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [57]
Gefitinib DM15F0X Colon adenocarcinoma Approved [18]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [99]
Selenium DM25CGV N. A. N. A. Approved [70]
Etretinate DM2CZFA Keratosis ED56 Approved [399]
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [266]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [172]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [673]
Arsenic DMTL2Y1 N. A. N. A. Approved [674]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [673]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [675]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [676]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [677]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interleukin-8 (CXCL8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [678]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [679]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [680]
Pantothenic acid DM091H2 Vitamin deficiency 5B55-5B71 Approved [86]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [56]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [17]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [19]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [20]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [681]
Lumiracoxib DM1S4AG Chronic renal failure GB61.Z Approved [19]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By C-C motif chemokine 3 (CCL3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [245]
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [266]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [101]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [296]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [244]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [682]
Betamethasone DMAHJEF Acute adrenal insufficiency Approved [683]
Emetine DMCT2YF Hepatitis virus infection 1E50-1E51 Approved [683]
Nelfinavir mesylate DMFX6G8 N. A. N. A. Approved [245]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [684]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [685]
Allopurinol DMLPAOB Gout FA25 Approved [686]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [225]
Ticlopidine DMO946V Acute coronary syndrome BA41 Approved [687]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [298]
Selenium DM25CGV N. A. N. A. Approved [70]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [323]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [182]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [40]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [499]
Mitotane DMU1GX0 Adrenocortical carcinoma 2D11.Z Approved [688]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [689]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [690]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [335]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
NVP-AUY922 DMTYXQF Multiple myeloma 2A83 Phase 2 [691]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [165]
Etretinate DM2CZFA Keratosis ED56 Approved [399]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Quercetin DM3NC4M Obesity 5B81 Approved [615]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [266]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [144]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [692]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [187]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [188]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Proto-oncogene DBL (MCF2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [149]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [190]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [577]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [303]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [57]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [165]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Etretinate DM2CZFA Keratosis ED56 Approved [399]
Quercetin DM3NC4M Obesity 5B81 Approved [615]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [296]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [269]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [103]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [693]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [35]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [694]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [695]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Vinblastine DM5TVS3 Advanced cancer 2A00-2F9Z Approved [385]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [391]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [147]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [147]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [126]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [696]
Scopolamine DMOM8AL Addictive disorder 6C50-6C5Z Approved [697]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [322]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Arsenic DMTL2Y1 N. A. N. A. Approved [698]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Nucleoprotein TPR (TPR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [62]
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [195]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [699]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Benzatropine DMF7EXL Parkinsonian disorder Approved [164]
Clozapine DMFC71L Schizophrenia 6A20 Approved [164]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Annexin A3 (ANXA3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [154]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [37]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [37]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Ski-like protein (SKIL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [82]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [147]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Arsenic DMTL2Y1 N. A. N. A. Approved [328]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [700]
SPI-1005 DM6XFHS Reperfusion injury ND56.Z Approved [701]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [702]
Mitotane DMU1GX0 Adrenocortical carcinoma 2D11.Z Approved [703]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [704]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [54]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By C-C motif chemokine 4 (CCL4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [266]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [101]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [682]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [35]
Betamethasone DMAHJEF Acute adrenal insufficiency Approved [683]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [365]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Emetine DMCT2YF Hepatitis virus infection 1E50-1E51 Approved [683]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [291]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [705]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [706]
Bicalutamide DMZMSPF Prostate cancer 2C82.0 Approved [707]
Paclitaxel DMLB81S Breast carcinoma Approved [385]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [39]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By C-C motif chemokine 5 (CCL5)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [58]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [708]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [284]
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [533]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [449]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [682]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [263]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [607]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [9]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [608]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [196]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [612]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [9]
Bexarotene DMOBIKY Cutaneous T-cell lymphoma 2B01 Approved [610]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [335]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [709]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [556]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [171]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [354]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Pyruvate kinase PKM (PKM)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [62]
Selenium DM25CGV N. A. N. A. Approved [70]
Epinephrine DM3KJBC Acute asthma CA23 Approved [710]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [405]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [711]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [550]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [429]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [403]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Myosin light chain 6B (MYL6B)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [252]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [292]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [147]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [147]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [376]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Insulin-degrading enzyme (IDE)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [303]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [712]
Bortezomib DMNO38U Leukemia Approved [178]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [147]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [147]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Ezrin (EZR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [164]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Selenium DM25CGV N. A. N. A. Approved [70]
Methotrexate DM2TEOL Anterior urethra cancer Approved [91]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [40]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [713]
Haloperidol DM96SE0 Delirium Approved [164]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Fos-related antigen 1 (FOSL1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [200]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [174]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [108]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [515]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [714]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [252]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Aspirin DM672AH Acute coronary syndrome BA41 Approved [715]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [716]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [59]
Selenium DM25CGV N. A. N. A. Approved [70]
Methotrexate DM2TEOL Anterior urethra cancer Approved [364]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [717]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [718]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [718]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [719]
Ergotidine DM78IME Osteoarthritis FA00-FA05 Approved [720]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [721]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [116]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [588]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [722]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [723]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [724]
Dacarbazine DMNPZL4 Adenocarcinoma 2D40 Approved [725]
Topotecan DMP6G8T Central nervous system neoplasm Approved [726]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Folic Acid DMEMBJC Colorectal carcinoma Approved [317]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [225]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [184]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Penfluridol DMG1DTE Schizophrenia 6A20 Approved [727]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [70]
PP-242 DM2348V Discovery agent N.A. Investigative [650]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [40]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Benzoic Acid DMKB9FI Alopecia areata ED70.2 Approved [728]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [353]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [80]
Seocalcitol DMKL9QO Rickets 5B57 Phase 3 [477]
URSOLIC ACID DM4SOAW Metabolic syndrome x 5C50-5D2Z Phase 2 [729]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [394]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [85]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [99]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [330]
Methotrexate DM2TEOL Anterior urethra cancer Approved [730]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [154]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [482]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [149]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [187]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [51]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [612]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [731]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [115]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [732]
Sulforaphane DMQY3L0 Skin disease EA00-EM0Z Investigative [733]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [84]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [713]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [57]
Gefitinib DM15F0X Colon adenocarcinoma Approved [734]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [298]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [735]
Methotrexate DM2TEOL Anterior urethra cancer Approved [507]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [288]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [228]
Quercetin DM3NC4M Obesity 5B81 Approved [308]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Filamin-A (FLNA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [736]
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [403]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [737]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [150]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [40]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Clozapine DMFC71L Schizophrenia 6A20 Approved [164]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [38]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Lenalidomide DM6Q7U4 Adult T-cell leukemia/lymphoma Approved [738]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [738]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [739]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [740]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [694]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [741]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Tamibarotene DM3G74J T-cell leukaemia 2A90 Phase 3 [168]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Benzoic Acid DMKB9FI Alopecia areata ED70.2 Approved [728]
Aminoglutethimide DMWFHMZ Cushing disease 5A70 Approved [274]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [742]
Vinblastine DM5TVS3 Advanced cancer 2A00-2F9Z Approved [385]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [385]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [70]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [743]
Quercetin DM3NC4M Obesity 5B81 Approved [195]
Panobinostat DM58WKG Chronic graft versus host disease Approved [362]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [330]
Deferasirox DM6ETS0 Beta thalassemia 3A50.2 Approved [744]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [745]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [746]
Teriflunomide DMQ2FKJ Hyperlipidaemia 5C80 Approved [747]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [748]
Arsenic DMTL2Y1 N. A. N. A. Approved [749]
Curcumin DMQPH29 Solid tumour/cancer 2A00-2F9Z Phase 3 [750]
PBI-05204 DM05WIU Pancreatic cancer 2C10 Phase 2 [751]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [70]
phorbol 12-myristate 13-acetate DMJWD62 Acute myeloid leukaemia 2A60 Phase 2 [752]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [374]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [172]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [137]
Quercetin DM3NC4M Obesity 5B81 Approved [308]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [150]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [108]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [252]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [164]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [753]
Quercetin DM3NC4M Obesity 5B81 Approved [754]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [133]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [755]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [42]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [403]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [756]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [292]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [16]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [286]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [757]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [550]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [758]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [286]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [759]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Moesin (MSN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [117]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [737]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [383]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Catenin alpha-2 (CTNNA2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [159]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [354]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [39]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [302]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [195]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [173]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [760]
Cladribine DM3JDRP Hairy cell leukaemia 2A82.2 Approved [761]
Quercetin DM3NC4M Obesity 5B81 Approved [419]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [762]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [763]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [764]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [765]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [242]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [164]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [165]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [13]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [13]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [766]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [767]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [716]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [603]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [768]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [769]
Secobarbital DM14RF5 Epilepsy 8A60-8A68 Approved [770]
Gefitinib DM15F0X Colon adenocarcinoma Approved [771]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [772]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [773]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Calnexin (CANX)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [187]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [145]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [774]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Efavirenz DMC0GSJ Human immunodeficiency virus infection 1C62 Approved [775]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Motexafin gadolinium DMEJKRF Brain cancer 2A00 Approved [187]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ethanol DMDRQZU Chronic pain MG30 Approved [776]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [767]
Carvedilol DMHTEAO Chronic heart failure BD1Z Approved [777]
Paclitaxel DMLB81S Breast carcinoma Approved [778]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [779]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [766]
Urokinase DM0GOUD Myocardial infarction BA41-BA43 Approved [54]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [16]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [603]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [768]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tripeptidyl-peptidase 2 (TPP2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [780]
Hydroxyurea DMOQVU9 Chronic myelogenous leukaemia 2A20.0 Approved [780]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [780]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [781]
Torcetrapib DMDHYM7 Hyperlipidaemia 5C80 Discontinued in Phase 2 [782]
Geldanamycin DMS7TC5 Kidney cancer 2C90.0 Discontinued in Phase 2 [141]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [544]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Transketolase (TKT)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [470]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [405]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [783]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Caspase-1 (CASP1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [16]
Gefitinib DM15F0X Colon adenocarcinoma Approved [18]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [784]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [21]
Salicyclic acid DM2F8XZ Acne vulgaris ED80 Approved [648]
Quercetin DM3NC4M Obesity 5B81 Approved [343]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [405]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [116]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [785]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [406]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [49]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [365]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [170]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [318]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [786]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [786]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [252]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [146]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [478]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [299]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Adenylosuccinate lyase (ADSL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [178]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [592]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [372]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [100]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [117]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Tofacitinib DMBS370 Rheumatoid arthritis FA20 Approved [787]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [788]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Arsenic DMTL2Y1 N. A. N. A. Approved [789]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [620]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [330]
Quercetin DM3NC4M Obesity 5B81 Approved [585]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [49]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [330]
Testosterone DM7HUNW Hot flushes GA30 Approved [790]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Menthol DMG2KW7 Back pain ME84.Z Approved [189]
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [791]
Paclitaxel DMLB81S Breast carcinoma Approved [792]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [793]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [515]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [68]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [794]
Haloperidol DM96SE0 Delirium Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Tubocurarine DMBZIVP Anaesthesia 9A78.6 Approved [795]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Benzatropine DMF7EXL Parkinsonian disorder Approved [164]
Clozapine DMFC71L Schizophrenia 6A20 Approved [164]
Mecamylamine DMGQFYB Essential hypertension BA00 Approved [795]
Paclitaxel DMLB81S Breast carcinoma Approved [796]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [690]
Nabiximols DMHKJ5I Cancer related pain MG30 Phase 3 [797]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [781]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [392]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [326]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [49]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [798]
Tolcapone DM8MNVO Parkinson disease 8A00.0 Approved [256]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [13]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [13]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [13]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [172]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [137]
Selenium DM25CGV N. A. N. A. Approved [70]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [51]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [108]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [141]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Catenin alpha-1 (CTNNA1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [298]
Selenium DM25CGV N. A. N. A. Approved [70]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Quercetin DM3NC4M Obesity 5B81 Approved [343]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [144]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [11]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [144]
Haloperidol DM96SE0 Delirium Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [169]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Radixin (RDX)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Haloperidol DM96SE0 Delirium Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [568]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [53]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [192]
Topotecan DMP6G8T Central nervous system neoplasm Approved [385]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Pro-adrenomedullin (ADM)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [126]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [799]
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [800]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [365]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [84]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Myosin-9 (MYH9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [615]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [291]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [801]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [737]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [85]
Triacetin DM0AEPG Onychomycosis EE12.1 Approved [802]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [57]
Bepridil DM0RKS4 Chronic/stable angina BA40.1 Approved [803]
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [253]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [99]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [804]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [805]
Methotrexate DM2TEOL Anterior urethra cancer Approved [138]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Myosin-11 (MYH11)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [806]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [612]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [276]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [190]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [147]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [147]
Nifedipine DMSVOZT Angina pectoris BA40 Approved [807]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [69]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [69]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [478]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [366]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [690]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [808]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [809]
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [195]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [810]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [811]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [145]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [401]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [174]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [42]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Arsenic DMTL2Y1 N. A. N. A. Approved [264]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Epigallocatechin gallate DMCGWBJ Hepatic fibrosis DB93.0 Phase 3 [301]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [70]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [302]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [812]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [149]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [335]
Bortezomib DMNO38U Leukemia Approved [178]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [70]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Glycine--tRNA ligase (GARS1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Gefitinib DM15F0X Colon adenocarcinoma Approved [734]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [291]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [252]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [13]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [13]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [13]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [244]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [330]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [252]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [13]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [13]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [13]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [165]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [99]
Quercetin DM3NC4M Obesity 5B81 Approved [195]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [141]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [172]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [813]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [108]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [814]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [276]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [91]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [815]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [40]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Clozapine DMFC71L Schizophrenia 6A20 Approved [164]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [816]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [55]
Gefitinib DM15F0X Colon adenocarcinoma Approved [605]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [44]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [60]
Quercetin DM3NC4M Obesity 5B81 Approved [308]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [692]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [817]
Vinblastine DM5TVS3 Advanced cancer 2A00-2F9Z Approved [60]
Ethacrynic acid DM60QMR Edema MG29 Approved [818]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Levonorgestrel DM1DP7T Atypical endometrial hyperplasia Approved [819]
Methotrexate DM2TEOL Anterior urethra cancer Approved [138]
Quercetin DM3NC4M Obesity 5B81 Approved [195]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [51]
Remdesivir DMBFZ6L Coronavirus Disease 2019 (COVID-19) 1D6Y Approved [820]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [108]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [821]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [822]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Probable 28S rRNA (NOP2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [184]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [184]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [302]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Crk-like protein (CRKL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [823]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [824]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [825]
Sorafenib DMS8IFC Adenocarcinoma 2D40 Approved [826]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [193]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Rigosertib DMOSTXF Myelodysplastic syndrome 2A37 Phase 3 [827]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [394]
PMID25656651-Compound-5 DMAI95U Chronic myeloid leukaemia 2A20 Patented [828]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [165]
Quercetin DM3NC4M Obesity 5B81 Approved [100]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [829]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [403]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Folic Acid DMEMBJC Colorectal carcinoma Approved [317]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Glycogenin-1 (GYG1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [159]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [145]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [169]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [318]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [795]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [302]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Quercetin DM3NC4M Obesity 5B81 Approved [100]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [571]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Folic Acid DMEMBJC Colorectal carcinoma Approved [317]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [607]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [578]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [184]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [171]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PD-153035 DM7KJTI Psoriasis vulgaris EA90 Discontinued in Phase 1 [607]
chloropicrin DMSGBQA Discovery agent N.A. Investigative [830]
⏷ Show the Full List of 8 Drug(s)
Drug(s) Affected By Fatty acid synthase (FASN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Lindane DMB8CNL Infestations of lice and scabies 1G00.Z Approved [831]
Selenium DM25CGV N. A. N. A. Approved [70]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [620]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [253]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [832]
Quercetin DM3NC4M Obesity 5B81 Approved [358]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [49]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [833]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [834]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Deoxyhypusine synthase (DHPS)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [835]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [795]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [169]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [269]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [403]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [571]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [302]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [269]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [13]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [13]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [169]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Clozapine DMFC71L Schizophrenia 6A20 Approved [164]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [13]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [147]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Clavulanate DM2FGRT Bacteremia 1A73 Approved [54]
Amoxicillin DMUYNEI Acute otitis media AB00 Approved [54]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Arsenic DMTL2Y1 N. A. N. A. Approved [836]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [837]
MLN4924 DMP36KD Myelodysplastic syndrome 2A37 Phase 3 [838]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [374]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [142]
Nickel chloride DMI12Y8 Discovery agent N.A. Investigative [839]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [105]
Quercetin DM3NC4M Obesity 5B81 Approved [308]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [51]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [123]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [840]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By RNA-binding protein 25 (RBM25)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [699]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [318]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [795]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [158]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By GMP synthase (GMPS)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [269]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [335]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [394]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [195]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [195]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [841]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [695]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [335]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Emerin (EMD)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [801]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Ethanol DMDRQZU Chronic pain MG30 Approved [316]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [195]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [195]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Paclitaxel DMLB81S Breast carcinoma Approved [842]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [335]
Orlistat DMRJSP8 Obesity 5B81 Approved [842]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [560]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Aminoglutethimide DMWFHMZ Cushing disease 5A70 Approved [274]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [589]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [195]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [326]
Okadaic acid DM47CO1 Discovery agent N.A. Investigative [843]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Lindane DMB8CNL Infestations of lice and scabies 1G00.Z Approved [844]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [571]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Menthol DMG2KW7 Back pain ME84.Z Approved [189]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [845]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Bortezomib DMNO38U Leukemia Approved [846]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [366]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Paclitaxel DMLB81S Breast carcinoma Approved [657]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [147]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [147]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Arsenic DMTL2Y1 N. A. N. A. Approved [339]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estrone DM5T6US Acne vulgaris ED80 Approved [847]
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [847]
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [117]
Haloperidol DM96SE0 Delirium Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [169]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [149]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [57]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Capsaicin DMGMF6V Back pain ME84.Z Approved [848]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [578]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [165]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [849]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [557]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [850]
Palbociclib DMD7L94 Breast cancer 2C60-2C65 Approved [851]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [172]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [132]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By ATP-citrate synthase (ACLY)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [253]
Quercetin DM3NC4M Obesity 5B81 Approved [419]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [149]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [852]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [853]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [198]
OPC-34712 DMHG57U Major depressive disorder 6A70.3 Approved [854]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [150]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [117]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Milchsaure DM462BT Pruritus EC90 Investigative [375]
methyl p-hydroxybenzoate DMO58UW Discovery agent N.A. Investigative [369]
chloropicrin DMSGBQA Discovery agent N.A. Investigative [582]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [105]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Quercetin DM3NC4M Obesity 5B81 Approved [100]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [101]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [117]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [34]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [252]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By NHP2-like protein 1 (SNU13)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [117]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [336]
Arsenic DMTL2Y1 N. A. N. A. Approved [590]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [70]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PP-242 DM2348V Discovery agent N.A. Investigative [650]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [388]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [800]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Bortezomib DMNO38U Leukemia Approved [800]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [181]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Affected By Actin, cytoplasmic 1 (ACTB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [298]
Selenium DM25CGV N. A. N. A. Approved [70]
Etretinate DM2CZFA Keratosis ED56 Approved [399]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [855]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [8]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Selenium DM25CGV N. A. N. A. Approved [70]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [117]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Amiloride DMRTSGP Congestive heart failure BD10 Approved [856]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [857]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Aminoglutethimide DMWFHMZ Cushing disease 5A70 Approved [274]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [365]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Clozapine DMFC71L Schizophrenia 6A20 Approved [164]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
MG-132 DMKA2YS N. A. N. A. Preclinical [858]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [392]
Milchsaure DM462BT Pruritus EC90 Investigative [375]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Histone H4 (H4C1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [105]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [99]
Selenium DM25CGV N. A. N. A. Approved [70]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [330]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Panobinostat DM58WKG Chronic graft versus host disease Approved [859]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [40]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [330]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [169]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [324]
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [54]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Hemoglobin subunit beta (HBB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [62]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [860]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [861]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Voxelotor DMCS6M5 Sickle-cell disorder 3A51 Approved [862]
Ibrutinib DMHZCPO Mantle cell lymphoma 2A85.5 Approved [863]
Flucloxacillin DMNUWST Bacterial infection 1A00-1C4Z Approved [864]
Capecitabine DMTS85L Adenocarcinoma 2D40 Approved [865]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [866]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [115]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [169]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [326]
MICROCYSTIN-LR DMTMLRN Discovery agent N.A. Investigative [867]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Aspirin DM672AH Acute coronary syndrome BA41 Approved [330]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [178]
Paclitaxel DMLB81S Breast carcinoma Approved [657]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [689]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [165]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Quercetin DM3NC4M Obesity 5B81 Approved [419]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [187]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [868]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [588]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Bortezomib DMNO38U Leukemia Approved [178]
Arsenic DMTL2Y1 N. A. N. A. Approved [869]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [356]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [301]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [870]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [583]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [335]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [70]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [43]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [870]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By Vigilin (HDLBP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [195]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [871]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [39]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By CD83 antigen (CD83)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [463]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [286]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [35]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [872]
Exemestane DM9HPW3 Hormonally-responsive breast cancer 2C60-2C65 Approved [873]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [874]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [165]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Menthol DMG2KW7 Back pain ME84.Z Approved [189]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [875]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Arsenic DMTL2Y1 N. A. N. A. Approved [876]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Lamin-B2 (LMNB2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [877]
Aminoglutethimide DMWFHMZ Cushing disease 5A70 Approved [274]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [592]
GSK2110183 DMZHB37 leukaemia 2A60-2B33 Phase 2 [878]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [25]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [150]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [879]
Daunorubicin DMQUSBT Acute monocytic leukemia Approved [879]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [115]
Camptothecin DM6CHNJ Solid tumour/cancer 2A00-2F9Z Phase 3 [879]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [16]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [880]
Selenium DM25CGV N. A. N. A. Approved [70]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [881]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [228]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [614]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [882]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [883]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcipotriol DM03CP7 Psoriasis EA90 Approved [652]
Selenium DM25CGV N. A. N. A. Approved [70]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [154]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [9]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [652]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [9]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [100]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [884]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [365]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Clozapine DMFC71L Schizophrenia 6A20 Approved [164]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [885]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [430]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [291]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [886]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Benzatropine DMF7EXL Parkinsonian disorder Approved [164]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [324]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [165]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [571]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [335]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [887]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [336]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Folic Acid DMEMBJC Colorectal carcinoma Approved [317]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [341]
Chloroquine DMSI5CB Malaria 1F40-1F45 Approved [888]
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [554]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [354]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Selenium DM25CGV N. A. N. A. Approved [70]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Ethanol DMDRQZU Chronic pain MG30 Approved [889]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [171]
APR-246 DMNFADH Ovarian cancer 2C73 Phase 2 [890]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Hyaluronidase-1 (HYAL1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Folic Acid DMEMBJC Colorectal carcinoma Approved [317]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [891]
Arsenic DMTL2Y1 N. A. N. A. Approved [891]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [171]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [561]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [892]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [193]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [893]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [394]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [388]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [142]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [195]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [147]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [372]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [232]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [318]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [356]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
Tamibarotene DM3G74J T-cell leukaemia 2A90 Phase 3 [168]
Epigallocatechin gallate DMCGWBJ Hepatic fibrosis DB93.0 Phase 3 [301]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Panobinostat DM58WKG Chronic graft versus host disease Approved [730]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
2-deoxyglucose DMIAHVU Solid tumour/cancer 2A00-2F9Z Approved [730]
Bleomycin DMNER5S Cervical cancer 2C77.0 Approved [730]
Hydroxyurea DMOQVU9 Chronic myelogenous leukaemia 2A20.0 Approved [730]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [150]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [356]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [171]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [372]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [40]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [894]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [308]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [196]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Menthol DMG2KW7 Back pain ME84.Z Approved [189]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Paclitaxel DMLB81S Breast carcinoma Approved [895]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Arsenic DMTL2Y1 N. A. N. A. Approved [896]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [117]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [70]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [781]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [195]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [544]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [164]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [897]
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [195]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Haloperidol DM96SE0 Delirium Approved [164]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Benzatropine DMF7EXL Parkinsonian disorder Approved [164]
Clozapine DMFC71L Schizophrenia 6A20 Approved [164]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [190]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [170]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [170]
Methotrexate DM2TEOL Anterior urethra cancer Approved [385]
Mitomycin DMH0ZJE Breast cancer 2C60-2C65 Approved [898]
Camptothecin DM6CHNJ Solid tumour/cancer 2A00-2F9Z Phase 3 [898]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [291]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Afimoxifene DMFORDT Breast cancer 2C60-2C65 Phase 2 [899]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [392]
Milchsaure DM462BT Pruritus EC90 Investigative [375]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [900]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Enzalutamide DMGL19D Prostate cancer 2C82.0 Approved [354]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [376]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [318]
Arsenic DMTL2Y1 N. A. N. A. Approved [339]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [353]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
Methotrexate DM2TEOL Anterior urethra cancer Approved [385]
Mitoxantrone DMM39BF Acute myelogenous leukaemia 2A41 Approved [385]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cullin-1 (CUL1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [57]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [515]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Bortezomib DMNO38U Leukemia Approved [901]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Tamibarotene DM3G74J T-cell leukaemia 2A90 Phase 3 [168]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cullin-4A (CUL4A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [296]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [324]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interleukin-18 (IL18)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [16]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [298]
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [902]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [406]
Ergotidine DM78IME Osteoarthritis FA00-FA05 Approved [903]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [365]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [904]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [905]
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [904]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Quercetin DM3NC4M Obesity 5B81 Approved [36]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [170]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [499]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [9]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Clozapine DMFC71L Schizophrenia 6A20 Approved [164]
Pioglitazone DMKJ485 Amyotrophic lateral sclerosis 8B60.0 Approved [906]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [835]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [252]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Clorgyline DMCEUJD Parkinson disease 8A00.0 Approved [907]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Clozapine DMFC71L Schizophrenia 6A20 Approved [164]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [335]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [225]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [354]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Selenium DM25CGV N. A. N. A. Approved [70]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [252]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Benzatropine DMF7EXL Parkinsonian disorder Approved [164]
Clozapine DMFC71L Schizophrenia 6A20 Approved [164]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [150]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [318]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [117]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [908]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Menthol DMG2KW7 Back pain ME84.Z Approved [189]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [909]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [115]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [910]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [165]
Selenium DM25CGV N. A. N. A. Approved [70]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [165]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
Afimoxifene DMFORDT Breast cancer 2C60-2C65 Phase 2 [165]
MG-132 DMKA2YS N. A. N. A. Preclinical [858]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [392]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Quercetin DM3NC4M Obesity 5B81 Approved [754]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Benzatropine DMF7EXL Parkinsonian disorder Approved [164]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [690]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [326]
AMINOHIPPURIC ACID DMUN54G Discovery agent N.A. Investigative [911]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Calponin-3 (CNN3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Ethanol DMDRQZU Chronic pain MG30 Approved [889]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [335]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [318]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [353]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [126]
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Pioglitazone DMKJ485 Amyotrophic lateral sclerosis 8B60.0 Approved [906]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [326]
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Clozapine DMFC71L Schizophrenia 6A20 Approved [164]
Bortezomib DMNO38U Leukemia Approved [178]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [220]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [302]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [195]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By ELAV-like protein 1 (ELAVL1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [912]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [913]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Flurbiprofen DMGN4BY Osteoarthritis FA00-FA05 Approved [913]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [914]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
Amsacrine DMZKYIV Acute lymphoblastic leukaemia 2A85 Approved [915]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fluoxetine DM3PD2C Bipolar depression Approved [359]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [117]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [225]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [219]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
Afimoxifene DMFORDT Breast cancer 2C60-2C65 Phase 2 [916]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [68]
Verapamil DMA7PEW Angina pectoris BA40 Approved [87]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [57]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [20]
Selenium DM25CGV N. A. N. A. Approved [70]
TECFIDERA DM2OVDT Multiple sclerosis 8A40 Approved [917]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [97]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [46]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Furazolidone DM3P6V7 Diarrhea ME05.1 Approved [918]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [169]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [388]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [919]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [68]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [44]
Methotrexate DM2TEOL Anterior urethra cancer Approved [107]
Quercetin DM3NC4M Obesity 5B81 Approved [502]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [108]
Ethacrynic acid DM60QMR Edema MG29 Approved [818]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [920]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [921]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [922]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [403]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Benzatropine DMF7EXL Parkinsonian disorder Approved [164]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Fascin (FSCN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [923]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [31]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [405]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [116]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [564]
Adenosine triphosphate DM79F6G Malnutrition 5B50-5B71 Approved [134]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
Drug(s) Affected By GON-4-like protein (GON4L)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [190]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [372]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [302]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [232]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [195]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [195]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [26]
Milchsaure DM462BT Pruritus EC90 Investigative [375]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [137]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [13]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [13]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [13]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Lindane DMB8CNL Infestations of lice and scabies 1G00.Z Approved [498]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [321]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein FAM76B (FAM76B)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [59]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [894]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By RNA-binding protein 26 (RBM26)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [302]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [394]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Clozapine DMFC71L Schizophrenia 6A20 Approved [164]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [115]
GSK2110183 DMZHB37 leukaemia 2A60-2B33 Phase 2 [878]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [392]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Clorgyline DMCEUJD Parkinson disease 8A00.0 Approved [907]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [812]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Rootletin (CROCC)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Folic Acid DMEMBJC Colorectal carcinoma Approved [317]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [568]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [25]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [326]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Bortezomib DMNO38U Leukemia Approved [178]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [199]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Tamibarotene DM3G74J T-cell leukaemia 2A90 Phase 3 [168]
Lithium DMZ3OU6 Bipolar disorder 6A60 Phase 2 [924]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [567]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [11]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [699]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Clorgyline DMCEUJD Parkinson disease 8A00.0 Approved [907]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [341]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Daporinad DMCU74R leukaemia 2A60-2B33 Phase 2 [925]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [388]
OXYRESVERATROL DMN7S4L Discovery agent N.A. Investigative [926]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By CD109 antigen (CD109)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [16]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [326]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Clorgyline DMCEUJD Parkinson disease 8A00.0 Approved [907]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [388]
crotylaldehyde DMTWRQI Discovery agent N.A. Investigative [927]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [374]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [326]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [195]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [386]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [195]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [195]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [8]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [8]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [354]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [372]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [326]
Milchsaure DM462BT Pruritus EC90 Investigative [375]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [195]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [556]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [302]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [25]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [41]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [232]
Milchsaure DM462BT Pruritus EC90 Investigative [375]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [115]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [928]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [169]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [158]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [321]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [178]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [318]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [54]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [149]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [141]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [929]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
Pioglitazone DMKJ485 Amyotrophic lateral sclerosis 8B60.0 Approved [930]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [190]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [184]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [329]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [385]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [184]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [184]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [931]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
L-Glutamic Acid DM4PUDW Schizophrenia 6A20 Approved [932]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [933]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [330]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Aldosterone DM9S2JW Hypertension BA00-BA04 Approved [931]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [169]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [115]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [374]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
acetaldehyde DMJFKG4 Discovery agent N.A. Investigative [934]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
Milchsaure DM462BT Pruritus EC90 Investigative [375]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [171]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [225]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [70]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [372]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [26]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [117]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [67]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [302]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [841]
Milchsaure DM462BT Pruritus EC90 Investigative [375]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein FAM3C (FAM3C)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [9]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [324]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
Vinblastine DM5TVS3 Advanced cancer 2A00-2F9Z Approved [385]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [266]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [166]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [187]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [123]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [109]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [103]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [365]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [343]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [117]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [169]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [326]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [549]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [560]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [195]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [244]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [82]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [299]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [147]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [147]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [225]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [180]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Envoplakin (EVPL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [196]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [935]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [936]
Drug(s) Affected By Hyaluronan synthase 2 (HAS2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [105]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [801]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [276]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [937]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [322]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Hyaluronan synthase 1 (HAS1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Malathion DMXZ84M Pediculus capitis infestation 1G00.0 Approved [938]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [159]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [939]
Epigallocatechin gallate DMCGWBJ Hepatic fibrosis DB93.0 Phase 3 [939]
GUAIACOL DMN4E7T N. A. N. A. Phase 3 [939]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [939]
Puerarin DMJIMXH Alcohol dependence 6C40.2 Phase 2 [939]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
Chlorogenic acid DM2Y3P4 Discovery agent N.A. Investigative [939]
methyl p-hydroxybenzoate DMO58UW Discovery agent N.A. Investigative [940]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [59]
Quercetin DM3NC4M Obesity 5B81 Approved [615]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [266]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [123]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Testosterone enanthate DMB6871 N. A. N. A. Approved [119]
Clorgyline DMCEUJD Parkinson disease 8A00.0 Approved [907]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Drug(s) Affected By m7GpppX diphosphatase (DCPS)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Bortezomib DMNO38U Leukemia Approved [178]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Mdm2-binding protein (MTBP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [276]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [579]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [302]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [319]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [394]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [26]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [16]
Selenium DM25CGV N. A. N. A. Approved [22]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [902]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [406]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [941]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [547]
Ethanol DMDRQZU Chronic pain MG30 Approved [942]
Atropine DMEN6X7 Organophosphate poisoning NE6Z Approved [943]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Importin-9 (IPO9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [557]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [169]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [169]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [812]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [187]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Motexafin gadolinium DMEJKRF Brain cancer 2A00 Approved [187]
Paclitaxel DMLB81S Breast carcinoma Approved [944]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [945]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [302]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [195]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [195]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [195]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [292]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [176]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [887]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [569]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [225]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [159]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [169]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [946]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [302]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [115]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [302]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [396]
Methotrexate DM2TEOL Anterior urethra cancer Approved [138]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Palbociclib DMD7L94 Breast cancer 2C60-2C65 Approved [851]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [244]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Clozapine DMFC71L Schizophrenia 6A20 Approved [947]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [143]
Pioglitazone DMKJ485 Amyotrophic lateral sclerosis 8B60.0 Approved [344]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [326]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [948]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [326]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Haloperidol DM96SE0 Delirium Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [195]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [195]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [26]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [184]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [341]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [190]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [187]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Motexafin gadolinium DMEJKRF Brain cancer 2A00 Approved [187]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [318]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
ACYLINE DM9GRTK Prostate cancer 2C82.0 Phase 2 [949]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [195]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [870]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [324]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [356]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [950]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [196]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [612]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [569]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [633]
Curcumin DMQPH29 Solid tumour/cancer 2A00-2F9Z Phase 3 [951]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [232]
Nickel chloride DMI12Y8 Discovery agent N.A. Investigative [839]
KOJIC ACID DMP84CS Discovery agent N.A. Investigative [952]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By CTP synthase 2 (CTPS2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [326]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [558]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [170]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [170]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [142]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [219]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [354]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [302]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Obg-like ATPase 1 (OLA1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Selenium DM25CGV N. A. N. A. Approved [70]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Panobinostat DM58WKG Chronic graft versus host disease Approved [39]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [953]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Benzatropine DMF7EXL Parkinsonian disorder Approved [164]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [909]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [195]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [326]
Milchsaure DM462BT Pruritus EC90 Investigative [375]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [126]
Selenium DM25CGV N. A. N. A. Approved [70]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [168]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [330]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [115]
Tamibarotene DM3G74J T-cell leukaemia 2A90 Phase 3 [168]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
ANW-32821 DMMJOZD N. A. N. A. Phase 2 [954]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [392]
Nickel chloride DMI12Y8 Discovery agent N.A. Investigative [839]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [326]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [146]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [302]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [59]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [225]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [169]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [955]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [956]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Panobinostat DM58WKG Chronic graft versus host disease Approved [957]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [330]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [822]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [958]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By DNA (DNMT3B)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [762]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [959]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [242]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [169]
Ethanol DMDRQZU Chronic pain MG30 Approved [960]
Folic Acid DMEMBJC Colorectal carcinoma Approved [317]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein CLN8 (CLN8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [326]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [132]
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [12]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Hydroxyurea DMOQVU9 Chronic myelogenous leukaemia 2A20.0 Approved [132]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [85]
Selenium DM25CGV N. A. N. A. Approved [70]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [266]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [166]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [187]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [11]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [475]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [109]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [85]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein NDRG3 (NDRG3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Bortezomib DMNO38U Leukemia Approved [178]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Serpin B13 (SERPINB13)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [124]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [326]
Milchsaure DM462BT Pruritus EC90 Investigative [375]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [70]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By tRNA (TRMT6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [115]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [25]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [392]
Milchsaure DM462BT Pruritus EC90 Investigative [375]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [105]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [82]
Menthol DMG2KW7 Back pain ME84.Z Approved [189]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [335]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Methotrexate DM2TEOL Anterior urethra cancer Approved [961]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [962]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [963]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [115]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [964]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [634]
Sulforaphane DMQY3L0 Skin disease EA00-EM0Z Investigative [965]
paraquat DMR8O3X Discovery agent N.A. Investigative [966]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [70]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Clozapine DMFC71L Schizophrenia 6A20 Approved [164]
Bortezomib DMNO38U Leukemia Approved [178]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [193]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [321]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [335]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [395]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [159]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [579]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [812]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [302]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [967]
Milchsaure DM462BT Pruritus EC90 Investigative [375]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [114]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [184]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [968]
Epigallocatechin gallate DMCGWBJ Hepatic fibrosis DB93.0 Phase 3 [301]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [160]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [194]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [8]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [302]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [8]
Geldanamycin DMS7TC5 Kidney cancer 2C90.0 Discontinued in Phase 2 [141]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [195]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [26]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [111]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [356]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [157]
Urethane DM7NSI0 N. A. N. A. Phase 4 [177]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [592]
Nickel chloride DMI12Y8 Discovery agent N.A. Investigative [969]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Heme-binding protein 2 (HEBP2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [970]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [78]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [356]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [159]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [354]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Artemisinin DMOY7W3 Malaria 1F40-1F45 Approved [971]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [972]
Thiotepa DMIZKOP Breast cancer 2C60-2C65 Approved [973]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [974]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [975]
Ethacrynic acid DM60QMR Edema MG29 Approved [976]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [977]
Busulfan DMXYJ9C Chronic myelogenous leukaemia 2A20.0 Approved [978]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [7]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [69]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Eicosapentaenoic acid/docosa-hexaenoic acid DMMUCG4 Hypertriglyceridemia 5C80.1 Approved [979]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [980]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [981]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Lopinavir DMITQS0 Human immunodeficiency virus infection 1C62 Approved [982]
Sulfinpyrazone DMEV954 Gout FA25 Approved [983]
Probenecid DMMFWOJ Acute gonococcal cervicitis Approved [984]
Docetaxel DMDI269 Advanced cancer 2A00-2F9Z Approved [985]
Methotrexate DM2TEOL Anterior urethra cancer Approved [793]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [986]
Cholic Acid DM7OKQV Cholelithiasis DC11 Approved [987]
Epirubicin DMPDW6T Solid tumour/cancer 2A00-2F9Z Approved [988]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [989]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [266]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [101]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [72]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [40]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [112]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [990]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [155]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [69]
Quercetin DM3NC4M Obesity 5B81 Approved [8]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [32]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [40]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Bortezomib DMNO38U Leukemia Approved [178]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [980]
Arsenic DMTL2Y1 N. A. N. A. Approved [156]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [158]
Methotrexate DM2TEOL Anterior urethra cancer Approved [991]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [69]
Quercetin DM3NC4M Obesity 5B81 Approved [400]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [10]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [11]
Testosterone DM7HUNW Hot flushes GA30 Approved [118]
Glutathione DMAHMT9 Human immunodeficiency virus infection 1C62 Approved [992]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [43]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [135]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [83]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [190]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Busulfan DMXYJ9C Chronic myelogenous leukaemia 2A20.0 Approved [661]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [993]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [385]
Ethanol DMDRQZU Chronic pain MG30 Approved [994]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [9]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [9]
Methyldopa DM5I621 Hypertension BA00-BA04 Approved [995]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Testosterone DM7HUNW Hot flushes GA30 Approved [66]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [66]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [996]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [997]
Methotrexate DM2TEOL Anterior urethra cancer Approved [218]
Leflunomide DMR8ONJ Arthritis FA20 Approved [104]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [146]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [998]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [113]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [7]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [999]
Mefenamic acid DMK7HFI Dysmenorrhea GA34.3 Approved [1000]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Lipocalin-type prostaglandin-D synthase (PTGDS) DER3H9C PTGDS_HUMAN Substrate [2]
Prostaglandin E synthase 2 (PTGES2) DE3OALH PGES2_HUMAN Substrate [3]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
26S proteasome non-ATPase regulatory subunit 11 (PSMD11) OT8KO67V PSD11_HUMAN Protein Interaction/Cellular Processes [4]
26S proteasome non-ATPase regulatory subunit 5 (PSMD5) OTYLM6S2 PSMD5_HUMAN Protein Interaction/Cellular Processes [4]
26S proteasome non-ATPase regulatory subunit 6 (PSMD6) OTX59EGK PSMD6_HUMAN Protein Interaction/Cellular Processes [4]
26S proteasome regulatory subunit 8 (PSMC5) OTJOORMR PRS8_HUMAN Protein Interaction/Cellular Processes [4]
3',5'-cyclic-AMP phosphodiesterase 4B (PDE4B) OTOA8WU2 PDE4B_HUMAN Gene/Protein Processing [5]
3',5'-cyclic-AMP phosphodiesterase 4D (PDE4D) OT1RWFV0 PDE4D_HUMAN Gene/Protein Processing [5]
5'-nucleotidase domain-containing protein 1 (NT5DC1) OTNI9MFH NT5D1_HUMAN Protein Interaction/Cellular Processes [4]
6-phosphogluconate dehydrogenase, decarboxylating (PGD) OTVG296F 6PGD_HUMAN Gene/Protein Processing [6]
60 kDa heat shock protein, mitochondrial (HSPD1) OTTO1Y11 CH60_HUMAN Protein Interaction/Cellular Processes [4]
A-kinase anchor protein 13 (AKAP13) OTOZAR14 AKP13_HUMAN Protein Interaction/Cellular Processes [4]

References

1 ClinicalTrials.gov (NCT00000870) A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone. U.S. National Institutes of Health.
2 Glutathione transferases immobilized on nanoporous alumina: flow system kinetics, screening, and stability. Anal Biochem. 2014 Feb 1;446:59-63.
3 Human microsomal prostaglandin E synthase-1: purification, functional characterization, and projection structure determination. J Biol Chem. 2003 Jun 20;278(25):22199-209.
4 Proteomic analysis of the cellular response to a potent sensitiser unveils the dynamics of haptenation in living cells. Toxicology. 2020 Dec 1;445:152603. doi: 10.1016/j.tox.2020.152603. Epub 2020 Sep 28.
5 Microarray analyses in dendritic cells reveal potential biomarkers for chemical-induced skin sensitization. Mol Immunol. 2007 May;44(12):3222-33.
6 Keratinocyte gene expression profiles discriminate sensitizing and irritating compounds. Toxicol Sci. 2010 Sep;117(1):81-9.
7 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
8 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
9 Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J Invest Dermatol. 2005 Jul;125(1):143-53.
10 Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action. Dermatoendocrinol. 2009 May;1(3):177-87.
11 Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation. Blood. 2005 Jul 1;106(1):304-10.
12 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.
13 Transcriptomics hit the target: monitoring of ligand-activated and stress response pathways for chemical testing. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):7-18.
14 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
15 Evaluation of the sensitizing potential of antibiotics in vitro using the human cell lines THP-1 and MUTZ-LC and primary monocyte-derived dendritic cells. Toxicol Appl Pharmacol. 2012 Aug 1;262(3):283-92.
16 Cannabidiol Modulates the Immunophenotype and Inhibits the Activation of the Inflammasome in Human Gingival Mesenchymal Stem Cells. Front Physiol. 2016 Nov 24;7:559. doi: 10.3389/fphys.2016.00559. eCollection 2016.
17 ERE-independent ERalpha target genes differentially expressed in human breast tumors. Mol Cell Endocrinol. 2005 Dec 21;245(1-2):53-9. doi: 10.1016/j.mce.2005.10.003. Epub 2005 Nov 17.
18 Reactive metabolite of gefitinib activates inflammasomes: implications for gefitinib-induced idiosyncratic reaction. J Toxicol Sci. 2020;45(11):673-680. doi: 10.2131/jts.45.673.
19 An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury. Arch Toxicol. 2021 Jan;95(1):149-168. doi: 10.1007/s00204-020-02882-4. Epub 2020 Aug 20.
20 Gypenosides protect retinal pigment epithelium cells from oxidative stress. Food Chem Toxicol. 2018 Feb;112:76-85.
21 (9)-Tetrahydrocannabinol Suppresses Monocyte-Mediated Astrocyte Production of Monocyte Chemoattractant Protein 1 and Interleukin-6 in a Toll-Like Receptor 7-Stimulated Human Coculture. J Pharmacol Exp Ther. 2019 Oct;371(1):191-201. doi: 10.1124/jpet.119.260661. Epub 2019 Aug 5.
22 Changes in gene expression profiles in response to selenium supplementation among individuals with arsenic-induced pre-malignant skin lesions. Toxicol Lett. 2007 Mar 8;169(2):162-76. doi: 10.1016/j.toxlet.2007.01.006. Epub 2007 Jan 19.
23 Profiling the immunotoxicity of chemicals based on in vitro evaluation by a combination of the Multi-ImmunoTox assay and the IL-8 Luc assay. Arch Toxicol. 2018 Jun;92(6):2043-2054. doi: 10.1007/s00204-018-2199-7. Epub 2018 Mar 29.
24 Spironolactone induces apoptosis in human mononuclear cells. Association between apoptosis and cytokine suppression. Apoptosis. 2006 Apr;11(4):573-9. doi: 10.1007/s10495-006-4919-3.
25 Exome-wide mutation profile in benzo[a]pyrene-derived post-stasis and immortal human mammary epithelial cells. Mutat Res Genet Toxicol Environ Mutagen. 2014 Dec;775-776:48-54. doi: 10.1016/j.mrgentox.2014.10.011. Epub 2014 Nov 4.
26 Environmental pollutant induced cellular injury is reflected in exosomes from placental explants. Placenta. 2020 Jan 1;89:42-49. doi: 10.1016/j.placenta.2019.10.008. Epub 2019 Oct 17.
27 Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1. Redox Biol. 2020 Jan;28:101321. doi: 10.1016/j.redox.2019.101321. Epub 2019 Sep 5.
28 Fumarate Mediates a Chronic Proliferative Signal in Fumarate Hydratase-Inactivated Cancer Cells by Increasing Transcription and Translation of Ferritin Genes. Mol Cell Biol. 2017 May 16;37(11):e00079-17. doi: 10.1128/MCB.00079-17. Print 2017 Jun 1.
29 Growth-suppressive effect of non-steroidal anti-inflammatory drugs on 11 colon-cancer cell lines and fluorescence differential display of genes whose expression is influenced by sulindac. Int J Cancer. 2000 Dec 15;88(6):873-80. doi: 10.1002/1097-0215(20001215)88:6<873::aid-ijc6>3.0.co;2-b.
30 Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
31 Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells. World J Gastroenterol. 2009 Jan 21;15(3):310-20.
32 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
33 [Construction of subtracted cDNA library in human Jurkat T cell line induced by arsenic trioxide in vitro]. Zhonghua Yu Fang Yi Xue Za Zhi. 2003 Nov;37(6):403-7.
34 Survival of retinal pigment epithelium after exposure to prolonged oxidative injury: a detailed gene expression and cellular analysis. Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3767-77.
35 Single-cell Transcriptome Mapping Identifies Common and Cell-type Specific Genes Affected by Acute Delta9-tetrahydrocannabinol in Humans. Sci Rep. 2020 Feb 26;10(1):3450. doi: 10.1038/s41598-020-59827-1.
36 Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics. 2004 Jul;4(7):2160-74.
37 Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain. Pain. 2007 Mar;128(1-2):136-47.
38 Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers. Clin Breast Cancer. 2013 Oct;13(5):401-8.
39 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
40 Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicol Appl Pharmacol. 2012 Jun 1;261(2):204-16.
41 Keratinocyte-derived IL-36gama plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes. Arch Toxicol. 2019 Aug;93(8):2307-2320.
42 Proteomics analysis of the proliferative effect of low-dose ouabain on human endothelial cells. Biol Pharm Bull. 2007 Feb;30(2):247-53. doi: 10.1248/bpb.30.247.
43 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
44 Neuroprotective effects of glucomoringin-isothiocyanate against H(2)O(2)-Induced cytotoxicity in neuroblastoma (SH-SY5Y) cells. Neurotoxicology. 2019 Dec;75:89-104. doi: 10.1016/j.neuro.2019.09.008. Epub 2019 Sep 12.
45 Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther. 2009;11(1):R15.
46 P450 3A-catalyzed O-dealkylation of lapatinib induces mitochondrial stress and activates Nrf2. Chem Res Toxicol. 2016 May 16;29(5):784-96.
47 Epinephrine upregulates superoxide dismutase in human coronary artery endothelial cells. Free Radic Biol Med. 2001 Jan 15;30(2):148-53.
48 Cissus quadrangularis ethanol extract upregulates superoxide dismutase, glutathione peroxidase and endothelial nitric oxide synthase expression in hydrogen peroxide-injured human ECV304 cells. J Ethnopharmacol. 2012 Sep 28;143(2):664-72.
49 Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system. Toxicol In Vitro. 2017 Mar;39:93-103.
50 Manganese superoxide dismutase is a promising target for enhancing chemosensitivity of basal-like breast carcinoma. Antioxid Redox Signal. 2014 May 20;20(15):2326-46. doi: 10.1089/ars.2013.5295. Epub 2013 Nov 14.
51 Effect of retinoic acid on gene expression in human conjunctival epithelium: secretory phospholipase A2 mediates retinoic acid induction of MUC16. Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4050-61.
52 High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells. Blood. 1993 Nov 15;82(10):3133-40.
53 Gene expression data from acetaminophen-induced toxicity in human hepatic in vitro systems and clinical liver samples. Data Brief. 2016 Mar 26;7:1052-1057. doi: 10.1016/j.dib.2016.03.069. eCollection 2016 Jun.
54 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
55 Inhibition of autophagic flux differently modulates cannabidiol-induced death in 2D and 3D glioblastoma cell cultures. Sci Rep. 2020 Feb 14;10(1):2687. doi: 10.1038/s41598-020-59468-4.
56 Nitrogen mustard prevents transport of Fra-1 into the nucleus to promote c-Fos- and FosB-dependent IL-8 induction in injured mouse epidermis. Toxicol Lett. 2020 Feb 1;319:256-263. doi: 10.1016/j.toxlet.2019.10.006. Epub 2019 Oct 19.
57 Sertraline induces endoplasmic reticulum stress in hepatic cells. Toxicology. 2014 Aug 1;322:78-88. doi: 10.1016/j.tox.2014.05.007. Epub 2014 May 24.
58 Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor. Cancer Res. 2002 Aug 1;62(15):4419-26.
59 Oxidative stress modulates theophylline effects on steroid responsiveness. Biochem Biophys Res Commun. 2008 Dec 19;377(3):797-802.
60 Nocodazole-induced p53-dependent c-Jun N-terminal kinase activation reduces apoptosis in human colon carcinoma HCT116 cells. J Biol Chem. 2002 Nov 15;277(46):43648-58. doi: 10.1074/jbc.M203214200. Epub 2002 Sep 6.
61 [Regulation mechanism of autophagy-related protein LC3 by c-Jun in methotrexate resistant human choriocarcinoma JEG-3 cells]. Zhonghua Fu Chan Ke Za Zhi. 2014 Jul;49(7):531-5.
62 MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia. Cell Biol Toxicol. 2023 Feb;39(1):201-216. doi: 10.1007/s10565-021-09639-4. Epub 2021 Sep 28.
63 Arsenic trioxide, retinoic acid and Ara-c regulated the expression of annexin II on the surface of APL cells, a novel co-receptor for plasminogen/tissue plasminogen activator. Thromb Res. 2002 Apr 1;106(1):63-70. doi: 10.1016/s0049-3848(02)00075-0.
64 [Clinical study on the fibrinolytic activity in patients with acute promyelocytic leukemia]. Zhonghua Xue Ye Xue Za Zhi. 2009 Mar;30(3):145-9.
65 [Effects of thalidomide on Annexin II gene regulation]. Zhonghua Xue Ye Xue Za Zhi. 2009 Jul;30(7):464-7.
66 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
67 Protein profile in neuroblastoma cells incubated with S- and R-enantiomers of ibuprofen by iTRAQ-coupled 2-D LC-MS/MS analysis: possible action of induced proteins on Alzheimer's disease. Proteomics. 2008 Apr;8(8):1595-607. doi: 10.1002/pmic.200700556.
68 Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked With Amyotrophic Lateral Sclerosis. J Cell Biochem. 2017 Apr;118(4):819-828. doi: 10.1002/jcb.25757. Epub 2016 Nov 28.
69 Beta-carotene and apocarotenals promote retinoid signaling in BEAS-2B human bronchioepithelial cells. Arch Biochem Biophys. 2006 Nov 1;455(1):48-60.
70 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
71 Proton pump inhibitors interfere with the anti-tumor potency of RC48ADC. Toxicol In Vitro. 2022 Mar;79:105292. doi: 10.1016/j.tiv.2021.105292. Epub 2021 Dec 3.
72 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
73 Pyrimethamine induces apoptosis of melanoma cells via a caspase and cathepsin double-edged mechanism. Cancer Res. 2008 Jul 1;68(13):5291-300. doi: 10.1158/0008-5472.CAN-08-0222.
74 Synergistic effects of arsenic trioxide and silibinin on apoptosis and invasion in human glioblastoma U87MG cell line. Neurochem Res. 2012 Feb;37(2):370-80. doi: 10.1007/s11064-011-0620-1. Epub 2011 Oct 4.
75 Thyroid organotypic rat and human cultures used to investigate drug effects on thyroid function, hormone synthesis and release pathways. Toxicol Appl Pharmacol. 2012 Apr 1;260(1):81-8. doi: 10.1016/j.taap.2012.01.029. Epub 2012 Feb 8.
76 Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization. Autophagy. 2016 Nov;12(11):2213-2229. doi: 10.1080/15548627.2016.1213927. Epub 2016 Sep 16.
77 Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin. Am J Respir Cell Mol Biol. 2004 May;30(5):662-70. doi: 10.1165/rcmb.2003-0267OC. Epub 2003 Nov 20.
78 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
79 N-acylation of glucosamine modulates chondrocyte growth, proteoglycan synthesis, and gene expression. J Rheumatol. 2005 Sep;32(9):1775-86.
80 Grouping of histone deacetylase inhibitors and other toxicants disturbing neural crest migration by transcriptional profiling. Neurotoxicology. 2015 Sep;50:56-70.
81 Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells. Int J Cancer. 2008 May 1;122(9):2115-24. doi: 10.1002/ijc.23315.
82 Stem cell transcriptome responses and corresponding biomarkers that indicate the transition from adaptive responses to cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
83 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
84 Dexamethasone and the inflammatory response in explants of human omental adipose tissue. Mol Cell Endocrinol. 2010 Feb 5;315(1-2):292-8.
85 Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells. Anticancer Res. 2015 Nov;35(11):5827-37.
86 Calcium pantothenate modulates gene expression in proliferating human dermal fibroblasts. Exp Dermatol. 2009 Nov;18(11):969-78. doi: 10.1111/j.1600-0625.2009.00884.x. Epub 2009 Apr 8.
87 Protective role of HO-1 for alcohol-dependent liver damage. Dig Dis. 2010;28(6):792-8. doi: 10.1159/000324287. Epub 2011 Apr 27.
88 High selenium status in individuals exposed to arsenic through coal-burning in Shaanxi (PR of China) modulates antioxidant enzymes, heme oxygenase-1 and DNA damage. Clin Chim Acta. 2010 Sep 6;411(17-18):1312-8.
89 Dimethyl Fumarate Inhibits the Nuclear Factor B Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein. J Biol Chem. 2016 Feb 12;291(7):3639-47. doi: 10.1074/jbc.M115.679704. Epub 2015 Dec 18.
90 Combination treatment with arsenic trioxide and sulindac enhances apoptotic cell death in lung cancer cells via activation of oxidative stress and mitogen-activated protein kinases. Oncol Rep. 2008 Aug;20(2):379-84.
91 Functional gene expression profile underlying methotrexate-induced senescence in human colon cancer cells. Tumour Biol. 2011 Oct;32(5):965-76.
92 Effect of subchronic exposure to inorganic arsenic on the structure and function of the intestinal epithelium. Toxicol Lett. 2018 Apr;286:80-88.
93 Effect of aspirin on cell proliferation and differentiation of colon adenocarcinoma Caco-2 cells. Int J Cancer. 1997 Dec 10;73(6):880-4. doi: 10.1002/(sici)1097-0215(19971210)73:6<880::aid-ijc20>3.0.co;2-7.
94 Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study. Naunyn Schmiedebergs Arch Pharmacol. 2010 Apr;381(4):371-81. doi: 10.1007/s00210-010-0502-0. Epub 2010 Mar 13.
95 Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes. Arch Toxicol. 2018 Jan;92(1):371-381.
96 Enhanced cytotoxicity of bioreductive antitumor agents with dimethyl fumarate in human glioblastoma cells. Anticancer Drugs. 2005 Feb;16(2):167-74.
97 Simvastatin protects dopaminergic neurons against MPP+-induced oxidative stress and regulates the endogenous anti-oxidant system through ERK. Cell Physiol Biochem. 2018;51(4):1957-1968.
98 Induction of human NAD(P)H:quinone oxidoreductase (NQO1) gene expression by the flavonol quercetin. Toxicol Lett. 2001 Feb 3;119(1):49-57.
99 Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cells. Cancer Res. 2002 Nov 1;62(21):6246-54.
100 Quantitative proteomic analysis of HepG2 cells treated with quercetin suggests IQGAP1 involved in quercetin-induced regulation of cell proliferation and migration. OMICS. 2009 Apr;13(2):93-103. doi: 10.1089/omi.2008.0075.
101 D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis. Apoptosis. 2012 Oct;17(10):1079-94.
102 Arsenic trioxide induces Hsp70 expression via reactive oxygen species and JNK pathway in MDA231 cells. Life Sci. 2005 Oct 14;77(22):2783-93. doi: 10.1016/j.lfs.2005.04.024.
103 Gene expression changes in human small airway epithelial cells exposed to Delta9-tetrahydrocannabinol. Toxicol Lett. 2005 Aug 14;158(2):95-107.
104 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
105 Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Sci Rep. 2020 Nov 26;10(1):20622. doi: 10.1038/s41598-020-77674-y.
106 Complex genetic response of human cells to sublethal levels of pure nitric oxide. Cancer Res. 1998 Aug 1;58(15):3435-40.
107 Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway. Toxicology. 2009 Feb 27;256(3):183-90. doi: 10.1016/j.tox.2008.11.016. Epub 2008 Nov 28.
108 Effects of chlorpromazine with and without UV irradiation on gene expression of HepG2 cells. Mutat Res. 2005 Aug 4;575(1-2):47-60. doi: 10.1016/j.mrfmmm.2005.03.002. Epub 2005 Apr 26.
109 Polyunsaturated fatty acids synergize with lipid droplet binding thalidomide analogs to induce oxidative stress in cancer cells. Lipids Health Dis. 2010 Jun 2;9:56. doi: 10.1186/1476-511X-9-56.
110 Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action. Arthritis Res Ther. 2012 Jun 8;14(3):R138. doi: 10.1186/ar3871.
111 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
112 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
113 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
114 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
115 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
116 Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitors. Leuk Res. 2007 Nov;31(11):1511-20.
117 Proteomics-based identification of differentially abundant proteins from human keratinocytes exposed to arsenic trioxide. J Proteomics Bioinform. 2014 Jul;7(7):166-178.
118 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
119 Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss. J Clin Endocrinol Metab. 2007 Jul;92(7):2793-802. doi: 10.1210/jc.2006-2722. Epub 2007 Apr 17.
120 Inhibition of invasion and induction of apoptosis by selenium in human malignant brain tumour cells in vitro. Int J Oncol. 2007 May;30(5):1263-71.
121 Pentosan polysulfate decreases proliferation and extracellular matrix deposition by vascular smooth muscle cells isolated from failed hemodialysis access grafts. Clin Nephrol. 2000 Aug;54(2):121-7.
122 Rofecoxib regulates the expression of genes related to the matrix metalloproteinase pathway in humans: implication for the adverse effects of cyclooxygenase-2 inhibitors. Clin Pharmacol Ther. 2006 Apr;79(4):303-15. doi: 10.1016/j.clpt.2005.12.306.
123 Arsenic trioxide induces different gene expression profiles of genes related to growth and apoptosis in glioma cells dependent on the p53 status. Mol Biol Rep. 2008 Sep;35(3):421-9.
124 Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 Nov;19(11):2685-95.
125 Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells. Mutagenesis. 2005 Mar;20(2):139-46. doi: 10.1093/mutage/gei019. Epub 2005 Mar 22.
126 Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells. J Cell Biochem. 2017 Jun;118(6):1531-1546. doi: 10.1002/jcb.25815. Epub 2016 Dec 29.
127 Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells. Toxicol Appl Pharmacol. 2017 Nov 15;335:16-27. doi: 10.1016/j.taap.2017.09.017. Epub 2017 Sep 21.
128 BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile. J Biochem Mol Toxicol. 2019 May;33(5):e22286. doi: 10.1002/jbt.22286. Epub 2019 Jan 23.
129 Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma. Br J Dermatol. 2009 Mar;160(3):519-26. doi: 10.1111/j.1365-2133.2008.08931.x. Epub 2008 Nov 25.
130 Glucocorticoids induce G1 arrest of lymphoblastic cells through retinoblastoma protein Rb1 dephosphorylation in childhood acute lymphoblastic leukemia in vivo. Cancer Biol Ther. 2004 May;3(5):470-6. doi: 10.4161/cbt.3.5.838. Epub 2004 May 9.
131 Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin Cancer Res. 2000 Mar;6(3):891-900.
132 Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity. Toxicology. 2014 Jan 6;315:8-16. doi: 10.1016/j.tox.2013.10.009. Epub 2013 Nov 6.
133 Detection of gene expression alteration of myeloma cells treated with arsenic trioxide. Zhonghua Xue Ye Xue Za Zhi. 2005 Apr;26(4):209-13.
134 Extracellular ATP drives breast cancer cell migration and metastasis via S100A4 production by cancer cells and fibroblasts. Cancer Lett. 2018 Aug 28;430:1-10. doi: 10.1016/j.canlet.2018.04.043. Epub 2018 May 5.
135 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
136 Folate deficiency in normal human fibroblasts leads to altered expression of genes primarily linked to cell signaling, the cytoskeleton and extracellular matrix. J Nutr Biochem. 2007 Aug;18(8):541-52. doi: 10.1016/j.jnutbio.2006.11.002. Epub 2007 Feb 22.
137 Time series analysis of oxidative stress response patterns in HepG2: a toxicogenomics approach. Toxicology. 2013 Apr 5;306:24-34.
138 Methotrexate modulates folate phenotype and inflammatory profile in EA.hy 926 cells. Eur J Pharmacol. 2014 Jun 5;732:60-7.
139 Inter-laboratory comparison of human renal proximal tubule (HK-2) transcriptome alterations due to Cyclosporine A exposure and medium exhaustion. Toxicol In Vitro. 2009 Apr;23(3):486-99.
140 Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells. Arch Toxicol. 2018 Apr;92(4):1507-1524.
141 Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. Arch Toxicol. 2016 Jan;90(1):159-80.
142 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
143 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
144 Comparison of the gene expression profiles of monocytic versus granulocytic lineages of HL-60 leukemia cell differentiation by DNA microarray analysis. Life Sci. 2003 Aug 15;73(13):1705-19. doi: 10.1016/s0024-3205(03)00515-0.
145 Expression profile analysis of human peripheral blood mononuclear cells in response to aspirin. Arch Immunol Ther Exp (Warsz). 2005 Mar-Apr;53(2):151-8.
146 Integrated 'omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes. Toxicol Lett. 2018 Jun 1;289:1-13.
147 Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. PLoS One. 2012;7(12):e53003. doi: 10.1371/journal.pone.0053003. Epub 2012 Dec 27.
148 Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs. J Biomol Screen. 2007 Apr;12(3):328-40. doi: 10.1177/1087057107299261. Epub 2007 Mar 22.
149 Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):27-35.
150 Retinoic acid-induced downmodulation of telomerase activity in human cancer cells. Exp Mol Pathol. 2005 Oct;79(2):108-17.
151 Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol. 2011 Dec;28(4):1225-54.
152 Detection of the mechanism of immunotoxicity of cyclosporine A in murine in vitro and in vivo models. Arch Toxicol. 2015 Dec;89(12):2325-37. doi: 10.1007/s00204-014-1365-9. Epub 2014 Sep 17.
153 Oxidative stress modulates KLF6Full and its splice variants. Alcohol Clin Exp Res. 2012 Nov;36(11):1851-62. doi: 10.1111/j.1530-0277.2012.01798.x. Epub 2012 Apr 6.
154 Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells. Cancer Sci. 2007 Jun;98(6):890-9.
155 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
156 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
157 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
158 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
159 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
160 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
161 Activin/nodal signaling switches the terminal fate of human embryonic stem cell-derived trophoblasts. J Biol Chem. 2015 Apr 3;290(14):8834-48.
162 PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J Exp Med. 2006 Oct 2;203(10):2351-62.
163 An approach to elucidate potential mechanism of renal toxicity of arsenic trioxide. Exp Hematol. 2007 Feb;35(2):252-62.
164 Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021 May 28;14:673144. doi: 10.3389/fnmol.2021.673144. eCollection 2021.
165 Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells. J Cell Biochem. 2006 Aug 1;98(5):1163-84.
166 Transcriptome-based functional classifiers for direct immunotoxicity. Arch Toxicol. 2014 Mar;88(3):673-89.
167 Classification of heavy-metal toxicity by human DNA microarray analysis. Environ Sci Technol. 2007 May 15;41(10):3769-74.
168 Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis. Biochem Pharmacol. 2004 Dec 1;68(11):2177-86.
169 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
170 Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNF-mediated hepatotoxicity. Toxicol Sci. 2014 Jul;140(1):144-59. doi: 10.1093/toxsci/kfu072. Epub 2014 Apr 20.
171 Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions. Toxicol In Vitro. 2009 Apr;23(3):466-75. doi: 10.1016/j.tiv.2008.12.018. Epub 2008 Dec 30.
172 Cannabidiol-induced transcriptomic changes and cellular senescence in human Sertoli cells. Toxicol Sci. 2023 Feb 17;191(2):227-238. doi: 10.1093/toxsci/kfac131.
173 mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels. Cancer Sci. 2008 Oct;99(10):1992-2003. doi: 10.1111/j.1349-7006.2008.00955.x.
174 Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury. Arch Toxicol. 2020 Apr;94(4):1151-1172. doi: 10.1007/s00204-020-02691-9. Epub 2020 Mar 10.
175 Analysis of the transcriptional regulation of cancer-related genes by aberrant DNA methylation of the cis-regulation sites in the promoter region during hepatocyte carcinogenesis caused by arsenic. Oncotarget. 2015 Aug 28;6(25):21493-506. doi: 10.18632/oncotarget.4085.
176 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
177 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
178 The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide. Exp Hematol. 2011 Jan;39(1):55-65.
179 ON 01910.Na is selectively cytotoxic for chronic lymphocytic leukemia cells through a dual mechanism of action involving PI3K/AKT inhibition and induction of oxidative stress. Clin Cancer Res. 2012 Apr 1;18(7):1979-91. doi: 10.1158/1078-0432.CCR-11-2113. Epub 2012 Feb 20.
180 Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma. Int J Cancer. 2015 May 1;136(9):2055-64.
181 Comparison of transcriptome expression alterations by chronic exposure to low-dose bisphenol A in different subtypes of breast cancer cells. Toxicol Appl Pharmacol. 2019 Dec 15;385:114814. doi: 10.1016/j.taap.2019.114814. Epub 2019 Nov 9.
182 Cyclosporine A--induced oxidative stress in human renal mesangial cells: a role for ERK 1/2 MAPK signaling. Toxicol Sci. 2012 Mar;126(1):101-13.
183 Arsenic exposure, telomere length, and expression of telomere-related genes among Bangladeshi individuals. Environ Res. 2015 Jan;136:462-9. doi: 10.1016/j.envres.2014.09.040. Epub 2014 Nov 25.
184 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
185 Microarray analysis of bicalutamide action on telomerase activity, p53 pathway and viability of prostate carcinoma cell lines. J Pharm Pharmacol. 2005 Jan;57(1):83-92.
186 Chronic cyclophosphamide exposure alters the profile of rat sperm nuclear matrix proteins. Biol Reprod. 2007 Aug;77(2):303-11. doi: 10.1095/biolreprod.107.060244. Epub 2007 May 2.
187 Motexafin gadolinium and zinc induce oxidative stress responses and apoptosis in B-cell lymphoma lines. Cancer Res. 2005 Dec 15;65(24):11676-88.
188 Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line. Mol Cancer Ther. 2009 May;8(5):1197-206.
189 Repurposing L-menthol for systems medicine and cancer therapeutics? L-menthol induces apoptosis through caspase 10 and by suppressing HSP90. OMICS. 2016 Jan;20(1):53-64.
190 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
191 The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):124-34.
192 Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer. BMC Genomics. 2006 Apr 3;7:68. doi: 10.1186/1471-2164-7-68.
193 Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787-95.
194 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
195 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
196 Identification of vitamin D3 target genes in human breast cancer tissue. J Steroid Biochem Mol Biol. 2016 Nov;164:90-97.
197 Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia. J Exp Med. 2010 Apr 12;207(4):731-50. doi: 10.1084/jem.20091488. Epub 2010 Apr 5.
198 Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium. Mol Hum Reprod. 2007 Sep;13(9):641-54.
199 Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta. Mol Biol Cell. 2004 Mar;15(3):1262-72. doi: 10.1091/mbc.e03-06-0360. Epub 2003 Dec 29.
200 Unique signatures of stress-induced senescent human astrocytes. Exp Neurol. 2020 Dec;334:113466. doi: 10.1016/j.expneurol.2020.113466. Epub 2020 Sep 17.
201 Effect of spironolactone on impaired fibrinolysis of hypertensive patients. Kidney Blood Press Res. 2002;25(4):260-4. doi: 10.1159/000066348.
202 Involvement of retinoic acid receptor alpha in the stimulation of tissue-type plasminogen-activator gene expression in human endothelial cells. Eur J Biochem. 1995 Sep 1;232(2):425-32.
203 Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation. J Heart Lung Transplant. 1999 Jul;18(7):693-700. doi: 10.1016/s1053-2498(99)00021-2.
204 Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering. Kidney Int. 2002 Nov;62(5):1611-9. doi: 10.1046/j.1523-1755.2002.00601.x.
205 Non-nutritional sweeteners effects on endothelial vascular function. Toxicol In Vitro. 2020 Feb;62:104694. doi: 10.1016/j.tiv.2019.104694. Epub 2019 Oct 23.
206 Indomethacin activates carbonic anhydrase and antagonizes the effect of the specific carbonic anhydrase inhibitor acetazolamide, by a direct mechanism of action. Int J Clin Pharmacol Ther. 2001 Jun;39(6):265-70.
207 Effects of beta-adrenergic agonists on bone-resorbing activity in human osteoclast-like cells. Biochim Biophys Acta. 2003 May 12;1640(2-3):137-42.
208 Inhibition profiling of human carbonic anhydrase II by high-throughput screening of structurally diverse, biologically active compounds. J Biomol Screen. 2006 Oct;11(7):782-91.
209 Design, synthesis, and biological evaluation of novel carbohydrate-based sulfamates as carbonic anhydrase inhibitors. J Med Chem. 2011 Mar 10;54(5):1481-9.
210 Inhibition profiles of Voriconazole against acetylcholinesterase, -glycosidase, and human carbonic anhydrase I and II isoenzymes. J Biochem Mol Toxicol. 2019 Oct;33(10):e22385. doi: 10.1002/jbt.22385. Epub 2019 Sep 3.
211 Acetaminophen-induced proliferation of estrogen-responsive breast cancer cells is associated with increases in c-myc RNA expression and NF-kappaB activity. Toxicol Sci. 2002 Apr;66(2):233-43. doi: 10.1093/toxsci/66.2.233.
212 Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. J Mol Endocrinol. 2004 Apr;32(2):397-414.
213 ZD1839 induces p15INK4b and causes G1 arrest by inhibiting the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway. Mol Cancer Ther. 2007 May;6(5):1579-87. doi: 10.1158/1535-7163.MCT-06-0814.
214 Selenite and selenomethionine promote HL-60 cell cycle progression. J Nutr. 2002 Apr;132(4):674-9. doi: 10.1093/jn/132.4.674.
215 Ribavirin augments doxorubicin's efficacy in human hepatocellular carcinoma through inhibiting doxorubicin-induced eIF4E activation. J Biochem Mol Toxicol. 2018 Jan;32(1). doi: 10.1002/jbt.22007. Epub 2017 Nov 7.
216 Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner. Clin Cancer Res. 2012 Aug 15;18(16):4345-55. doi: 10.1158/1078-0432.CCR-11-3227. Epub 2012 Jun 25.
217 Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. Cancer Res. 2002 Nov 1;62(21):6006-10.
218 The contribution of methotrexate exposure and host factors on transcriptional variance in human liver. Toxicol Sci. 2007 Jun;97(2):582-94.
219 Persistent and non-persistent changes in gene expression result from long-term estrogen exposure of MCF-7 breast cancer cells. J Steroid Biochem Mol Biol. 2011 Feb;123(3-5):140-50.
220 Arsenite and cadmium promote the development of mammary tumors. Carcinogenesis. 2020 Jul 14;41(7):1005-1014. doi: 10.1093/carcin/bgz176.
221 Comparative effects of microtubules disruption on glucocorticoid receptor functions in proliferating and quiescent cells. Int J Toxicol. 2010 May-Jun;29(3):326-35. doi: 10.1177/1091581810366486.
222 Adipocyte differentiation, mitochondrial gene expression and fat distribution: differences between zidovudine and tenofovir after 6 months. Antivir Ther. 2009;14(8):1089-100. doi: 10.3851/IMP1457.
223 Effects of all-trans and 9-cis retinoic acid on differentiating human neural stem cells in vitro. Toxicology. 2023 Mar 15;487:153461. doi: 10.1016/j.tox.2023.153461. Epub 2023 Feb 16.
224 Inhibition of norepinephrine-induced cardiac hypertrophy in s100beta transgenic mice. J Clin Invest. 1998 Oct 15;102(8):1609-16. doi: 10.1172/JCI3077.
225 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
226 An evaluation of myeloperoxidase-mediated bio-activation of NSAIDs in promyelocytic leukemia (HL-60) cells for potential cytotoxic selectivity. Toxicol Lett. 2017 Oct 5;280:48-56.
227 Differentiation between stoichiometric and anticatalytic antioxidant properties of benzoic acid analogues: a structure/redox potential relationship study. Chem Biol Interact. 2013 Nov 25;206(2):194-203.
228 Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2716-23.
229 Effect of anti-rheumatic drugs on the release of lysosomal enzymes from human leukocytes. Z Rheumatol. 1984 Jan-Feb;43(1):23-6.
230 Benzodithiophenes induce differentiation and apoptosis in human leukemia cells. Cancer Res. 2005 Sep 1;65(17):7847-55. doi: 10.1158/0008-5472.CAN-05-1053.
231 Inhibition of oxidation activity of myeloperoxidase (MPO) by propylthiouracil (PTU) and anti-MPO antibodies from patients with PTU-induced vasculitis. Clin Immunol. 2007 Feb;122(2):187-93. doi: 10.1016/j.clim.2006.09.011. Epub 2006 Oct 27.
232 Benzo[a]pyrene-induced changes in microRNA-mRNA networks. Chem Res Toxicol. 2012 Apr 16;25(4):838-49.
233 Phenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts. J Periodontol. 2000 Jun;71(6):955-60. doi: 10.1902/jop.2000.71.6.955.
234 The antimalarial amodiaquine causes autophagic-lysosomal and proliferative blockade sensitizing human melanoma cells to starvation- and chemotherapy-induced cell death. Autophagy. 2013 Dec;9(12):2087-102. doi: 10.4161/auto.26506. Epub 2013 Oct 8.
235 A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo. Carcinogenesis. 2012 Jul;33(7):1421-9.
236 A role for the autophagy regulator Transcription Factor EB in amiodarone-induced phospholipidosis. Biochem Pharmacol. 2015 Jun 1;95(3):201-9. doi: 10.1016/j.bcp.2015.03.017. Epub 2015 Apr 13.
237 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
238 5-Fluorouracil up-regulates interferon pathway gene expression in esophageal cancer cells. Anticancer Res. 2005 Sep-Oct;25(5):3271-8.
239 Moving toward integrating gene expression profiling into high-throughput testing: a gene expression biomarker accurately predicts estrogen receptor alpha modulation in a microarray compendium. Toxicol Sci. 2016 May;151(1):88-103.
240 Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagn Lab Immunol. 2004 Jan;11(1):63-9. doi: 10.1128/cdli.11.1.63-69.2004.
241 Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells. J Pharmacol Exp Ther. 2003 Jun;305(3):932-42. doi: 10.1124/jpet.103.049098. Epub 2003 Mar 20.
242 Hypomethylation mediated by decreased DNMTs involves in the activation of proto-oncogene MPL in TK6 cells treated with hydroquinone. Toxicol Lett. 2012 Mar 25;209(3):239-45. doi: 10.1016/j.toxlet.2011.12.020. Epub 2012 Jan 8.
243 Thalidomide alters c-MYB and PIM-1 signaling in K-562 cells. Pharmacol Res. 2006 Aug;54(2):91-6. doi: 10.1016/j.phrs.2006.02.010. Epub 2006 Mar 8.
244 Global effects of inorganic arsenic on gene expression profile in human macrophages. Mol Immunol. 2009 Feb;46(4):649-56.
245 Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages. Antivir Ther. 2007;12(4):489-500.
246 Crosstalk between alveolar macrophages and alveolar epithelial cells/fibroblasts contributes to the pulmonary toxicity of gefitinib. Toxicol Lett. 2021 Mar 1;338:1-9. doi: 10.1016/j.toxlet.2020.11.011. Epub 2020 Nov 25.
247 Oxidative Stress Alters miRNA and Gene Expression Profiles in Villous First Trimester Trophoblasts. Biomed Res Int. 2015;2015:257090. doi: 10.1155/2015/257090. Epub 2015 Aug 3.
248 Cannabidiol selectively modulates interleukin (IL)-1 and IL-6 production in toll-like receptor activated human peripheral blood monocytes. Toxicology. 2021 Dec;464:153016. doi: 10.1016/j.tox.2021.153016. Epub 2021 Nov 2.
249 Monitoring of deiodinase deficiency based on transcriptomic responses in SH-SY5Y cells. Arch Toxicol. 2013 Jun;87(6):1103-13. doi: 10.1007/s00204-013-1018-4. Epub 2013 Feb 10.
250 Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1194-9. doi: 10.1161/01.atv.0000022694.16328.cc.
251 Plant polyphenols differentially modulate inflammatory responses of human keratinocytes by interfering with activation of transcription factors NFB and AhR and EGFR-ERK pathway. Toxicol Appl Pharmacol. 2011 Sep 1;255(2):138-49.
252 JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells. Oncogene. 2008 Aug 28;27(37):5033-44.
253 Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity. Cell Biol Toxicol. 2021 Apr;37(2):151-175. doi: 10.1007/s10565-020-09537-1. Epub 2020 Jun 14.
254 Editor's Highlight: Mechanistic Toxicity Tests Based on an Adverse Outcome Pathway Network for Hepatic Steatosis. Toxicol Sci. 2017 Sep 1;159(1):159-169. doi: 10.1093/toxsci/kfx121.
255 Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy. Thromb Res. 2004;113(3-4):197-204. doi: 10.1016/j.thromres.2004.03.002.
256 Effect of the Catechol-O-Methyltransferase Inhibitors Tolcapone and Entacapone on Fatty Acid Metabolism in HepaRG Cells. Toxicol Sci. 2018 Aug 1;164(2):477-488.
257 Regulation of CD36 expression in human melanoma cells. Adv Exp Med Biol. 2002;507:337-42. doi: 10.1007/978-1-4615-0193-0_52.
258 Comparative study of the effects of ziram and disulfiram on human monocyte-derived macrophage functions and polarization: involvement of zinc. Cell Biol Toxicol. 2021 Jun;37(3):379-400. doi: 10.1007/s10565-020-09540-6. Epub 2020 Jul 25.
259 Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial. Eur J Pharmacol. 2004 Sep 24;499(3):315-24. doi: 10.1016/j.ejphar.2004.07.114.
260 Cyclooxygenase-independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer. J Biol Chem. 2003 Nov 28;278(48):47762-75.
261 Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells. Biochem J. 2006 Feb 15;394(Pt 1):317-24.
262 Human oligodendrocytes derived from embryonic stem cells: Effect of noggin on phenotypic differentiation in vitro and on myelination in vivo. Mol Cell Neurosci. 2007 Mar;34(3):310-23. doi: 10.1016/j.mcn.2006.11.008. Epub 2006 Dec 28.
263 2,3,7,8-tetrachlorodibenzo-p-dioxin augments the modulation of gene expression mediated by the thyroid hormone receptor. Toxicol Appl Pharmacol. 2004 Feb 1;194(3):201-10. doi: 10.1016/j.taap.2003.09.010.
264 Nucleophosmin in the pathogenesis of arsenic-related bladder carcinogenesis revealed by quantitative proteomics. Toxicol Appl Pharmacol. 2010 Jan 15;242(2):126-35. doi: 10.1016/j.taap.2009.09.016. Epub 2009 Oct 7.
265 Expression profiling of nucleotide metabolism-related genes in human breast cancer cells after treatment with 5-fluorouracil. Cancer Invest. 2009 Jun;27(5):561-7.
266 Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model. Toxicol In Vitro. 2009 Oct;23(7):1387-95.
267 Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line. Nucl Med Biol. 2006 Oct;33(7):875-82. doi: 10.1016/j.nucmedbio.2006.07.004.
268 Ethinylestradiol and testosterone have divergent effects on circulating IGF system components in adolescents with constitutional tall stature. Eur J Endocrinol. 2005 Apr;152(4):597-604. doi: 10.1530/eje.1.01880.
269 Proteomic and functional analyses reveal a dual molecular mechanism underlying arsenic-induced apoptosis in human multiple myeloma cells. J Proteome Res. 2009 Jun;8(6):3006-19.
270 Changes in composition and activities of 26S proteasomes under the action of doxorubicin--apoptosis inductor of erythroleukemic K562 cells. Cell Biol Int. 2007 Apr;31(4):338-48. doi: 10.1016/j.cellbi.2007.01.018. Epub 2007 Jan 21.
271 Quercetin induces the expression of peroxiredoxins 3 and 5 via the Nrf2/NRF1 transcription pathway. Invest Ophthalmol Vis Sci. 2011 Feb 22;52(2):1055-63. doi: 10.1167/iovs.10-5777.
272 Downregulation of the c-MYC target gene, peroxiredoxin III, contributes to arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Int J Cancer. 2009 Jul 15;125(2):264-75. doi: 10.1002/ijc.24341.
273 Mitochondrial proteomics investigation of a cellular model of impaired dopamine homeostasis, an early step in Parkinson's disease pathogenesis. Mol Biosyst. 2014 Jun;10(6):1332-44.
274 Proteomic profile of aminoglutethimide-induced apoptosis in HL-60 cells: role of myeloperoxidase and arylamine free radicals. Chem Biol Interact. 2015 Sep 5;239:129-38.
275 Gene expression profile changes in NB4 cells induced by arsenic trioxide. Acta Pharmacol Sin. 2003 Jul;24(7):646-50.
276 Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts. Mol Cancer. 2010 Jun 27;9:168.
277 Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 2009 Aug 21;138(4):645-659. doi: 10.1016/j.cell.2009.06.034. Epub 2009 Aug 13.
278 HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo. Circulation. 2005 Mar 22;111(11):1439-47. doi: 10.1161/01.CIR.0000158484.18024.1F.
279 Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome. Blood. 2009 Dec 24;114(27):5512-21. doi: 10.1182/blood-2009-02-204834. Epub 2009 Oct 14.
280 Role of MCP-1 in alcohol-induced aggressiveness of colorectal cancer cells. Mol Carcinog. 2016 May;55(5):1002-11. doi: 10.1002/mc.22343. Epub 2015 May 25.
281 Differential regulation of CC chemokine receptors by 9-cis retinoic acid in the human mast cell line, HMC-1. Life Sci. 2006 Aug 22;79(13):1293-300. doi: 10.1016/j.lfs.2006.03.046. Epub 2006 Apr 22.
282 Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer. Mol Oncol. 2011 Oct;5(5):438-53. doi: 10.1016/j.molonc.2011.07.003. Epub 2011 Jul 26.
283 Responsiveness of human monocyte-derived dendritic cells to thimerosal and mercury derivatives. Toxicol Appl Pharmacol. 2010 Jul;246(1-2):66-73. doi: 10.1016/j.taap.2010.04.007. Epub 2010 Apr 22.
284 Regulatory role of nitric oxide on monocyte-derived dendritic cell functions. J Interferon Cytokine Res. 2003 Aug;23(8):423-31. doi: 10.1089/107999003322277838.
285 A plasmacytoid dendritic cell (CD123+/CD11c-) based assay system to predict contact allergenicity of chemicals. Toxicology. 2009 Oct 1;264(1-2):1-9. doi: 10.1016/j.tox.2009.07.021. Epub 2009 Aug 7.
286 Differential effects of statins on relevant functions of human monocyte-derived dendritic cells. J Leukoc Biol. 2006 Mar;79(3):529-38. doi: 10.1189/jlb.0205064. Epub 2005 Dec 30.
287 Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J Biol Chem. 1999 Jun 18;274(25):17580-6. doi: 10.1074/jbc.274.25.17580.
288 Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathways. BMC Cancer. 2005 Jul 7;5:74. doi: 10.1186/1471-2407-5-74.
289 Molecular mechanisms underlying the inhibition of IFN--induced, STAT1-mediated gene transcription in human macrophages by simvastatin and agonists of PPARs and LXRs. J Cell Biochem. 2011 Feb;112(2):675-83. doi: 10.1002/jcb.22976.
290 Quercetin and Its Fermented Extract as a Potential Inhibitor of Bisphenol A-Exposed HT-29 Colon Cancer Cells' Viability. Int J Mol Sci. 2023 Mar 15;24(6):5604. doi: 10.3390/ijms24065604.
291 Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regulated gene expression. Cancer Res. 2005 Sep 1;65(17):7856-65. doi: 10.1158/0008-5472.CAN-05-1056.
292 Identification of mechanisms of action of bisphenol a-induced human preadipocyte differentiation by transcriptional profiling. Obesity (Silver Spring). 2014 Nov;22(11):2333-43.
293 Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells. Carcinogenesis. 2006 Aug;27(8):1567-78.
294 Association of PTGER gene family polymorphisms with aspirin intolerant asthma in Korean asthmatics. BMB Rep. 2010 Jun;43(6):445-9. doi: 10.5483/bmbrep.2010.43.6.445.
295 Suppressive effects of antimycotics on tumor necrosis factor-alpha-induced CCL27, CCL2, and CCL5 production in human keratinocytes. Biochem Pharmacol. 2006 Aug 14;72(4):463-73. doi: 10.1016/j.bcp.2006.05.001. Epub 2006 Jun 19.
296 Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity. Blood. 2007 May 15;109(10):4450-60.
297 Inhibition of nicotinamide phosphoribosyltransferase and depletion of nicotinamide adenine dinucleotide contribute to arsenic trioxide suppression of oral squamous cell carcinoma. Toxicol Appl Pharmacol. 2017 Sep 15;331:54-61. doi: 10.1016/j.taap.2017.05.008. Epub 2017 May 10.
298 Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med. 2002 Nov 15;33(10):1419-32.
299 Bone marrow osteoblast damage by chemotherapeutic agents. PLoS One. 2012;7(2):e30758. doi: 10.1371/journal.pone.0030758. Epub 2012 Feb 17.
300 Progesterone regulation of implantation-related genes: new insights into the role of oestrogen. Cell Mol Life Sci. 2007 Apr;64(7-8):1009-32.
301 Comparative proteomics reveals concordant and discordant biochemical effects of caffeine versus epigallocatechin-3-gallate in human endothelial cells. Toxicol Appl Pharmacol. 2019 Sep 1;378:114621. doi: 10.1016/j.taap.2019.114621. Epub 2019 Jun 10.
302 Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies. J Biol Chem. 2019 Oct 18;294(42):15218-15234. doi: 10.1074/jbc.RA119.009147. Epub 2019 Jul 8.
303 Cannabidiol Modulates the Expression of Alzheimer's Disease-Related Genes in Mesenchymal Stem Cells. Int J Mol Sci. 2016 Dec 23;18(1):26. doi: 10.3390/ijms18010026.
304 Effects and mechanisms of betulinic acid on improving EGFR TKI-resistance of lung cancer cells. Environ Toxicol. 2018 Nov;33(11):1153-1159.
305 The protective effects of liraglutide on AD-like neurodegeneration induced by oxidative stress in human neuroblastoma SH-SY5Y cells. Chem Biol Interact. 2019 Sep 1;310:108688. doi: 10.1016/j.cbi.2019.06.001. Epub 2019 Jun 4.
306 Dysregulation of integrin-linked kinase (ILK) signaling in colonic polyposis. Oncogene. 2001 Sep 27;20(43):6250-7. doi: 10.1038/sj.onc.1204791.
307 Differential effects of simvastatin and pravastatin on expression of Alzheimer's disease-related genes in human astrocytes and neuronal cells. J Lipid Res. 2009 Oct;50(10):2095-102. doi: 10.1194/jlr.M900236-JLR200. Epub 2009 May 21.
308 Quercetin potentiates apoptosis by inhibiting nuclear factor-kappaB signaling in H460 lung cancer cells. Biol Pharm Bull. 2013;36(6):944-51. doi: 10.1248/bpb.b12-01004.
309 Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone. Chem Biol Interact. 2010 Oct 6;188(1):75-85. doi: 10.1016/j.cbi.2010.06.001. Epub 2010 Jun 9.
310 NGBR is required to ameliorate type 2 diabetes in mice by enhancing insulin sensitivity. J Biol Chem. 2021 Jan-Jun;296:100624. doi: 10.1016/j.jbc.2021.100624. Epub 2021 Apr 2.
311 Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse model. Ann Oncol. 2008 Aug;19(8):1488-1494. doi: 10.1093/annonc/mdn056. Epub 2008 Mar 17.
312 BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITD. Mol Cancer Ther. 2014 Oct;13(10):2315-27. doi: 10.1158/1535-7163.MCT-14-0258. Epub 2014 Jul 22.
313 Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma. Cancer Discov. 2012 Jul;2(7):591-7. doi: 10.1158/2159-8290.CD-12-0028. Epub 2012 Jun 15.
314 Differential effect of dexamethasone on cell death and STAT5 activation during in vitro eosinopoiesis. Br J Haematol. 2003 Dec;123(5):933-41. doi: 10.1046/j.1365-2141.2003.04700.x.
315 Progesterone pre-treatment potentiates EGF pathway signaling in the breast cancer cell line ZR-75. Breast Cancer Res Treat. 2005 Nov;94(2):171-83. doi: 10.1007/s10549-005-7726-6.
316 Gene expression signatures after ethanol exposure in differentiating embryoid bodies. Toxicol In Vitro. 2018 Feb;46:66-76.
317 Folic acid supplementation dysregulates gene expression in lymphoblastoid cells--implications in nutrition. Biochem Biophys Res Commun. 2011 Sep 9;412(4):688-92. doi: 10.1016/j.bbrc.2011.08.027. Epub 2011 Aug 16.
318 Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma. PLoS One. 2011;6(8):e23569.
319 Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation. Br J Pharmacol. 2011 Apr;162(8):1743-56.
320 Levonorgestrel enhances spermatogenesis suppression by testosterone with greater alteration in testicular gene expression in men. Biol Reprod. 2009 Mar;80(3):484-92.
321 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
322 Epigenetic silencing of novel tumor suppressors in malignant melanoma. Cancer Res. 2006 Dec 1;66(23):11187-93. doi: 10.1158/0008-5472.CAN-06-1274.
323 Changes in gene expression profiles of multiple myeloma cells induced by arsenic trioxide (ATO): possible mechanisms to explain ATO resistance in vivo. Br J Haematol. 2005 Mar;128(5):636-44.
324 Clinical determinants of response to irinotecan-based therapy derived from cell line models. Clin Cancer Res. 2008 Oct 15;14(20):6647-55.
325 Gene expression profile of multiple myeloma cell line treated by arsenic trioxide. J Huazhong Univ Sci Technolog Med Sci. 2007 Dec;27(6):646-9. doi: 10.1007/s11596-007-0606-z.
326 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
327 Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment. Arch Toxicol. 2016 Nov;90(11):2763-2777.
328 Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population. Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1367-75. doi: 10.1158/1055-9965.EPI-06-0106.
329 Gene expression in endometrial cancer cells (Ishikawa) after short time high dose exposure to progesterone. Steroids. 2008 Jan;73(1):116-28.
330 Expression profile analysis of colon cancer cells in response to sulindac or aspirin. Biochem Biophys Res Commun. 2002 Mar 29;292(2):498-512.
331 Interactive gene expression pattern in prostate cancer cells exposed to phenolic antioxidants. Life Sci. 2002 Mar 1;70(15):1821-39.
332 Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine. Arch Toxicol. 2014 Mar;88(3):609-23. doi: 10.1007/s00204-013-1169-3. Epub 2013 Nov 30.
333 Comparison of base-line and chemical-induced transcriptomic responses in HepaRG and RPTEC/TERT1 cells using TempO-Seq. Arch Toxicol. 2018 Aug;92(8):2517-2531.
334 Riboflavin depletion impairs cell proliferation in adult human duodenum: identification of potential effectors. Dig Dis Sci. 2011 Apr;56(4):1007-19. doi: 10.1007/s10620-010-1374-3. Epub 2010 Sep 17.
335 Identification of biomarkers and outcomes of endocrine disruption in human ovarian cortex using In Vitro Models. Toxicology. 2023 Feb;485:153425. doi: 10.1016/j.tox.2023.153425. Epub 2023 Jan 5.
336 The effect of DNA methylation inhibitor 5-Aza-2'-deoxycytidine on human endometrial stromal cells. Hum Reprod. 2010 Nov;25(11):2859-69.
337 NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells. J Biol Chem. 2019 May 24;294(21):8543-8554. doi: 10.1074/jbc.RA118.006983. Epub 2019 Apr 2.
338 Presenilin-2 regulates the degradation of RBP-Jk protein through p38 mitogen-activated protein kinase. J Cell Sci. 2012 Mar 1;125(Pt 5):1296-308. doi: 10.1242/jcs.095984. Epub 2012 Feb 2.
339 Epigenetic changes in individuals with arsenicosis. Chem Res Toxicol. 2011 Feb 18;24(2):165-7. doi: 10.1021/tx1004419. Epub 2011 Feb 4.
340 Histamine up-regulates phosphodiesterase 4 activity and reduces prostaglandin E2-inhibitory effects in human neutrophils. Inflamm Res. 2000 Nov;49(11):600-9. doi: 10.1007/s000110050637.
341 Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res. 2023 Jan 18;83(2):181-194. doi: 10.1158/0008-5472.CAN-22-1029.
342 In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cells. Mol Cancer Ther. 2005 Jun;4(6):885-900.
343 Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur J Nutr. 2005 Mar;44(3):143-56. doi: 10.1007/s00394-004-0503-1. Epub 2004 Apr 30.
344 Peroxisome proliferator activated receptor gamma (PPAR-gama) ligand pioglitazone regulated gene networks in term human primary trophoblast cells. Reprod Toxicol. 2018 Oct;81:99-107.
345 Prediction of the contact sensitizing potential of chemicals using analysis of gene expression changes in human THP-1 monocytes. Toxicol Lett. 2010 Nov 10;199(1):51-9.
346 Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis. Toxicol Appl Pharmacol. 2016 Jul 1;302:1-9. doi: 10.1016/j.taap.2016.04.007. Epub 2016 Apr 16.
347 In vitro assessment of drug-induced liver steatosis based on human dermal stem cell-derived hepatic cells. Arch Toxicol. 2016 Mar;90(3):677-89. doi: 10.1007/s00204-015-1483-z. Epub 2015 Feb 26.
348 Replacement per- and polyfluoroalkyl substances (PFAS) are potent modulators of lipogenic and drug metabolizing gene expression signatures in primary human hepatocytes. Toxicol Appl Pharmacol. 2022 May 1;442:115991. doi: 10.1016/j.taap.2022.115991. Epub 2022 Mar 23.
349 Integrated analysis of rifampicin-induced microRNA and gene expression changes in human hepatocytes. Drug Metab Pharmacokinet. 2014;29(4):333-40.
350 Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity. Eur J Cancer. 1997 Nov;33(13):2258-64. doi: 10.1016/s0959-8049(97)00261-x.
351 DPD is a molecular determinant of capecitabine efficacy in colorectal cancer. Int J Oncol. 2007 Aug;31(2):413-8.
352 Dihydropyrimidine dehydrogenases and cytidine-deaminase gene polymorphisms as outcome predictors in resected gastric cancer patients treated with fluoropyrimidine adjuvant chemotherapy. J Surg Oncol. 2008 Aug 1;98(2):130-4.
353 Identification of novel low-dose bisphenol a targets in human foreskin fibroblast cells derived from hypospadias patients. PLoS One. 2012;7(5):e36711. doi: 10.1371/journal.pone.0036711. Epub 2012 May 4.
354 LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4179-E4188.
355 Antiepileptic drugs are endocrine disruptors for the human fetal testis ex vivo. Toxicol Sci. 2023 Sep 28;195(2):169-183. doi: 10.1093/toxsci/kfad076.
356 Increased mitochondrial ROS formation by acetaminophen in human hepatic cells is associated with gene expression changes suggesting disruption of the mitochondrial electron transport chain. Toxicol Lett. 2015 Apr 16;234(2):139-50.
357 Gene alterations of ovarian cancer cells expressing estrogen receptors by estrogen and bisphenol a using microarray analysis. Lab Anim Res. 2011 Jun;27(2):99-107. doi: 10.5625/lar.2011.27.2.99. Epub 2011 Jun 22.
358 Hypoxia-inducible factor-1 (HIF-1) pathway activation by quercetin in human lens epithelial cells. Exp Eye Res. 2009 Dec;89(6):995-1002. doi: 10.1016/j.exer.2009.08.011. Epub 2009 Sep 1.
359 Screening autism-associated environmental factors in differentiating human neural progenitors with fractional factorial design-based transcriptomics. Sci Rep. 2023 Jun 29;13(1):10519. doi: 10.1038/s41598-023-37488-0.
360 Effect of prenatal arsenic exposure on DNA methylation and leukocyte subpopulations in cord blood. Epigenetics. 2014 May;9(5):774-82. doi: 10.4161/epi.28153. Epub 2014 Feb 13.
361 Bisphenol A effects on gene expression in adipocytes from children: association with metabolic disorders. J Mol Endocrinol. 2015 Jun;54(3):289-303.
362 Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells. Mol Cancer Ther. 2014 May;13(5):1142-54.
363 Direct activation of ATM by resveratrol under oxidizing conditions. PLoS One. 2014 Jun 16;9(6):e97969. doi: 10.1371/journal.pone.0097969. eCollection 2014.
364 Distinct genetic profile in peripheral blood mononuclear cells of psoriatic arthritis patients treated with methotrexate and TNF-inhibitors. Clin Rheumatol. 2014 Dec;33(12):1815-21. doi: 10.1007/s10067-014-2807-8. Epub 2014 Oct 24.
365 Integrative "-Omics" analysis in primary human hepatocytes unravels persistent mechanisms of cyclosporine A-induced cholestasis. Chem Res Toxicol. 2016 Dec 19;29(12):2164-2174.
366 Role of phenytoin in wound healing: microarray analysis of early transcriptional responses in human dermal fibroblasts. Biochem Biophys Res Commun. 2004 Feb 13;314(3):661-6. doi: 10.1016/j.bbrc.2003.12.146.
367 Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells. Biochem J. 2011 Sep 1;438(2):349-58. doi: 10.1042/BJ20101653.
368 Hepatocyte growth factor receptor signaling mediates the anti-fibrotic action of 9-cis-retinoic acid in glomerular mesangial cells. Am J Pathol. 2005 Oct;167(4):947-57. doi: 10.1016/S0002-9440(10)61185-6.
369 Transcriptome dynamics of alternative splicing events revealed early phase of apoptosis induced by methylparaben in H1299 human lung carcinoma cells. Arch Toxicol. 2020 Jan;94(1):127-140. doi: 10.1007/s00204-019-02629-w. Epub 2019 Nov 20.
370 CBD Promotes Oral Ulcer Healing via Inhibiting CMPK2-Mediated Inflammasome. J Dent Res. 2022 Feb;101(2):206-215. doi: 10.1177/00220345211024528. Epub 2021 Jul 16.
371 Cardiac toxicity from ethanol exposure in human-induced pluripotent stem cell-derived cardiomyocytes. Toxicol Sci. 2019 May 1;169(1):280-292.
372 Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem. 2012 Dec 14;287(51):43137-55.
373 Cystathionine metabolic enzymes play a role in the inflammation resolution of human keratinocytes in response to sub-cytotoxic formaldehyde exposure. Toxicol Appl Pharmacol. 2016 Nov 1;310:185-194.
374 CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. J Clin Invest. 2016 Feb;126(2):639-52.
375 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
376 Effects of progesterone treatment on expression of genes involved in uterine quiescence. Reprod Sci. 2011 Aug;18(8):781-97.
377 Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine. Clin Pharmacol Ther. 2006 Nov;80(5):440-456.
378 Role of transporter genes in cisplatin resistance. In Vivo. 2008 May-Jun;22(3):279-83.
379 Persistence of epigenomic effects after recovery from repeated treatment with two nephrocarcinogens. Front Genet. 2018 Dec 3;9:558.
380 Effects of chronic rosiglitazone therapy on gene expression in human adipose tissue in vivo in patients with type 2 diabetes. J Clin Endocrinol Metab. 2007 Feb;92(2):720-4.
381 Microarray analysis of bisphenol A-induced changes in gene expression in human oral epithelial cells. Acta Biochim Biophys Sin (Shanghai). 2007 Nov;39(11):879-84. doi: 10.1111/j.1745-7270.2007.00351.x.
382 Effects of Perinatal Exposure to Dibutyltin Chloride on Fat and Glucose Metabolism in Mice, and Molecular Mechanisms, in Vitro. Environ Health Perspect. 2018 May 21;126(5):057006. doi: 10.1289/EHP3030. eCollection 2018 May.
383 Nuclear proteome analysis of cisplatin-treated HeLa cells. Mutat Res. 2010 Sep 10;691(1-2):1-8. doi: 10.1016/j.mrfmmm.2010.06.002. Epub 2010 Jun 9.
384 Human splicing factor SPF45 (RBM17) confers broad multidrug resistance to anticancer drugs when overexpressed--a phenotype partially reversed by selective estrogen receptor modulators. Cancer Res. 2005 Aug 1;65(15):6593-600. doi: 10.1158/0008-5472.CAN-03-3675.
385 Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer. 2006 Apr 1;118(7):1699-712. doi: 10.1002/ijc.21570.
386 Transcriptional signature of human macrophages exposed to the environmental contaminant benzo(a)pyrene. Toxicol Sci. 2010 Apr;114(2):247-59.
387 Gene expression network regulated by DNA methylation and microRNA during microcystin-leucine arginine induced malignant transformation in human hepatocyte L02 cells. Toxicol Lett. 2018 Jun 1;289:42-53. doi: 10.1016/j.toxlet.2018.03.003. Epub 2018 Mar 5.
388 Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. Environ Int. 2021 Nov;156:106730. doi: 10.1016/j.envint.2021.106730. Epub 2021 Jun 27.
389 A genomic approach to predict synergistic combinations for breast cancer treatment. Pharmacogenomics J. 2013 Feb;13(1):94-104. doi: 10.1038/tpj.2011.48. Epub 2011 Nov 15.
390 Triggering of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin induces Fas/CD95-mediated apoptosis of urothelial cancer cells in an ATM-dependent manner. Carcinogenesis. 2009 Aug;30(8):1320-9. doi: 10.1093/carcin/bgp138. Epub 2009 Jun 5.
391 Endoplasmic reticulum stress impairs insulin signaling through mitochondrial damage in SH-SY5Y cells. Neurosignals. 2012;20(4):265-80.
392 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
393 Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9. Oncotarget. 2016 Dec 13;7(50):83359-83377.
394 Effect of aflatoxin B(1), benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells. Food Chem Toxicol. 2018 Nov;121:214-223. doi: 10.1016/j.fct.2018.08.034. Epub 2018 Aug 26.
395 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
396 Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses. PLoS One. 2010 Dec 17;5(12):e14352. doi: 10.1371/journal.pone.0014352.
397 Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro. Toxicol Appl Pharmacol. 2012 Jan 15;258(2):166-75.
398 Characterization of antioxidant properties of natural killer-enhancing factor-B and induction of its expression by hydrogen peroxide. Toxicol Appl Pharmacol. 1997 Nov;147(1):135-42. doi: 10.1006/taap.1997.8270.
399 Consequences of the natural retinoid/retinoid X receptor ligands action in human breast cancer MDA-MB-231 cell line: Focus on functional proteomics. Toxicol Lett. 2017 Nov 5;281:26-34. doi: 10.1016/j.toxlet.2017.09.001. Epub 2017 Sep 5.
400 Quercetin reduces oxidative damage induced by paraquat via modulating expression of antioxidant genes in A549 cells. J Appl Toxicol. 2013 Dec;33(12):1460-7. doi: 10.1002/jat.2812. Epub 2012 Sep 20.
401 Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway. Blood. 2005 Feb 1;105(3):1214-21. doi: 10.1182/blood-2004-03-1182. Epub 2004 Sep 28.
402 The neuroprotective effect of ladostigil against hydrogen peroxide-mediated cytotoxicity. Chem Biol Interact. 2008 Sep 25;175(1-3):318-26. doi: 10.1016/j.cbi.2008.05.038. Epub 2008 Jun 12.
403 Untargeted Proteomics and Systems-Based Mechanistic Investigation of Artesunate in Human Bronchial Epithelial Cells. Chem Res Toxicol. 2015 Oct 19;28(10):1903-13. doi: 10.1021/acs.chemrestox.5b00105. Epub 2015 Sep 21.
404 Nrf2 but not autophagy inhibition is associated with the survival of wild-type epidermal growth factor receptor non-small cell lung cancer cells. Toxicol Appl Pharmacol. 2016 Nov 1;310:140-149. doi: 10.1016/j.taap.2016.09.010. Epub 2016 Sep 14.
405 Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proc Natl Acad Sci U S A. 2005 May 24;102(21):7653-8.
406 Hydroquinone triggers pyroptosis and endoplasmic reticulum stress via AhR-regulated oxidative stress in human lymphocytes. Toxicol Lett. 2023 Mar 1;376:39-50. doi: 10.1016/j.toxlet.2023.01.005. Epub 2023 Jan 13.
407 Kinetic analysis of the liver-type (GLUT2) and brain-type (GLUT3) glucose transporters in Xenopus oocytes: substrate specificities and effects of transport inhibitors. Biochem J. 1993 Mar 15;290 ( Pt 3)(Pt 3):701-6. doi: 10.1042/bj2900701.
408 A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system. Toxicol Sci. 2005 Feb;83(2):282-92.
409 In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies. Toxicol Sci. 2007 Sep;99(1):162-73.
410 Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. Biochim Biophys Acta. 2005 Oct 15;1731(1):48-56. doi: 10.1016/j.bbaexp.2005.08.006. Epub 2005 Sep 1.
411 Docosahexaenoic acid regulates gene expression in HUVEC cells treated with polycyclic aromatic hydrocarbons. Toxicol Lett. 2015 Jul 16;236(2):75-81.
412 Etoposide induces necrosis through p53-mediated antiapoptosis in human kidney proximal tubule cells. Toxicol Sci. 2015 Nov;148(1):204-19.
413 Conjugated linoleic acid, unlike other unsaturated fatty acids, strongly induces glutathione synthesis without any lipoperoxidation. Br J Nutr. 2006 Nov;96(5):811-9.
414 COX-2 and PPAR-gama confer cannabidiol-induced apoptosis of human lung cancer cells. Mol Cancer Ther. 2013 Jan;12(1):69-82.
415 Mitochondrial involvement in schizophrenia and other functional psychoses. Neurochem Res. 1996 Sep;21(9):995-1004.
416 Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression. Eur Neuropsychopharmacol. 2007 Dec;17(12):774-80.
417 Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer. Cancer Res. 2006 Feb 15;66(4):2067-73.
418 A2E selectively induces cox-2 in ARPE-19 and human neural cells. Curr Eye Res. 2006 Mar;31(3):259-63.
419 Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy. Med Oncol. 2011 Dec;28(4):1395-404. doi: 10.1007/s12032-010-9603-3. Epub 2010 Jul 2.
420 Omeprazole inhibits pancreatic cancer cell invasion through a nongenomic aryl hydrocarbon receptor pathway. Chem Res Toxicol. 2015 May 18;28(5):907-18.
421 Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration. Oncotarget. 2016 Nov 22;7(47):77543-77557. doi: 10.18632/oncotarget.12721.
422 Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-B signaling in cervical cancer. Ann Surg Oncol. 2014 Dec;21 Suppl 4:S687-95. doi: 10.1245/s10434-014-3812-5. Epub 2014 Jul 22.
423 Etodolac induces apoptosis and inhibits cell adhesion to bone marrow stromal cells in human myeloma cells. Leuk Res. 2006 Feb;30(2):123-35. doi: 10.1016/j.leukres.2005.06.009. Epub 2005 Jul 25.
424 Concise prediction models of anticancer efficacy of 8 drugs using expression data from 12 selected genes. Int J Cancer. 2004 Sep 10;111(4):617-26. doi: 10.1002/ijc.20289.
425 Binding and hydrolysis of meperidine by human liver carboxylesterase hCE-1. J Pharmacol Exp Ther. 1999 Jul;290(1):314-8.
426 Human carboxylesterase 1: from drug metabolism to drug discovery. Biochem Soc Trans. 2003 Jun;31(Pt 3):620-4. doi: 10.1042/bst0310620.
427 Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibition. Chem Biol. 2003 Apr;10(4):341-9. doi: 10.1016/s1074-5521(03)00071-1.
428 Dexamethasone differentially regulates expression of carboxylesterase genes in humans and rats. Drug Metab Dispos. 2000 Feb;28(2):186-91.
429 Proteomics investigations of drug-induced hepatotoxicity in HepG2 cells. Toxicol Sci. 2011 Mar;120(1):109-22.
430 Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci. 2006 Jan;97(1):64-71.
431 Manganese superoxide dismutase induces migration and invasion of tongue squamous cell carcinoma via H2O2-dependent Snail signaling. Free Radic Biol Med. 2012 Jul 1;53(1):44-50. doi: 10.1016/j.freeradbiomed.2012.04.031. Epub 2012 May 9.
432 Ciprofloxacin mediates cancer stem cell phenotypes in lung cancer cells through caveolin-1-dependent mechanism. Chem Biol Interact. 2016 Apr 25;250:1-11.
433 Quercetin suppresses pancreatic ductal adenocarcinoma progression via inhibition of SHH and TGF-/Smad signaling pathways. Cell Biol Toxicol. 2021 Jun;37(3):479-496. doi: 10.1007/s10565-020-09562-0. Epub 2020 Oct 17.
434 Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal. Toxicol Sci. 2015 Jan;143(1):156-64. doi: 10.1093/toxsci/kfu218. Epub 2014 Oct 10.
435 In vitro antitumoral effects of the steroid ouabain on human thyroid papillary carcinoma cell lines. Environ Toxicol. 2021 Jul;36(7):1338-1348. doi: 10.1002/tox.23130. Epub 2021 Mar 24.
436 Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin. Am J Physiol Renal Physiol. 2007 Sep;293(3):F723-31. doi: 10.1152/ajprenal.00480.2006. Epub 2007 Jun 27.
437 Anti-invasive activity of sanguinarine through modulation of tight junctions and matrix metalloproteinase activities in MDA-MB-231 human breast carcinoma cells. Chem Biol Interact. 2009 May 15;179(2-3):185-91. doi: 10.1016/j.cbi.2008.11.009. Epub 2008 Nov 21.
438 Selection of drugs to test the specificity of the Tg.AC assay by screening for induction of the gadd153 promoter in vitro. Toxicol Sci. 2003 Aug;74(2):260-70. doi: 10.1093/toxsci/kfg113. Epub 2003 May 2.
439 Methotrexate induces production of IL-1 and IL-6 in the monocytic cell line U937. Arthritis Res Ther. 2014 Jan 20;16(1):R17. doi: 10.1186/ar4444.
440 Simvastatin inhibits NOR-1 expression induced by hyperlipemia by interfering with CREB activation. Cardiovasc Res. 2005 Aug 1;67(2):333-41. doi: 10.1016/j.cardiores.2005.03.016. Epub 2005 Apr 21.
441 The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. J Biol Chem. 2004 Jun 25;279(26):27008-16. doi: 10.1074/jbc.M403588200. Epub 2004 Apr 16.
442 Estradiol attenuates EGF-induced rapid uPAR mobilization and cell migration via the G-protein-coupled receptor 30 in ovarian cancer cells. Int J Gynecol Cancer. 2009 Feb;19(2):214-22. doi: 10.1111/IGC.0b013e31819bcb75.
443 N-O Reduction and ROS-Mediated AKT/FOXO1 and AKT/P53 Pathways Are Involved in Growth Promotion and Cytotoxicity of Cyadox. Chem Res Toxicol. 2018 Nov 19;31(11):1219-1229. doi: 10.1021/acs.chemrestox.8b00194. Epub 2018 Oct 11.
444 Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3). Cell Biochem Funct. 2011 Mar;29(2):87-95. doi: 10.1002/cbf.1725. Epub 2011 Feb 9.
445 Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo. Prostate. 2009 May 15;69(7):744-54. doi: 10.1002/pros.20923.
446 Effects of histamine H(2)-receptor antagonists on human plasma levels of calcitonin gene-related peptide, substance P and vasoactive intestinal peptide. J Pharm Pharmacol. 2002 Nov;54(11):1559-63. doi: 10.1211/002235702117.
447 Transient receptor potential vanilloid 1-mediated expression and secretion of endothelial cell-derived calcitonin gene-related peptide. Regul Pept. 2008 Oct 9;150(1-3):66-72. doi: 10.1016/j.regpep.2008.05.007. Epub 2008 Jun 3.
448 Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7. Blood. 2009 Mar 19;113(12):2867-8. doi: 10.1182/blood-2008-12-195693.
449 13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy. Am J Pathol. 2005 Jul;167(1):285-98. doi: 10.1016/S0002-9440(10)62973-2.
450 Characterization of drug-specific signaling between primary human hepatocytes and immune cells. Toxicol Sci. 2017 Jul 1;158(1):76-89.
451 Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by JAK inhibitors. Arthritis Rheum. 2012 Dec;64(12):3856-66. doi: 10.1002/art.37691.
452 Oxidative Stress-Protective and Anti-Melanogenic Effects of Loliolide and Ethanol Extract from Fresh Water Green Algae, Prasiola japonica. Int J Mol Sci. 2018 Sep 18;19(9):2825. doi: 10.3390/ijms19092825.
453 The effects of a novel synthetic retinoid, seletinoid G, on the expression of extracellular matrix proteins in aged human skin in vivo. Clin Chim Acta. 2005 Dec;362(1-2):161-9. doi: 10.1016/j.cccn.2005.06.016. Epub 2005 Aug 1.
454 Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1beta in human tendon-derived cells. A potential mechanism of fluoroquinolone-induced tendinopathy. Arthritis Rheum. 2002 Nov;46(11):3034-40. doi: 10.1002/art.10617.
455 Simvastatin reduces MMP1 expression in human smooth muscle cells cultured on polymerized collagen by inhibiting Rac1 activation. Arterioscler Thromb Vasc Biol. 2007 May;27(5):1043-9. doi: 10.1161/ATVBAHA.107.139881. Epub 2007 Feb 15.
456 Quercetin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells through extracellular signal-regulated kinase. Arch Biochem Biophys. 2001 Jul 1;391(1):72-8. doi: 10.1006/abbi.2001.2402.
457 Interaction between the aryl hydrocarbon receptor and retinoic acid pathways increases matrix metalloproteinase-1 expression in keratinocytes. J Biol Chem. 2004 Jun 11;279(24):25284-93. doi: 10.1074/jbc.M402168200. Epub 2004 Apr 9.
458 Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate. Arthritis Rheum. 2004 Oct;50(10):3286-95. doi: 10.1002/art.20518.
459 Quercetin inhibits IL-1-induced proliferation and production of MMPs, COX-2, and PGE2 by rheumatoid synovial fibroblast. Inflammation. 2012 Aug;35(4):1585-94. doi: 10.1007/s10753-012-9473-2.
460 Zinc induces chemokine and inflammatory cytokine release from human promonocytes. J Hazard Mater. 2011 Nov 30;196:335-41. doi: 10.1016/j.jhazmat.2011.09.035. Epub 2011 Sep 19.
461 Progesterone and calcitriol attenuate inflammatory cytokines CXCL1 and CXCL2 in ovarian and endometrial cancer cells. J Cell Biochem. 2012 Oct;113(10):3143-52. doi: 10.1002/jcb.24191.
462 Human embryonic stem cell derived hepatocyte-like cells as a tool for in vitro hazard assessment of chemical carcinogenicity. Toxicol Sci. 2011 Dec;124(2):278-90. doi: 10.1093/toxsci/kfr225. Epub 2011 Aug 27.
463 Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate. J Rheumatol. 2007 Sep;34(9):1817-22. Epub 2007 Aug 1.
464 Mapping the dynamics of Nrf2 antioxidant and NFB inflammatory responses by soft electrophilic chemicals in human liver cells defines the transition from adaptive to adverse responses. Toxicol In Vitro. 2022 Oct;84:105419. doi: 10.1016/j.tiv.2022.105419. Epub 2022 Jun 17.
465 The hepatotoxic fluoroquinolone trovafloxacin disturbs TNF- and LPS-induced p65 nuclear translocation in vivo and in vitro. Toxicol Appl Pharmacol. 2020 Mar 15;391:114915. doi: 10.1016/j.taap.2020.114915. Epub 2020 Feb 6.
466 Expression and mitogenic effect of fibroblast growth factor-9 in human endometriotic implant is regulated by aberrant production of estrogen. J Clin Endocrinol Metab. 2003 Nov;88(11):5547-54. doi: 10.1210/jc.2003-030597.
467 Fibroblast growth factor-9 is an endometrial stromal growth factor. Endocrinology. 2002 Jul;143(7):2715-21. doi: 10.1210/endo.143.7.8900.
468 Ouabain impairs cell migration, and invasion and alters gene expression of human osteosarcoma U-2 OS cells. Environ Toxicol. 2017 Nov;32(11):2400-2413. doi: 10.1002/tox.22453. Epub 2017 Aug 10.
469 Blood cell oxidative stress precedes hemolysis in whole blood-liver slice co-cultures of rat, dog, and human tissues. Toxicol Appl Pharmacol. 2010 May 1;244(3):354-65. doi: 10.1016/j.taap.2010.01.017. Epub 2010 Feb 6.
470 Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: Role of NRF2 and FXR pathways. Food Chem Toxicol. 2021 Dec;158:112664. doi: 10.1016/j.fct.2021.112664. Epub 2021 Nov 9.
471 Induction of multidrug resistance proteins MRP1 and MRP3 and gamma-glutamylcysteine synthetase gene expression by nonsteroidal anti-inflammatory drugs in human colon cancer cells. Biochem Biophys Res Commun. 2002 Feb 8;290(5):1427-33. doi: 10.1006/bbrc.2002.6367.
472 Flavonoids increase the intracellular glutathione level by transactivation of the gamma-glutamylcysteine synthetase catalytical subunit promoter. Free Radic Biol Med. 2002 Mar 1;32(5):386-93. doi: 10.1016/s0891-5849(01)00812-7.
473 Glycidamide and cis-2-butene-1,4-dial (BDA) as potential carcinogens and promoters of liver cancer - An in vitro study. Food Chem Toxicol. 2022 Aug;166:113251. doi: 10.1016/j.fct.2022.113251. Epub 2022 Jun 21.
474 Essential role of Nrf2 in keratinocyte protection from UVA by quercetin. Biochem Biophys Res Commun. 2009 Sep 11;387(1):109-14. doi: 10.1016/j.bbrc.2009.06.136. Epub 2009 Jul 1.
475 An in vitro skin sensitization assay termed EpiSensA for broad sets of chemicals including lipophilic chemicals and pre/pro-haptens. Toxicol In Vitro. 2017 Apr;40:11-25. doi: 10.1016/j.tiv.2016.12.005. Epub 2016 Dec 10.
476 Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1. Oncotarget. 2016 Apr 26;7(17):24125-40. doi: 10.18632/oncotarget.8214.
477 Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol Endocrinol. 2002 Jun;16(6):1243-56.
478 CXCL14 downregulation in human keratinocytes is a potential biomarker for a novel in vitro skin sensitization test. Toxicol Appl Pharmacol. 2020 Jan 1;386:114828. doi: 10.1016/j.taap.2019.114828. Epub 2019 Nov 14.
479 Effect of ovarian steroids on gene expression profile in human uterine microvascular endothelial cells. Fertil Steril. 2009 Aug;92(2):709-21.
480 Id2 gene-targeted crosstalk between Wnt and retinoid signaling regulates proliferation in human keratinocytes. Oncogene. 2007 Aug 2;26(35):5038-45. doi: 10.1038/sj.onc.1210320. Epub 2007 Feb 19.
481 Expression pattern of cisplatin-induced metallothionein isoforms in squamous cell carcinoma. Anticancer Res. 2003 Jan-Feb;23(1A):299-303.
482 Identification of novel activators of the metal responsive transcription factor (MTF-1) using a gene expression biomarker in a microarray compendium. Metallomics. 2020 Sep 23;12(9):1400-1415. doi: 10.1039/d0mt00071j.
483 Expression of antioxidant proteins in human intestinal Caco-2 cells treated with dietary flavonoids. Cancer Lett. 1999 Nov 15;146(2):161-7.
484 Cytochrome P450 1A1/2 induction by antiparasitic drugs: dose-dependent increase in ethoxyresorufin O-deethylase activity and mRNA caused by quinine, primaquine and albendazole in HepG2 cells. Eur J Clin Pharmacol. 2002 Nov;58(8):537-42.
485 Association of CYP1A1 and CYP1B1 inhibition in in vitro assays with drug-induced liver injury. J Toxicol Sci. 2021;46(4):167-176. doi: 10.2131/jts.46.167.
486 Anti-androgenic effect of 6-formylindolo[3,2-b]carbazole (FICZ) in LNCaP cells is mediated by the aryl hydrocarbon-androgen receptors cross-talk. Steroids. 2020 Jan;153:108508. doi: 10.1016/j.steroids.2019.108508. Epub 2019 Oct 3.
487 Pharmacologic profiling of human and rat cytochrome P450 1A1 and 1A2 induction and competition. Arch Toxicol. 2008 Dec;82(12):909-21.
488 Effect of CYP1A1 gene polymorphisms on estrogen metabolism and bone density. J Bone Miner Res. 2005 Feb;20(2):232-9. doi: 10.1359/JBMR.041110. Epub 2004 Nov 16.
489 Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. Cancer Res. 1999 Feb 1;59(3):607-14.
490 The metallohormone cadmium modulates AhR-associated gene expression in the small intestine of rats similar to ethinyl-estradiol. Arch Toxicol. 2013 Apr;87(4):633-43.
491 Evidence for a new human CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites. Gastroenterology. 2004 Nov;127(5):1436-45.
492 Type 5 17beta-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs. Chem Biol Interact. 2009 Mar 16;178(1-3):221-7.
493 Substrate specificity of human 3(20)alpha-hydroxysteroid dehydrogenase for neurosteroids and its inhibition by benzodiazepines. Biol Pharm Bull. 2002 Apr;25(4):441-5.
494 A new in vitro method for identifying chemical sensitizers combining peptide binding with ARE/EpRE-mediated gene expression in human skin cells. Cutan Ocul Toxicol. 2010 Sep;29(3):171-92.
495 Aberrantly expressed genes in HaCaT keratinocytes chronically exposed to arsenic trioxide. Biomark Insights. 2011 Feb 8;6:7-16.
496 Thyroid hormone responsive genes in cultured human fibroblasts. J Clin Endocrinol Metab. 2005 Feb;90(2):936-43.
497 Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles. Arch Toxicol. 2018 Apr;92(4):1435-1451.
498 Oxidative stress mechanisms do not discriminate between genotoxic and nongenotoxic liver carcinogens. Chem Res Toxicol. 2015 Aug 17;28(8):1636-46.
499 Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, proteomics, metabolomics and biokinetics. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):117-27.
500 Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83. Int J Mol Sci. 2020 Aug 1;21(15):5533. doi: 10.3390/ijms21155533.
501 Comparison of characteristics of peroxide-conditioned immortal human lens-epithelial cell lines with their murine counterparts. Exp Eye Res. 2004 Sep;79(3):411-7.
502 Quercetin modulates Nrf2 and glutathione-related defenses in HepG2 cells: Involvement of p38. Chem Biol Interact. 2012 Jan 25;195(2):154-64.
503 Glutathione depletion in antioxidant defense of differentiated NT2-LHON cybrids. Neurobiol Dis. 2007 Mar;25(3):536-44.
504 Poly(ADP-ribose) polymerase 1 contributes to oxidative stress through downregulation of sirtuin 3 during cisplatin nephrotoxicity. Anat Cell Biol. 2016 Sep;49(3):165-176. doi: 10.5115/acb.2016.49.3.165. Epub 2016 Sep 29.
505 Inactivation of cytochrome c oxidase by mutant SOD1s in mouse motoneuronal NSC-34 cells is independent from copper availability but is because of nitric oxide. J Neurochem. 2010 Jan;112(1):183-92. doi: 10.1111/j.1471-4159.2009.06441.x. Epub 2009 Oct 20.
506 Impairment of mitochondrial anti-oxidant defence in SOD1-related motor neuron injury and amelioration by ebselen. Brain. 2006 Jul;129(Pt 7):1693-709. doi: 10.1093/brain/awl118. Epub 2006 May 15.
507 Development of an alternative zebrafish model for drug-induced intestinal toxicity. J Appl Toxicol. 2018 Feb;38(2):259-273. doi: 10.1002/jat.3520. Epub 2017 Oct 13.
508 Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer. Cancer Biol Ther. 2005 Sep;4(9):949-55.
509 Comparison of replicative senescence and stress-induced premature senescence combining differential display and low-density DNA arrays. FEBS Lett. 2005 Jul 4;579(17):3651-9. doi: 10.1016/j.febslet.2005.05.056.
510 Role of antioxidant systems in human androgen-independent prostate cancer cells. Prostate. 2000 May 1;43(2):144-9. doi: 10.1002/(sici)1097-0045(20000501)43:2<144::aid-pros9>3.0.co;2-h.
511 Selenium deficiency alters epithelial cell morphology and responses to influenza. Free Radic Biol Med. 2007 Jun 15;42(12):1826-37.
512 Hepatocellular peroxisomes in human alcoholic and drug-induced hepatitis: a quantitative study. Hepatology. 1991 Nov;14(5):811-7.
513 Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment. Eur Arch Psychiatry Clin Neurosci. 2004 Aug;254(4):231-5.
514 The effect of statins on lipids peroxidation and activities of antioxidants enzymes in patients with dyslipidemia. Przegl Lek. 2006;63(9):738-42.
515 A comprehensive analysis of Wnt/beta-catenin signaling pathway-related genes and crosstalk pathways in the treatment of As2O3 in renal cancer. Ren Fail. 2018 Nov;40(1):331-339.
516 Natural antioxidants exhibit chemopreventive characteristics through the regulation of CNC b-Zip transcription factors in estrogen-induced breast carcinogenesis. J Biochem Mol Toxicol. 2014 Dec;28(12):529-38.
517 Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures. Arch Toxicol. 2018 Jun;92(6):1939-1952.
518 Isoniazid-induced apoptosis in HepG2 cells: generation of oxidative stress and Bcl-2 down-regulation. Toxicol Mech Methods. 2010 Jun;20(5):242-51. doi: 10.3109/15376511003793325.
519 Posttranslational glutathiolation of aldose reductase (AKR1B1): a possible mechanism of protein recovery from S-nitrosylation. Chem Biol Interact. 2009 Mar 16;178(1-3):250-8. doi: 10.1016/j.cbi.2008.11.007. Epub 2008 Nov 18.
520 Plasma glutathione peroxidase and its relationship to renal proximal tubule function. Mol Genet Metab. 1998 Nov;65(3):238-45. doi: 10.1006/mgme.1998.2760.
521 The Isoniazid Metabolites Hydrazine and Pyridoxal Isonicotinoyl Hydrazone Modulate Heme Biosynthesis. Toxicol Sci. 2019 Mar 1;168(1):209-224. doi: 10.1093/toxsci/kfy294.
522 Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3. Chem Biol Interact. 2011 May 30;191(1-3):227-33.
523 In-vivo effects of simvastatin and rosuvastatin on global gene expression in peripheral blood leucocytes in a human inflammation model. Pharmacogenet Genomics. 2008 Feb;18(2):109-20.
524 AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids. Chem Biol Interact. 2009 Mar 16;178(1-3):138-44.
525 Defenses against oxidation in human erythrocytes: role of glutathione reductase in the activation of glucose decarboxylation by hemolytic drugs. J Lab Clin Med. 1991 Apr;117(4):325-31.
526 The effect of zinc and D-penicillamine in a stable human hepatoma ATP7B knockout cell line. PLoS One. 2014 Jun 3;9(6):e98809. doi: 10.1371/journal.pone.0098809. eCollection 2014.
527 Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line. Chem Biol Interact. 2013 Feb 25;202(1-3):218-25.
528 Initro inhibition of AKR1Cs by sulphonylureas and the structural basis. Chem Biol Interact. 2015 Oct 5;240:310-5.
529 Human prostaglandin reductase 1 (PGR1): Substrate specificity, inhibitor analysis and site-directed mutagenesis. Chem Biol Interact. 2015 Jun 5;234:105-13.
530 Gene expression profile of human lymphoid CEM cells sensitive and resistant to glucocorticoid-evoked apoptosis. Genomics. 2003 Jun;81(6):543-55.
531 9-cis-Retinoic acid (9cRA), a retinoid X receptor (RXR) ligand, exerts immunosuppressive effects on dendritic cells by RXR-dependent activation: inhibition of peroxisome proliferator-activated receptor gamma blocks some of the 9cRA activities, and precludes them to mature phenotype development. J Immunol. 2007 May 15;178(10):6130-9. doi: 10.4049/jimmunol.178.10.6130.
532 THP-1 monocytes but not macrophages as a potential alternative for CD34+ dendritic cells to identify chemical skin sensitizers. Toxicol Appl Pharmacol. 2009 Apr 15;236(2):221-30.
533 Simvastatin down regulates mRNA expression of RANTES and CCR5 in posttransplant renal recipients with hyperlipidemia. Transplant Proc. 2006 Nov;38(9):2899-904. doi: 10.1016/j.transproceed.2006.08.136.
534 Chemicals with weak skin sensitizing properties can be identified using low-density microarrays on immature dendritic cells. Toxicol Lett. 2007 Nov 1;174(1-3):98-109. doi: 10.1016/j.toxlet.2007.08.015. Epub 2007 Sep 5.
535 Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model. J Leukoc Biol. 2005 Dec;78(6):1198-203. doi: 10.1189/jlb.0405219. Epub 2005 Oct 4.
536 Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs. Int Immunol. 2005 Dec;17(12):1561-72. doi: 10.1093/intimm/dxh335. Epub 2005 Nov 22.
537 Effects of tobacco compounds on gene expression in fetal lung fibroblasts. Environ Toxicol. 2008 Aug;23(4):423-34.
538 Aryl hydrocarbon receptor signaling modifies Toll-like receptor-regulated responses in human dendritic cells. Arch Toxicol. 2017 May;91(5):2209-2221.
539 Inhibition of Super-Enhancer Activity in Autoinflammatory Site-Derived T Cells Reduces Disease-Associated Gene Expression. Cell Rep. 2015 Sep 29;12(12):1986-96. doi: 10.1016/j.celrep.2015.08.046. Epub 2015 Sep 17.
540 Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Res. 2004 May 1;64(9):3022-9. doi: 10.1158/0008-5472.can-03-1880.
541 Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2. Biochem Pharmacol. 2011 Feb 15;81(4):510-7. doi: 10.1016/j.bcp.2010.11.014. Epub 2010 Nov 27.
542 Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c. Biochim Biophys Acta. 2010 Apr;1803(4):452-67. doi: 10.1016/j.bbamcr.2009.12.005. Epub 2010 Jan 4.
543 Adipogenic Effects and Gene Expression Profiling of Firemaster? 550 Components in Human Primary Preadipocytes. Environ Health Perspect. 2017 Sep 14;125(9):097013. doi: 10.1289/EHP1318.
544 Low-dose Bisphenol A exposure alters the functionality and cellular environment in a human cardiomyocyte model. Environ Pollut. 2023 Oct 15;335:122359. doi: 10.1016/j.envpol.2023.122359. Epub 2023 Aug 9.
545 Quercetin regulates oxidized LDL induced inflammatory changes in human PBMCs by modulating the TLR-NF-B signaling pathway. Immunobiology. 2011 Mar;216(3):367-73. doi: 10.1016/j.imbio.2010.07.011. Epub 2010 Aug 19.
546 Mechanical stress-activated immune response genes via Sirtuin 1 expression in human periodontal ligament cells. Clin Exp Immunol. 2012 Apr;168(1):113-24. doi: 10.1111/j.1365-2249.2011.04549.x.
547 Primary Human Hepatocyte Spheroids as Tools to Study the Hepatotoxic Potential of Non-Pharmaceutical Chemicals. Int J Mol Sci. 2021 Oct 12;22(20):11005. doi: 10.3390/ijms222011005.
548 Differential effects of omega-3 and omega-6 Fatty acids on gene expression in breast cancer cells. Breast Cancer Res Treat. 2007 Jan;101(1):7-16. doi: 10.1007/s10549-006-9269-x. Epub 2006 Jul 6.
549 Targeting MYCN in neuroblastoma by BET bromodomain inhibition. Cancer Discov. 2013 Mar;3(3):308-23.
550 Genomic and proteomic analysis of the effects of cannabinoids on normal human astrocytes. Brain Res. 2008 Jan 29;1191:1-11.
551 Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study. Proteomics. 2009 Apr;9(7):1952-66. doi: 10.1002/pmic.200701089.
552 Gene expression in human hippocampus from cocaine abusers identifies genes which regulate extracellular matrix remodeling. PLoS One. 2007 Nov 14;2(11):e1187. doi: 10.1371/journal.pone.0001187.
553 Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses. Cancer Res. 2007 Dec 15;67(24):12007-17. doi: 10.1158/0008-5472.CAN-07-2464.
554 Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression. J Neurooncol. 2005 Jul;73(3):189-98.
555 A high concentration of genistein down-regulates activin A, Smad3 and other TGF-beta pathway genes in human uterine leiomyoma cells. Exp Mol Med. 2012 Apr 30;44(4):281-92.
556 Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery. Mol Cancer. 2006 May 18;5:20. doi: 10.1186/1476-4598-5-20.
557 DNA microarray analysis of changes in gene expression induced by 1,25-dihydroxyvitamin D3 in human promyelocytic leukemia HL-60 cells. Biomed Res. 2006 Jun;27(3):99-109. doi: 10.2220/biomedres.27.99.
558 Synergistic effects of arsenic trioxide combined with ascorbic acid in human osteosarcoma MG-63 cells: a systems biology analysis. Eur Rev Med Pharmacol Sci. 2014;18(24):3877-88.
559 High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy. Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):2058-63.
560 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
561 The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells. J Biol Chem. 2009 Sep 4;284(36):24306-19.
562 Identification of potential protein targets of isothiocyanates by proteomics. Chem Res Toxicol. 2011 Oct 17;24(10):1735-43. doi: 10.1021/tx2002806. Epub 2011 Aug 26.
563 Exosomes mediated the delivery of ochratoxin A-induced cytotoxicity in HEK293 cells. Toxicology. 2021 Sep;461:152926. doi: 10.1016/j.tox.2021.152926. Epub 2021 Sep 3.
564 Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells. Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4578-83.
565 Inhibition of CXCL12-mediated chemotaxis of Jurkat cells by direct immunotoxicants. Arch Toxicol. 2016 Jul;90(7):1685-94. doi: 10.1007/s00204-015-1585-7. Epub 2015 Aug 28.
566 Gene expression profile analysis of gallic acid-induced cell death process. Sci Rep. 2021 Aug 18;11(1):16743. doi: 10.1038/s41598-021-96174-1.
567 Gene expression changes in primary human nasal epithelial cells exposed to formaldehyde in vitro. Toxicol Lett. 2010 Oct 5;198(2):289-95.
568 The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells. Leukemia. 2009 Jun;23(6):1019-28.
569 Differential expression of microRNAs and their predicted targets in renal cells exposed to amphotericin B and its complex with copper (II) ions. Toxicol Mech Methods. 2017 Sep;27(7):537-543. doi: 10.1080/15376516.2017.1333554. Epub 2017 Jun 8.
570 The retinoid anticancer signal: mechanisms of target gene regulation. Br J Cancer. 2005 Aug 8;93(3):310-8. doi: 10.1038/sj.bjc.6602700.
571 Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. Liver Int. 2008 Aug;28(7):997-1010. doi: 10.1111/j.1478-3231.2008.01744.x. Epub 2008 Apr 15.
572 Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway. Biochem Pharmacol. 2008 May 15;75(10):1946-58. doi: 10.1016/j.bcp.2008.02.016. Epub 2008 Mar 10.
573 Nuclear and Mitochondrial DNA Methylation Patterns Induced by Valproic Acid in Human Hepatocytes. Chem Res Toxicol. 2017 Oct 16;30(10):1847-1854. doi: 10.1021/acs.chemrestox.7b00171. Epub 2017 Sep 13.
574 Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinib. Blood. 2015 Sep 24;126(13):1565-74.
575 ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis. Blood. 2004 Jan 1;103(1):194-207.
576 The genomic response of Ishikawa cells to bisphenol A exposure is dose- and time-dependent. Toxicology. 2010 Apr 11;270(2-3):137-49. doi: 10.1016/j.tox.2010.02.008. Epub 2010 Feb 17.
577 Evaluation of developmental toxicity using undifferentiated human embryonic stem cells. J Appl Toxicol. 2015 Feb;35(2):205-18.
578 Extremely low copper concentrations affect gene expression profiles of human prostate epithelial cell lines. Chem Biol Interact. 2010 Oct 6;188(1):214-9.
579 Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget. 2014 May 15;5(9):2355-71.
580 Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis. Oncogene. 2010 Sep 16;29(37):5159-70. doi: 10.1038/onc.2010.255. Epub 2010 Jun 21.
581 Combined effects of arsenic and palmitic acid on oxidative stress and lipid metabolism disorder in human hepatoma HepG2 cells. Sci Total Environ. 2021 May 15;769:144849. doi: 10.1016/j.scitotenv.2020.144849. Epub 2021 Jan 19.
582 Transcriptomic analysis of human primary bronchial epithelial cells after chloropicrin treatment. Chem Res Toxicol. 2015 Oct 19;28(10):1926-35.
583 A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profiling. PLoS One. 2017 May 25;12(5):e0178302. doi: 10.1371/journal.pone.0178302. eCollection 2017.
584 Sulindac activates nuclear translocation of AIF, DFF40 and endonuclease G but not induces oligonucleosomal DNA fragmentation in HT-29 cells. Life Sci. 2005 Sep 2;77(16):2059-70. doi: 10.1016/j.lfs.2005.04.021.
585 Quercetin induced cell apoptosis and altered gene expression in AGS human gastric cancer cells. Environ Toxicol. 2018 Nov;33(11):1168-1181. doi: 10.1002/tox.22623. Epub 2018 Aug 27.
586 Arsenic trioxide-induced death of neuroblastoma cells involves activation of Bax and does not require p53. Clin Cancer Res. 2004 May 1;10(9):3179-88. doi: 10.1158/1078-0432.ccr-03-0309.
587 Clonidine Induces Apoptosis of Human Corneal Epithelial Cells through Death Receptors-Mediated, Mitochondria-Dependent Signaling Pathway. Toxicol Sci. 2017 Mar 1;156(1):252-260. doi: 10.1093/toxsci/kfw249.
588 Ouabain induces apoptotic cell death in human prostate DU 145 cancer cells through DNA damage and TRAIL pathways. Environ Toxicol. 2019 Dec;34(12):1329-1339. doi: 10.1002/tox.22834. Epub 2019 Aug 21.
589 Gene expression changes associated with altered growth and differentiation in benzo[a]pyrene or arsenic exposed normal human epidermal keratinocytes. J Appl Toxicol. 2008 May;28(4):491-508.
590 Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. Environ Health Perspect. 2008 Apr;116(4):524-31. doi: 10.1289/ehp.10861.
591 4-HPR modulates gene expression in ovarian cells. Int J Cancer. 2006 Sep 1;119(5):1005-13. doi: 10.1002/ijc.21797.
592 Quantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen genistein. Mol Cell Proteomics. 2011 Jan;10(1):M110.002170.
593 Cysteine mapping in conformationally distinct kinase nucleotide binding sites: application to the design of selective covalent inhibitors. J Med Chem. 2011 Mar 10;54(5):1347-55. doi: 10.1021/jm101396q. Epub 2011 Feb 15.
594 Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival. Cancer Res. 2006 Jun 1;66(11):5542-8. doi: 10.1158/0008-5472.CAN-05-4620.
595 Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004 May 20;350(21):2129-39. doi: 10.1056/NEJMoa040938. Epub 2004 Apr 29.
596 The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer. Cancer Res. 2005 Jan 1;65(1):18-25.
597 A fine-needle aspirate-based vulnerability assay identifies polo-like kinase 1 as a mediator of gemcitabine resistance in pancreatic cancer. Mol Cancer Ther. 2010 Feb;9(2):311-8. doi: 10.1158/1535-7163.MCT-09-0693. Epub 2010 Jan 26.
598 Prediction of chemosensitivity using multigene analysis in head and neck squamous cell carcinoma. Oncology. 2007;73(1-2):104-11. doi: 10.1159/000120998. Epub 2008 Mar 13.
599 Ligand-dependent activation of the epidermal growth factor receptor by secondary bile acids in polarizing colon cancer cells. Surgery. 2005 Sep;138(3):415-21. doi: 10.1016/j.surg.2005.06.030.
600 Thalidomide therapy. An open trial. Int J Dermatol. 1985 Mar;24(2):131-4. doi: 10.1111/j.1365-4362.1985.tb05400.x.
601 Indomethacin and juglone inhibit inflammatory molecules to induce apoptosis in colon cancer cells. J Biochem Mol Toxicol. 2020 Feb;34(2):e22433. doi: 10.1002/jbt.22433. Epub 2020 Jan 9.
602 A cell impedance-based real-time in vitro assay to assess the toxicity of amphotericin B formulations. Toxicol Appl Pharmacol. 2017 Nov 1;334:18-23. doi: 10.1016/j.taap.2017.08.017. Epub 2017 Sep 1.
603 Sertraline, an antidepressant, induces apoptosis in hepatic cells through the mitogen-activated protein kinase pathway. Toxicol Sci. 2014 Feb;137(2):404-15. doi: 10.1093/toxsci/kft254. Epub 2013 Nov 5.
604 Anti-inflammatory effects of the GABA(B) receptor agonist baclofen in allergic contact dermatitis. Exp Dermatol. 2010 Jul 1;19(7):661-6. doi: 10.1111/j.1600-0625.2010.01076.x. Epub 2010 Feb 25.
605 Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways. World J Gastrointest Oncol. 2022 Feb 15;14(2):450-477. doi: 10.4251/wjgo.v14.i2.450.
606 Sulfasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas. Int J Oncol. 2007 Jan;30(1):283-90.
607 Activation of PPAR and inhibition of cell proliferation reduces key proteins associated with the basal subtype of bladder cancer in As3+-transformed UROtsa cells. PLoS One. 2020 Aug 21;15(8):e0237976. doi: 10.1371/journal.pone.0237976. eCollection 2020.
608 Oral lichenoid eruption secondary to imatinib (Glivec). J Dermatolog Treat. 2004 Jul;15(4):253-5. doi: 10.1080/09546630410015556.
609 Impact of extracellular folate levels on global gene expression. Mol Pharmacol. 2001 Dec;60(6):1288-95. doi: 10.1124/mol.60.6.1288.
610 Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells. Cell Growth Differ. 1996 Aug;7(8):997-1004.
611 Methamphetamine alters the normal progression by inducing cell cycle arrest in astrocytes. PLoS One. 2014 Oct 7;9(10):e109603.
612 Evaluation of a human iPSC-derived BBB model for repeated dose toxicity testing with cyclosporine A as model compound. Toxicol In Vitro. 2021 Jun;73:105112. doi: 10.1016/j.tiv.2021.105112. Epub 2021 Feb 22.
613 Transformation of human urothelial cells (UROtsa) by as and cd induces the expression of keratin 6a. Environ Health Perspect. 2008 Apr;116(4):434-40. doi: 10.1289/ehp.10279.
614 Prevention of deoxycholate-induced gastric apoptosis by aspirin: roles of NF-kappaB and PKC signaling. J Surg Res. 2008 Mar;145(1):66-73. doi: 10.1016/j.jss.2007.04.039. Epub 2007 Jul 20.
615 Identification of biomarkers for the initiation of apoptosis in human preneoplastic colonocytes by proteome analysis. Int J Cancer. 2004 Mar 20;109(2):220-9. doi: 10.1002/ijc.11692.
616 [Differential proteomic expression in human liver cells stimulated by hydroquinone]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2006 Nov;24(11):658-61.
617 A protein-coated magnetic beads as a tool for the rapid drug-protein binding study. J Pharm Biomed Anal. 2010 Jul 8;52(3):420-4. doi: 10.1016/j.jpba.2009.06.023. Epub 2009 Jun 18.
618 The three recombinant domains of human serum albumin. Structural characterization and ligand binding properties. J Biol Chem. 1999 Oct 8;274(41):29303-10. doi: 10.1074/jbc.274.41.29303.
619 Exploring binding properties of sertraline with human serum albumin: Combination of spectroscopic and molecular modeling studies. Chem Biol Interact. 2015 Dec 5;242:235-46. doi: 10.1016/j.cbi.2015.10.006. Epub 2015 Oct 22.
620 Low-expressional IGF1 mediated methimazole-induced liver developmental toxicity in fetal mice. Toxicology. 2018 Sep 1;408:70-79. doi: 10.1016/j.tox.2018.07.004. Epub 2018 Jul 7.
621 Use of peak decay analysis and affinity microcolumns containing silica monoliths for rapid determination of drug-protein dissociation rates. J Chromatogr A. 2011 Apr 15;1218(15):2072-8. doi: 10.1016/j.chroma.2010.09.070. Epub 2010 Oct 16.
622 [Colchicine in chronic liver disease of alcoholic etiology. Double-blind, randomized study of its effects on blood levels of plasma proteins and clinical course in patients]. Rev Assoc Med Bras (1992). 1995 May-Jun;41(3):207-12.
623 Editor's Highlight: Modeling Compound-Induced Fibrogenesis In Vitro Using Three-Dimensional Bioprinted Human Liver Tissues. Toxicol Sci. 2016 Dec;154(2):354-367. doi: 10.1093/toxsci/kfw169. Epub 2016 Sep 7.
624 Covalent binding of the flavonoid quercetin to human serum albumin. J Agric Food Chem. 2005 May 18;53(10):4194-7. doi: 10.1021/jf050061m.
625 Estrogen-like activity of metals in MCF-7 breast cancer cells. Endocrinology. 2003 Jun;144(6):2425-36. doi: 10.1210/en.2002-221054.
626 Cross-talk between non-genomic and genomic signalling pathways--distinct effect profiles of environmental estrogens. Toxicol Appl Pharmacol. 2010 Jun 1;245(2):160-70. doi: 10.1016/j.taap.2010.02.015. Epub 2010 Mar 4.
627 Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growth. Breast Cancer Res Treat. 2006 Mar;96(2):131-46. doi: 10.1007/s10549-005-9070-2. Epub 2005 Oct 27.
628 Sensitivity of human dental pulp cells to eighteen chemical agents used for endodontic treatments in dentistry. Odontology. 2013 Jan;101(1):43-51.
629 Antitumoral activity of liraglutide, a new DNMT inhibitor in breast cancer cells in vitro and in vivo. Chem Biol Interact. 2021 Nov 1;349:109641. doi: 10.1016/j.cbi.2021.109641. Epub 2021 Sep 14.
630 Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol Pharmacol. 2001 Sep;60(3):595-602.
631 Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth. Br J Cancer. 2007 Apr 23;96(8):1204-15. doi: 10.1038/sj.bjc.6603705. Epub 2007 Mar 27.
632 Prediction of the combined effects of multiple estrogenic chemicals on MCF-7 human breast cancer cells and a preliminary molecular exploration of the estrogenic proliferative effects and related gene expression. Ecotoxicol Environ Saf. 2018 Sep 30;160:1-9. doi: 10.1016/j.ecoenv.2018.05.025. Epub 2018 May 21.
633 Characterizing the genetic basis for nicotine induced cancer development: a transcriptome sequencing study. PLoS One. 2013 Jun 18;8(6):e67252.
634 Regulation of chromatin assembly and cell transformation by formaldehyde exposure in human cells. Environ Health Perspect. 2017 Sep 21;125(9):097019.
635 Effects of Imatinib Mesylate (Gleevec) on human islet NF-kappaB activation and chemokine production in vitro. PLoS One. 2011;6(9):e24831. doi: 10.1371/journal.pone.0024831. Epub 2011 Sep 14.
636 Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells. Pharm Res. 2010 Oct;27(10):2162-74. doi: 10.1007/s11095-010-0219-2. Epub 2010 Jul 29.
637 Association of cell cycle arrest with anticancer drug-induced epithelial-mesenchymal transition in alveolar epithelial cells. Toxicology. 2019 Aug 1;424:152231. doi: 10.1016/j.tox.2019.06.002. Epub 2019 Jun 4.
638 Simvastatin inhibits tissue factor and plasminogen activator inhibitor-1 secretion by peripheral blood mononuclear cells in patients with primary nephrotic syndrome. Eur J Med Res. 2007 May 29;12(5):216-21.
639 Polyphenols downregulate PAI-1 gene expression in cultured human coronary artery endothelial cells: molecular contributor to cardiovascular protection. Thromb Res. 2007;121(1):59-65. doi: 10.1016/j.thromres.2007.02.001. Epub 2007 Mar 26.
640 Troglitazone reduces plasminogen activator inhibitor-1 expression and secretion in cultured human adipocytes. Diabetologia. 2000 Mar;43(3):377-83. doi: 10.1007/s001250050057.
641 Mechanisms of dexamethasone-induced disturbed sleep and fatigue in paediatric patients receiving treatment for ALL. Eur J Cancer. 2010 Jul;46(10):1848-55. doi: 10.1016/j.ejca.2010.03.026. Epub 2010 Apr 17.
642 Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis. J Antimicrob Chemother. 2004 Feb;53(2):174-9. doi: 10.1093/jac/dkh056. Epub 2004 Jan 16.
643 Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. FASEB J. 2012 Apr;26(4):1535-48. doi: 10.1096/fj.11-198184. Epub 2011 Dec 23.
644 The effect of fexofenadine on expression of intercellular adhesion molecule 1 and induction of apoptosis on peripheral eosinophils. Allergy Asthma Proc. 2005 Jul-Aug;26(4):292-8.
645 Antiallergic effects of H1-receptor antagonists. Allergy. 2000;55 Suppl 64:17-27. doi: 10.1034/j.1398-9995.2000.00803.x.
646 Cytokine mRNA profiles in cultured human skin component cells exposed to various chemicals: a simulation model of epicutaneous stimuli induced by skin barrier perturbation in comparison with that due to exposure to haptens or irritant. J Dermatol Sci. 2001 Jun;26(2):85-93. doi: 10.1016/s0923-1811(00)00165-1.
647 Correlation of sICAM-1 and sVCAM-1 level with biochemical, histological and viral findings in chronic hepatitis C after interferon-alpha + ribavirin therapy. Rom J Gastroenterol. 2003 Jun;12(2):91-5.
648 Some non-sensitizers upregulate CD54 expression by activation of the NLRP3 inflammasome in THP-1 cells. J Toxicol Sci. 2019;44(3):213-224. doi: 10.2131/jts.44.213.
649 Expression of protein kinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids. Int J Cancer. 1995 Mar 29;61(1):35-9. doi: 10.1002/ijc.2910610107.
650 Marine biogenics in sea spray aerosols interact with the mTOR signaling pathway. Sci Rep. 2019 Jan 24;9(1):675.
651 Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors. Arch Toxicol. 2021 Feb;95(2):591-615. doi: 10.1007/s00204-020-02970-5. Epub 2021 Jan 29.
652 Effects of 1 alpha,25-dihydroxy-vitamin D3 and calcipotriol on organotypic cultures of outer root sheath cells: a potential model to evaluate antipsoriatic drugs. Arch Dermatol Res. 1993;285(7):402-9. doi: 10.1007/BF00372133.
653 Retinoic acid receptors as regulators of human epidermal keratinocyte differentiation. Mol Endocrinol. 1992 May;6(5):667-76. doi: 10.1210/mend.6.5.1318502.
654 Retinoic acid and hydroquinone induce inverse expression patterns on cornified envelope-associated proteins: implication in skin irritation. J Dermatol Sci. 2014 Nov;76(2):112-9. doi: 10.1016/j.jdermsci.2014.08.003. Epub 2014 Aug 26.
655 Correlation of chemopreventive efficacy data from the human epidermal cell assay with in vivo data. Anticancer Res. 2000 Jan-Feb;20(1A):27-32.
656 Deducing signaling pathways from parallel actions of arsenite and antimonite in human epidermal keratinocytes. Sci Rep. 2020 Feb 19;10(1):2890. doi: 10.1038/s41598-020-59577-0.
657 Effects of paclitaxel on proliferation and apoptosis in human acute myeloid leukemia HL-60 cells. Acta Pharmacol Sin. 2004 Mar;25(3):378-84.
658 Tetracaine hydrochloride induces cell cycle arrest in melanoma by downregulating hnRNPA1. Toxicol Appl Pharmacol. 2022 Jan 1;434:115810. doi: 10.1016/j.taap.2021.115810. Epub 2021 Nov 23.
659 Folic acid induces cell type-specific changes in the transcriptome of breast cancer cell lines: a proof-of-concept study. J Nutr Sci. 2016 Apr 26;5:e17. doi: 10.1017/jns.2016.8. eCollection 2016.
660 Tofacitinib attenuates pathologic immune pathways in patients with psoriasis: A randomized phase 2 study. J Allergy Clin Immunol. 2016 Apr;137(4):1079-1090. doi: 10.1016/j.jaci.2015.12.1318.
661 Influence of glutathione S-transferase A1, P1, M1, T1 polymorphisms on oral busulfan pharmacokinetics in children with congenital hemoglobinopathies undergoing hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2010 Dec 1;55(6):1172-9. doi: 10.1002/pbc.22739.
662 The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance. J Pharmacol Exp Ther. 2000 Aug;294(2):480-7.
663 Cell-type-specific responses to chemotherapeutics in breast cancer. Cancer Res. 2004 Jun 15;64(12):4218-26.
664 Glutathione S-transferase pi as a target for tricyclic antidepressants in human brain. Acta Biochim Pol. 2004;51(1):207-12.
665 Resveratrol-induced cell growth inhibition and apoptosis is associated with modulation of phosphoglycerate mutase B in human prostate cancer cells: two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and mass spectrometry evaluation. Cancer Detect Prev. 2004;28(6):443-52. doi: 10.1016/j.cdp.2004.08.009.
666 Evidence of securin-mediated resistance to gefitinib-induced apoptosis in human cancer cells. Chem Biol Interact. 2013 Apr 25;203(2):412-22. doi: 10.1016/j.cbi.2013.03.011. Epub 2013 Mar 22.
667 Cigarette smoke and asbestos activate poly-ADP-ribose polymerase in alveolar epithelial cells. J Investig Med. 2001 Jan;49(1):68-76. doi: 10.2310/6650.2001.34092.
668 The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation. J Biochem Mol Toxicol. 1999;13(6):338-47. doi: 10.1002/(sici)1099-0461(1999)13:6<338::aid-jbt8>3.0.co;2-7.
669 Investigation of molecular mechanisms underlying the antiproliferative effects of colchicine against PC3 prostate cancer cells. Toxicol In Vitro. 2021 Jun;73:105138. doi: 10.1016/j.tiv.2021.105138. Epub 2021 Mar 6.
670 Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer. Mol Cancer Ther. 2005 Feb;4(2):291-304.
671 Methotrexate induces poly(ADP-ribose) polymerase-dependent, caspase 3-independent apoptosis in subsets of proliferating CD4+ T cells. Clin Exp Immunol. 2007 May;148(2):288-95. doi: 10.1111/j.1365-2249.2007.03335.x. Epub 2007 Feb 7.
672 Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster. Pharmacogenet Genomics. 2006 Apr;16(4):287-96. doi: 10.1097/01.fpc.0000189800.88596.7a.
673 DNA demethylation by 5-aza-2-deoxycytidine treatment abrogates 17 beta-estradiol-induced cell growth and restores expression of DNA repair genes in human breast cancer cells. Cancer Lett. 2012 Mar;316(1):62-9. doi: 10.1016/j.canlet.2011.10.022. Epub 2011 Oct 23.
674 Chronic exposure to arsenic causes increased cell survival, DNA damage, and increased expression of mitochondrial transcription factor A (mtTFA) in human prostate epithelial cells. Chem Res Toxicol. 2011 Mar 21;24(3):340-9. doi: 10.1021/tx1003112. Epub 2011 Jan 14.
675 Mitochondrial reactive oxygen species are scavenged by Cockayne syndrome B protein in human fibroblasts without nuclear DNA damage. Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):13487-92. doi: 10.1073/pnas.1414135111. Epub 2014 Aug 18.
676 The endoperoxide ascaridol shows strong differential cytotoxicity in nucleotide excision repair-deficient cells. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):302-10. doi: 10.1016/j.taap.2012.01.006. Epub 2012 Jan 17.
677 Late activation of stress-activated protein kinases/c-Jun N-terminal kinases triggered by cisplatin-induced DNA damage in repair-defective cells. J Biol Chem. 2011 Apr 15;286(15):12991-3001. doi: 10.1074/jbc.M110.190645. Epub 2011 Feb 15.
678 Monomeric and oligomeric flavanols maintain the endogenous glucocorticoid response in human macrophages in pro-oxidant conditions in vitro. Chem Biol Interact. 2018 Aug 1;291:237-244.
679 Nicotine up-regulates IL-8 expression in human gingival epithelial cells following stimulation with IL-1 or P. gingivalis lipopolysaccharide via nicotinic acetylcholine receptor signalling. Arch Oral Biol. 2012 May;57(5):483-90. doi: 10.1016/j.archoralbio.2011.10.007. Epub 2011 Nov 25.
680 Ca(2+) Signaling and IL-8 Secretion in Human Testicular Peritubular Cells Involve the Cation Channel TRPV2. Int J Mol Sci. 2018 Sep 19;19(9):2829. doi: 10.3390/ijms19092829.
681 Nitric oxide synthase inhibitors attenuate ozone-induced airway inflammation in guinea pigs. Possible role of interleukin-8. Am J Respir Crit Care Med. 2000 Jan;161(1):249-56. doi: 10.1164/ajrccm.161.1.9804096.
682 Identification of human cell responses to benzene and benzene metabolites. Genomics. 2007 Sep;90(3):324-33.
683 Cell-based and cytokine-directed chemical screen to identify potential anti-multiple myeloma agents. Leuk Res. 2010 Jul;34(7):917-24. doi: 10.1016/j.leukres.2009.12.002. Epub 2010 Feb 8.
684 Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics. 2006 Apr;16(4):297-306. doi: 10.1097/01.fpc.0000199500.46842.4a.
685 Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Pharmacogenomics. 2010 Mar;11(3):349-56. doi: 10.2217/pgs.09.162.
686 A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis. Int J Immunogenet. 2011 Aug;38(4):303-9. doi: 10.1111/j.1744-313X.2011.01011.x. Epub 2011 May 4.
687 Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case-control study. Pharmacogenomics J. 2008 Feb;8(1):29-33. doi: 10.1038/sj.tpj.6500442. Epub 2007 Mar 6.
688 The effect of mitotane on viability, steroidogenesis and gene expression in NCI295R adrenocortical cells. Mol Med Rep. 2013 Mar;7(3):893-900.
689 The G Protein-Coupled Estrogen Receptor Agonist G-1 Inhibits Nuclear Estrogen Receptor Activity and Stimulates Novel Phosphoproteomic Signatures. Toxicol Sci. 2016 Jun;151(2):434-46. doi: 10.1093/toxsci/kfw057. Epub 2016 Mar 29.
690 Expression Profiling of Human Pluripotent Stem Cell-Derived Cardiomyocytes Exposed to Doxorubicin-Integration and Visualization of Multi-Omics Data. Toxicol Sci. 2018 May 1;163(1):182-195. doi: 10.1093/toxsci/kfy012.
691 Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry. Cells. 2019 Jul 31;8(8):806. doi: 10.3390/cells8080806.
692 Lon protease and eiF2 are involved in acute, but not prolonged, antiretroviral induced stress response in HepG2 cells. Chem Biol Interact. 2016 May 25;252:82-6. doi: 10.1016/j.cbi.2016.03.021. Epub 2016 Apr 1.
693 Indomethacin and ibuprofen induce Hsc70 nuclear localization and activation of the heat shock response in HeLa cells. Biochem Biophys Res Commun. 2004 Jan 23;313(4):863-70. doi: 10.1016/j.bbrc.2003.12.018.
694 A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia. Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3378-83.
695 Zoledronate dysregulates fatty acid metabolism in renal tubular epithelial cells to induce nephrotoxicity. Arch Toxicol. 2018 Jan;92(1):469-485.
696 Tryptanthrin induces growth inhibition and neuronal differentiation in the human neuroblastoma LA-N-1 cells. Chem Biol Interact. 2013 Apr 25;203(2):512-21. doi: 10.1016/j.cbi.2013.03.001. Epub 2013 Mar 13.
697 Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells. PLoS One. 2011;6(11):e27265. doi: 10.1371/journal.pone.0027265. Epub 2011 Nov 11.
698 Arsenic metabolites affect expression of the neurofilament and tau genes: an in-vitro study into the mechanism of arsenic neurotoxicity. Toxicol In Vitro. 2007 Sep;21(6):1104-12. doi: 10.1016/j.tiv.2007.04.007. Epub 2007 Apr 27.
699 Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription. Mol Hum Reprod. 2006 May;12(5):321-33. doi: 10.1093/molehr/gal036. Epub 2006 Apr 5.
700 HIF and reactive oxygen species regulate oxidative phosphorylation in cancer. Carcinogenesis. 2008 Aug;29(8):1528-37. doi: 10.1093/carcin/bgn125. Epub 2008 May 29.
701 Altered redox mitochondrial biology in the neurodegenerative disorder fragile X-tremor/ataxia syndrome: use of antioxidants in precision medicine. Mol Med. 2016 Oct;22:548-559. doi: 10.2119/molmed.2016.00122. Epub 2016 Jun 30.
702 Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain. J Biol Chem. 2010 Dec 17;285(51):39759-67. doi: 10.1074/jbc.M110.147504. Epub 2010 Sep 24.
703 Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells. Endocr Relat Cancer. 2013 May 21;20(3):371-81.
704 Erythropoietin activates SIRT1 to protect human cardiomyocytes against doxorubicin-induced mitochondrial dysfunction and toxicity. Toxicol Lett. 2017 Jun 5;275:28-38. doi: 10.1016/j.toxlet.2017.04.018. Epub 2017 Apr 27.
705 Pyrroloquinoline quinine ameliorates doxorubicin-induced autophagy-dependent apoptosis via lysosomal-mitochondrial axis in vascular endothelial cells. Toxicology. 2019 Sep 1;425:152238. doi: 10.1016/j.tox.2019.152238. Epub 2019 Jun 18.
706 Nicotine induces apoptosis through exacerbation of blocked alveolar macrophage autophagic degradation in silicosis. Toxicol Lett. 2020 Nov 1;334:94-101. doi: 10.1016/j.toxlet.2020.09.019. Epub 2020 Sep 30.
707 Differentially expressed genes in the prostate cancer cell line LNCaP after exposure to androgen and anti-androgen. Cancer Genet Cytogenet. 2006 Apr 15;166(2):130-8. doi: 10.1016/j.cancergencyto.2005.09.012.
708 A copper-hydrogen peroxide redox system induces dityrosine cross-links and chemokine oligomerisation. Cytokine. 2011 Dec;56(3):669-75. doi: 10.1016/j.cyto.2011.08.025. Epub 2011 Oct 1.
709 Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. Toxicol Sci. 2000 Dec;58(2):399-415.
710 Epinephrine facilitates the growth of T cell lymphoma by altering cell proliferation, apoptosis, and glucose metabolism. Chem Biol Interact. 2023 Jan 5;369:110278. doi: 10.1016/j.cbi.2022.110278. Epub 2022 Nov 22.
711 Arsenic trioxide inhibits EMT in hepatocellular carcinoma by promoting lncRNA MEG3 via PKM2. Biochem Biophys Res Commun. 2019 Jun 11;513(4):834-840. doi: 10.1016/j.bbrc.2019.04.081. Epub 2019 Apr 16.
712 Rosiglitazone protects neuroblastoma cells against advanced glycation end products-induced injury. Acta Pharmacol Sin. 2011 Aug;32(8):991-8. doi: 10.1038/aps.2011.81. Epub 2011 Jul 18.
713 DNA array analysis of the effects of aspirin on colon cancer cells: involvement of Rac1. Carcinogenesis. 2004 Jul;25(7):1293-8.
714 Antitumor effect of aspirin in glioblastoma cells by modulation of -catenin/T-cell factor-mediated transcriptional activity. J Neurosurg. 2011 Oct;115(4):780-8. doi: 10.3171/2011.5.JNS113. Epub 2011 Jul 1.
715 Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. Arch Gen Psychiatry. 2007 Jun;64(6):689-97. doi: 10.1001/archpsyc.64.6.689.
716 Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPK. Chem Biol Interact. 2017 Aug 1;273:107-114. doi: 10.1016/j.cbi.2017.06.005. Epub 2017 Jun 7.
717 Peroxisome proliferator-activated receptor-gamma ligands suppress fibronectin gene expression in human lung carcinoma cells: involvement of both CRE and Sp1. Am J Physiol Lung Cell Mol Physiol. 2005 Sep;289(3):L419-28. doi: 10.1152/ajplung.00002.2005. Epub 2005 May 20.
718 Nonclassical action of retinoic acid on the activation of the cAMP response element-binding protein in normal human bronchial epithelial cells. Mol Biol Cell. 2006 Feb;17(2):566-75. doi: 10.1091/mbc.e05-06-0519. Epub 2005 Nov 9.
719 p38 MAPK/PP2Ac/TTP pathway on the connection of TNF- and caspases activation on hydroquinone-induced apoptosis. Carcinogenesis. 2013 Apr;34(4):818-27. doi: 10.1093/carcin/bgs409. Epub 2013 Jan 3.
720 Glycyrrhizin attenuates histamine-mediated MUC5AC upregulation, inflammatory cytokine production, and aquaporin 5 downregulation through suppressing the NF-B pathway in human nasal epithelial cells. Chem Biol Interact. 2018 Apr 1;285:21-26. doi: 10.1016/j.cbi.2018.02.010. Epub 2018 Feb 13.
721 Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. J Clin Oncol. 2006 Jan 10;24(2):274-87. doi: 10.1200/JCO.2005.02.9405. Epub 2005 Dec 19.
722 Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage. Carcinogenesis. 2014 Mar;35(3):692-702. doi: 10.1093/carcin/bgt366. Epub 2013 Nov 5.
723 Induction of the DNA repair gene O6-methylguanine-DNA methyltransferase by dexamethasone in glioblastomas. J Neurosurg. 2004 Oct;101(4):659-63. doi: 10.3171/jns.2004.101.4.0659.
724 Phenytoin may increase the efficacy of temozolomide by methylating DNA-repair enzyme, O6-methylguanine-DNA methyltransferase in patients with glioblastoma. Med Hypotheses. 2005;65(4):819-20. doi: 10.1016/j.mehy.2005.04.007.
725 Pharmacokinetic, biochemical and clinical effects of dimethyltriazenoimidazole-4-carboxamide-bischloroethylnitrosourea combination therapy in patients with advanced breast cancer. Int J Cancer. 2003 Feb 20;103(5):686-92. doi: 10.1002/ijc.10849.
726 Transcriptional repression of O6-methylguanine DNA methyltransferase gene rendering cells hypersensitive to N,N'-bis(2-chloroethyl)-N-nitrosurea in camptothecin-resistant cells. Mol Pharmacol. 2008 Aug;74(2):517-26. doi: 10.1124/mol.107.043620. Epub 2008 May 20.
727 Targeting PFKL with penfluridol inhibits glycolysis and suppresses esophageal cancer tumorigenesis in an AMPK/FOXO3a/BIM-dependent manner. Acta Pharm Sin B. 2022 Mar;12(3):1271-1287. doi: 10.1016/j.apsb.2021.09.007. Epub 2021 Sep 11.
728 Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells. Eur J Med Chem. 2014 Jan;71:112-27. doi: 10.1016/j.ejmech.2013.11.001. Epub 2013 Nov 11.
729 Coumarins from Angelica decursiva inhibit -glucosidase activity and protein tyrosine phosphatase 1B. Chem Biol Interact. 2016 May 25;252:93-101. doi: 10.1016/j.cbi.2016.04.020. Epub 2016 Apr 13.
730 Development and validation of the TGx-HDACi transcriptomic biomarker to detect histone deacetylase inhibitors in human TK6 cells. Arch Toxicol. 2021 May;95(5):1631-1645. doi: 10.1007/s00204-021-03014-2. Epub 2021 Mar 26.
731 Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer. Cancer Res. 2005 Aug 1;65(15):6789-800. doi: 10.1158/0008-5472.CAN-04-2684.
732 Low dose of bisphenol a modulates ovarian cancer gene expression profile and promotes epithelial to mesenchymal transition via canonical Wnt pathway. Toxicol Sci. 2018 Aug 1;164(2):527-538.
733 Transcriptome and DNA methylation changes modulated by sulforaphane induce cell cycle arrest, apoptosis, DNA damage, and suppression of proliferation in human liver cancer cells. Food Chem Toxicol. 2020 Feb;136:111047. doi: 10.1016/j.fct.2019.111047. Epub 2019 Dec 12.
734 Identification of genes linked to gefitinib treatment in prostate cancer cell lines with or without resistance to androgen: a clue to application of gefitinib to hormone-resistant prostate cancer. Oncol Rep. 2006 Jun;15(6):1453-60.
735 The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents. Cancer Res. 2008 Oct 15;68(20):8269-77. doi: 10.1158/0008-5472.CAN-08-2010.
736 Filamin A phosphorylation by Akt promotes cell migration in response to arsenic. Oncotarget. 2015 May 20;6(14):12009-19. doi: 10.18632/oncotarget.3617.
737 Proteomic analysis of human adipose tissue after rosiglitazone treatment shows coordinated changes to promote glucose uptake. Obesity (Silver Spring). 2010 Jan;18(1):27-34. doi: 10.1038/oby.2009.208. Epub 2009 Jun 25.
738 Thalidomide and Its Analogs Differentially Target Fibroblast Growth Factor Receptors: Thalidomide Suppresses FGFR Gene Expression while Pomalidomide Dampens FGFR2 Activity. Chem Res Toxicol. 2019 Apr 15;32(4):589-602. doi: 10.1021/acs.chemrestox.8b00286. Epub 2019 Mar 15.
739 Increased expression of fibroblast growth factor receptor 3 in CD34+ BCR-ABL+ cells from patients with chronic myeloid leukemia. Leukemia. 2003 Dec;17(12):2418-25. doi: 10.1038/sj.leu.2403152.
740 Characterization of arsenic trioxide resistant clones derived from Jurkat leukemia T cell line: focus on PI3K/Akt signaling pathway. Chem Biol Interact. 2013 Oct 5;205(3):198-211. doi: 10.1016/j.cbi.2013.07.011. Epub 2013 Aug 2.
741 Cisplatin transiently up-regulates hHR23 expression through enhanced translational efficiency in A549 adenocarcinoma cells. Toxicol Lett. 2011 Sep 10;205(3):341-50. doi: 10.1016/j.toxlet.2011.06.028. Epub 2011 Jul 2.
742 Proteomic analysis revealed association of aberrant ROS signaling with suberoylanilide hydroxamic acid-induced autophagy in Jurkat T-leukemia cells. Autophagy. 2010 Aug;6(6):711-24. doi: 10.4161/auto.6.6.12397. Epub 2010 Aug 17.
743 Phosphorylation of the RNA polymerase II largest subunit during heat shock and inhibition of transcription in HeLa cells. J Cell Physiol. 1994 Mar;158(3):417-26. doi: 10.1002/jcp.1041580305.
744 Iron chelators ICL670 and 311 inhibit HIV-1 transcription. Virology. 2007 Oct 25;367(2):324-33. doi: 10.1016/j.virol.2007.06.011. Epub 2007 Jul 13.
745 All-trans retinoic acid inhibits vascular endothelial growth factor expression in a cell model of neutrophil activation. Endocrinology. 2006 Mar;147(3):1264-70. doi: 10.1210/en.2005-0854. Epub 2005 Dec 1.
746 Immunological consequences of thalidomide treatment in Sj?gren's syndrome. Ann Rheum Dis. 2006 Jan;65(1):112-4. doi: 10.1136/ard.2005.038406.
747 Differential modulation of pro- and anti-inflammatory cytokine receptors by N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxy-crotonic acid amide (A77 1726), the physiologically active metabolite of the novel immunomodulator leflunomide. Biochem Pharmacol. 1998 May 1;55(9):1523-9. doi: 10.1016/s0006-2952(97)00677-1.
748 Effects of combined 17beta-estradiol with TCDD on secretion of chemokine IL-8 and expression of its receptor CXCR1 in endometriotic focus-associated cells in co-culture. Hum Reprod. 2006 Apr;21(4):870-9. doi: 10.1093/humrep/dei414. Epub 2006 Mar 3.
749 Arsenic exposure, diabetes-related genes and diabetes prevalence in a general population from Spain. Environ Pollut. 2018 Apr;235:948-955. doi: 10.1016/j.envpol.2018.01.008. Epub 2018 Feb 21.
750 Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface:impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer. 2002 Sep 15;95(6):1206-14. doi: 10.1002/cncr.10812.
751 Short-term exposure to oleandrin enhances responses to IL-8 by increasing cell surface IL-8 receptors. Br J Pharmacol. 2014 Jul;171(14):3339-51. doi: 10.1111/bph.12493.
752 Expression of neutrophil SOD2 is reduced after lipopolysaccharide stimulation: a potential cause of neutrophil dysfunction in chronic kidney disease. Nephrol Dial Transplant. 2011 Jul;26(7):2195-201. doi: 10.1093/ndt/gfq673. Epub 2010 Nov 2.
753 Tea polyphenols direct Bmal1-driven ameliorating of the redox imbalance and mitochondrial dysfunction in hepatocytes. Food Chem Toxicol. 2018 Dec;122:181-193.
754 Biotinylated quercetin as an intrinsic photoaffinity proteomics probe for the identification of quercetin target proteins. Bioorg Med Chem. 2011 Aug 15;19(16):4710-20. doi: 10.1016/j.bmc.2011.07.005. Epub 2011 Jul 13.
755 9-Tetrahydrocannabinol leads to endoplasmic reticulum stress and mitochondrial dysfunction in human BeWo trophoblasts. Reprod Toxicol. 2019 Aug;87:21-31. doi: 10.1016/j.reprotox.2019.04.008. Epub 2019 May 1.
756 Growth inhibition of ovarian tumor-initiating cells by niclosamide. Mol Cancer Ther. 2012 Aug;11(8):1703-12.
757 Curcumin reduces the expression of survivin, leading to enhancement of arsenic trioxide-induced apoptosis in myelodysplastic syndrome and leukemia stem-like cells. Oncol Rep. 2016 Sep;36(3):1233-42. doi: 10.3892/or.2016.4944. Epub 2016 Jul 15.
758 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 2000 Mar 1;164(5):2405-11. doi: 10.4049/jimmunol.164.5.2405.
759 Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFalpha/NF-kappaB signaling axis. Leukemia. 2010 Aug;24(8):1476-86. doi: 10.1038/leu.2010.117. Epub 2010 Jun 3.
760 Oxidative stress-induced epigenetic changes associated with malignant transformation of human kidney epithelial cells. Oncotarget. 2017 Feb 14;8(7):11127-11143. doi: 10.18632/oncotarget.12091.
761 Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells. Br J Nutr. 2012 Mar;107(6):781-90. doi: 10.1017/S0007114511003631. Epub 2011 Aug 1.
762 The low-toxicity 9-cis UAB30 novel retinoid down-regulates the DNA methyltransferases and has anti-telomerase activity in human breast cancer cells. Int J Oncol. 2007 Mar;30(3):641-50.
763 Cyclophosphamide perturbs cytosine methylation in Jurkat-T cells through LSD1-mediated stabilization of DNMT1 protein. Chem Res Toxicol. 2011 Nov 21;24(11):2040-3. doi: 10.1021/tx2003849. Epub 2011 Nov 1.
764 DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes. Mol Pharmacol. 2007 Mar;71(3):644-53. doi: 10.1124/mol.106.030635. Epub 2006 Oct 25.
765 Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells. Hum Pathol. 2006 Mar;37(3):298-311.
766 Treatment with anticancer agents induces dysregulation of specific Wnt signaling pathways in human ovarian luteinized granulosa cells in vitro. Toxicol Sci. 2013 Nov;136(1):183-92. doi: 10.1093/toxsci/kft175. Epub 2013 Aug 16.
767 Progesterone increases csk homologous kinase in HMC-1560 human mast cells and reduces cell proliferation. J Cell Biochem. 2007 Dec 1;102(5):1271-80. doi: 10.1002/jcb.21357.
768 Growth stimulation of human pulmonary adenocarcinoma cells and small airway epithelial cells by beta-carotene via activation of cAMP, PKA, CREB and ERK1/2. Int J Cancer. 2006 Mar 15;118(6):1370-80. doi: 10.1002/ijc.21537.
769 Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis. Toxicol Appl Pharmacol. 2014 Mar 1;275(2):176-81. doi: 10.1016/j.taap.2014.01.005. Epub 2014 Jan 17.
770 Inhibition of activator protein 1 by barbiturates is mediated by differential effects on mitogen-activated protein kinases and the small G proteins ras and rac-1. J Pharmacol Exp Ther. 2004 Dec;311(3):1232-40. doi: 10.1124/jpet.104.071332. Epub 2004 Jul 19.
771 Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance. Breast Cancer Res Treat. 2010 Feb;119(3):575-91. doi: 10.1007/s10549-009-0355-8. Epub 2009 Mar 15.
772 Effect of histamine H1 receptor antagonists on TARC/CCL17 and MDC/CCL22 production from CD14+ cells induced by antigenic stimulation in vitro. Int Arch Allergy Immunol. 2011;155(1):38-51. doi: 10.1159/000318720. Epub 2010 Nov 25.
773 SIRT3 Mediates the Antioxidant Effect of Hydrogen Sulfide in Endothelial Cells. Antioxid Redox Signal. 2016 Feb 20;24(6):329-43. doi: 10.1089/ars.2015.6331. Epub 2015 Nov 10.
774 Proteomics investigation of protein expression changes in ouabain induced apoptosis in human umbilical vein endothelial cells. J Cell Biochem. 2008 Jun 1;104(3):1054-64. doi: 10.1002/jcb.21691.
775 Lon protease: a novel mitochondrial matrix protein in the interconnection between drug-induced mitochondrial dysfunction and endoplasmic reticulum stress. Br J Pharmacol. 2017 Dec;174(23):4409-4429. doi: 10.1111/bph.14045. Epub 2017 Nov 7.
776 Downregulation of mitogen-activated protein kinases (MAPKs) in chronic ethanol-induced fatty liver. Toxicol Mech Methods. 2020 Jul;30(6):407-416. doi: 10.1080/15376516.2020.1747126. Epub 2020 Apr 1.
777 A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling. Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16657-62. doi: 10.1073/pnas.0707936104. Epub 2007 Oct 9.
778 The stent-eluting drugs sirolimus and paclitaxel suppress healing of the endothelium by induction of autophagy. Am J Pathol. 2009 Nov;175(5):2226-34.
779 Modulation of apoptosis in HaCaT keratinocytes via differential regulation of ERK signaling pathway by flavonoids. J Biol Chem. 2005 Sep 9;280(36):31498-507. doi: 10.1074/jbc.M505537200. Epub 2005 Jul 13.
780 MAP kinase-signaling controls nuclear translocation of tripeptidyl-peptidase II in response to DNA damage and oxidative stress. Biochem Biophys Res Commun. 2010 Aug 27;399(3):324-30. doi: 10.1016/j.bbrc.2010.06.133. Epub 2010 Jul 17.
781 Comparison of quantitation methods in proteomics to define relevant toxicological information on AhR activation of HepG2 cells by BaP. Toxicology. 2021 Jan 30;448:152652. doi: 10.1016/j.tox.2020.152652. Epub 2020 Dec 2.
782 Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach. BMC Syst Biol. 2012 Dec 10;6:152.
783 Proteomic analysis of the nucleus accumbens of rats with different vulnerability to cocaine addiction. Neuropharmacology. 2009 Jul;57(1):41-8. doi: 10.1016/j.neuropharm.2009.04.005. Epub 2009 Apr 22.
784 Cannabidiol Protects Human Skin Keratinocytes from Hydrogen-Peroxide-Induced Oxidative Stress via Modulation of the Caspase-1-IL-1 Axis. J Nat Prod. 2021 May 28;84(5):1563-1572. doi: 10.1021/acs.jnatprod.1c00083. Epub 2021 May 6.
785 Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatment. J Pharmacol Exp Ther. 2014 Mar;348(3):360-71. doi: 10.1124/jpet.113.210054. Epub 2013 Dec 17.
786 Mitochondrial Thioredoxin System as a Modulator of Cyclophilin D Redox State. Sci Rep. 2016 Mar 15;6:23071. doi: 10.1038/srep23071.
787 White-to-brown metabolic conversion of human adipocytes by JAK inhibition. Nat Cell Biol. 2015 Jan;17(1):57-67. doi: 10.1038/ncb3075. Epub 2014 Dec 8.
788 PPARgama activation rescues mitochondrial function from inhibition of complex I and loss of PINK1. Exp Neurol. 2014 Mar;253:16-27.
789 Aberrant cell proliferation by enhanced mitochondrial biogenesis via mtTFA in arsenical skin cancers. Am J Pathol. 2011 May;178(5):2066-76.
790 A pilot study on the transcriptional response of androgen- and insulin-related genes in peripheral blood mononuclear cells induced by testosterone administration in hypogonadal men. J Biol Regul Homeost Agents. 2011 Apr-Jun;25(2):291-4.
791 Glucocorticoid programming mechanism for hypercholesterolemia in prenatal ethanol-exposed adult offspring rats. Toxicol Appl Pharmacol. 2019 Jul 15;375:46-56.
792 Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol. Apoptosis. 2008 Feb;13(2):259-71. doi: 10.1007/s10495-007-0165-6.
793 Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis. Arthritis Rheum. 2013 Nov;65(11):2791-802.
794 Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment. Cancer Biol Ther. 2008 Oct;7(10):1607-18.
795 Nicotinic modulation of gene expression in SH-SY5Y neuroblastoma cells. Brain Res. 2006 Oct 20;1116(1):39-49.
796 Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells. Gynecol Oncol. 2005 Jul;98(1):45-53. doi: 10.1016/j.ygyno.2005.04.010.
797 Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis. Eur J Neurol. 2018 Jul;25(7):934-e70. doi: 10.1111/ene.13623. Epub 2018 Apr 16.
798 Combination of arsenic trioxide and Dasatinib: a new strategy to treat Philadelphia chromosome-positive acute lymphoblastic leukaemia. J Cell Mol Med. 2018 Mar;22(3):1614-1626.
799 Novel functional view of the crocidolite asbestos-treated A549 human lung epithelial transcriptome reveals an intricate network of pathways with opposing functions. BMC Genomics. 2008 Aug 7;9:376.
800 Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders. Cancer Genet Cytogenet. 2010 Jun;199(2):110-20. doi: 10.1016/j.cancergencyto.2010.02.010.
801 Endoplasmic reticulum stress contributes to arsenic trioxide-induced intrinsic apoptosis in human umbilical and bone marrow mesenchymal stem cells. Environ Toxicol. 2016 Mar;31(3):314-28.
802 Induction of CCAAT/enhancer-binding protein-homologous protein by cigarette smoke through the superoxide anion-triggered PERK-eIF2 pathway. Toxicology. 2011 Sep 5;287(1-3):105-12. doi: 10.1016/j.tox.2011.06.005. Epub 2011 Jun 15.
803 Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation. Neuro Oncol. 2011 Mar;13(3):267-79. doi: 10.1093/neuonc/noq195. Epub 2011 Feb 3.
804 High-content imaging-based BAC-GFP toxicity pathway reporters to assess chemical adversity liabilities. Arch Toxicol. 2017 Mar;91(3):1367-1383. doi: 10.1007/s00204-016-1781-0. Epub 2016 Jun 29.
805 Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury. Toxicol Sci. 2014 Jan;137(1):234-48. doi: 10.1093/toxsci/kft232. Epub 2013 Oct 17.
806 Differentiation of human embryonic stem cells into smooth muscle cells in adherent monolayer culture. Biochem Biophys Res Commun. 2006 Dec 15;351(2):321-7. doi: 10.1016/j.bbrc.2006.09.171. Epub 2006 Oct 17.
807 Nifedipine inhibits vascular smooth muscle cell dedifferentiation via downregulation of Akt signaling. Hypertension. 2010 Aug;56(2):247-52. doi: 10.1161/HYPERTENSIONAHA.110.149781. Epub 2010 Jun 7.
808 Cannabidiol and Oxygen-Ozone Combination Induce Cytotoxicity in Human Pancreatic Ductal Adenocarcinoma Cell Lines. Cancers (Basel). 2020 Sep 27;12(10):2774. doi: 10.3390/cancers12102774.
809 trans-Resveratrol inhibits H2O2-induced adenocarcinoma gastric cells proliferation via inactivation of MEK1/2-ERK1/2-c-Jun signalling axis. Biochem Pharmacol. 2009 Feb 1;77(3):337-47. doi: 10.1016/j.bcp.2008.10.034. Epub 2008 Nov 6.
810 Regulation of genistein-induced differentiation in human acute myeloid leukaemia cells (HL60, NB4) Protein kinase modulation and reactive oxygen species generation. Biochem Pharmacol. 2009 Feb 1;77(3):384-96. doi: 10.1016/j.bcp.2008.10.035. Epub 2008 Nov 6.
811 Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide. Int J Cancer. 2001 May 15;92(4):518-26. doi: 10.1002/ijc.1220.
812 New insights into BaP-induced toxicity: role of major metabolites in transcriptomics and contribution to hepatocarcinogenesis. Arch Toxicol. 2016 Jun;90(6):1449-58.
813 A novel mechanism for pergolide-induced neuroprotection: inhibition of NF-kappaB nuclear translocation. Biochem Pharmacol. 2004 May 1;67(9):1743-50. doi: 10.1016/j.bcp.2004.01.012.
814 Antitumor effects of aminobisphosphonates on renal cell carcinoma cell lines. J Urol. 2006 Nov;176(5):2255-61. doi: 10.1016/j.juro.2006.07.053.
815 Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells. Biochem Biophys Res Commun. 2001 Jan 26;280(3):664-74. doi: 10.1006/bbrc.2000.4216.
816 Cisplatin induces autophagy to enhance hepatitis B virus replication via activation of ROS/JNK and inhibition of the Akt/mTOR pathway. Free Radic Biol Med. 2019 Feb 1;131:225-236. doi: 10.1016/j.freeradbiomed.2018.12.008. Epub 2018 Dec 11.
817 Disease-modifying effects of glucosamine HCl involving regulation of metalloproteinases and chemokines activated by interleukin-1beta in human primary synovial fibroblasts. J Cell Biochem. 2008 May 1;104(1):38-50. doi: 10.1002/jcb.21597.
818 Characterization of cell death induced by ethacrynic acid in a human colon cancer cell line DLD-1 and suppression by N-acetyl-L-cysteine. Cancer Sci. 2003 Oct;94(10):886-93.
819 Effect of menstrual cycle and hormonal treatment on ki-67 and bcl-2 expression and adenomyosis. Gynecol Endocrinol. 2005 Mar;20(3):127-31. doi: 10.1080/09513590400021086.
820 An in vitro study on anti-carcinogenic effect of remdesivir in human ovarian cancer cells via generation of reactive oxygen species. Hum Exp Toxicol. 2022 Jan-Dec;41:9603271221089257. doi: 10.1177/09603271221089257.
821 Mitophagy inhibits proliferation by decreasing cyclooxygenase-2 (COX-2) in arsenic trioxide-treated HepG2 cells. Environ Toxicol Pharmacol. 2016 Jul;45:212-21.
822 Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454-3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC. Chem Biol Interact. 2021 Nov 1;349:109652. doi: 10.1016/j.cbi.2021.109652. Epub 2021 Sep 11.
823 Endoplasmic reticulum stress-mediated apoptosis in imatinib-resistant leukemic K562-r cells triggered by AMN107 combined with arsenic trioxide. Exp Biol Med (Maywood). 2013 Aug 1;238(8):932-42. doi: 10.1177/1535370213492689. Epub 2013 Jul 24.
824 Establishment and characterization of a novel imatinib-sensitive chronic myeloid leukemia cell line MYL, and an imatinib-resistant subline MYL-R showing overexpression of Lyn. Eur J Haematol. 2007 May;78(5):417-31. doi: 10.1111/j.1600-0609.2007.00835.x.
825 Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cells. Clin Cancer Res. 2006 Oct 1;12(19):5869-78. doi: 10.1158/1078-0432.CCR-06-0980.
826 Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway. Cancer Res. 2009 May 1;69(9):3927-36. doi: 10.1158/0008-5472.CAN-08-2978. Epub 2009 Apr 14.
827 Efficacy of the polo-like kinase inhibitor rigosertib, alone or in combination with Abelson tyrosine kinase inhibitors, against break point cluster region-c-Abelson-positive leukemia cells. Oncotarget. 2015 Aug 21;6(24):20231-40. doi: 10.18632/oncotarget.4047.
828 A multi-parameter in vitro screen in human stem cell-derived cardiomyocytes identifies ponatinib-induced structural and functional cardiac toxicity. Toxicol Sci. 2015 Jan;143(1):147-55. doi: 10.1093/toxsci/kfu215. Epub 2014 Oct 10.
829 Tyrosine phosphorylation of the scaffold protein IQGAP1 in the MET pathway alters function. J Biol Chem. 2020 Dec 25;295(52):18105-18121. doi: 10.1074/jbc.RA120.015891. Epub 2020 Oct 21.
830 Molecular targets of chloropicrin in human airway epithelial cells. Toxicol In Vitro. 2017 Aug;42:247-254.
831 Organochloride pesticides induced hepatic ABCG5/G8 expression and lipogenesis in Chinese patients with gallstone disease. Oncotarget. 2016 Jun 7;7(23):33689-702. doi: 10.18632/oncotarget.9399.
832 Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells. Biochem Pharmacol. 2001 Dec 1;62(11):1545-55. doi: 10.1016/s0006-2952(01)00790-0.
833 Species-specific toxicity of diclofenac and troglitazone in primary human and rat hepatocytes. Chem Biol Interact. 2009 Apr 15;179(1):17-24.
834 Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes. Toxicol Appl Pharmacol. 2013 Oct 1;272(1):245-55.
835 Gamma-irradiation and doxorubicin treatment of normal human cells cause cell cycle arrest via different pathways. Mol Cells. 2005 Dec 31;20(3):331-8.
836 Prenatal arsenic exposure and shifts in the newborn proteome: interindividual differences in tumor necrosis factor (TNF)-responsive signaling. Toxicol Sci. 2014 Jun;139(2):328-37. doi: 10.1093/toxsci/kfu053. Epub 2014 Mar 27.
837 Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatment. Toxicol Sci. 2010 Aug;116(2):467-76. doi: 10.1093/toxsci/kfq138. Epub 2010 May 10.
838 The Nedd8-activating enzyme inhibitor MLN4924 thwarts microenvironment-driven NF-B activation and induces apoptosis in chronic lymphocytic leukemia B cells. Clin Cancer Res. 2014 Mar 15;20(6):1576-89. doi: 10.1158/1078-0432.CCR-13-0987.
839 Preliminary discovery of novel markers for human cell line activation test (h-CLAT). Toxicol In Vitro. 2021 Aug;74:105154. doi: 10.1016/j.tiv.2021.105154. Epub 2021 Mar 25.
840 High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth. Clin Cancer Res. 2009 Oct 1;15(19):6070-8.
841 Bisphenol A Exposure Changes the Transcriptomic and Proteomic Dynamics of Human Retinoblastoma Y79 Cells. Genes (Basel). 2021 Feb 11;12(2):264. doi: 10.3390/genes12020264.
842 Orlistat Displays Antitumor Activity and Enhances the Efficacy of Paclitaxel in Human Hepatoma Hep3B Cells. Chem Res Toxicol. 2019 Feb 18;32(2):255-264. doi: 10.1021/acs.chemrestox.8b00269. Epub 2019 Jan 22.
843 Whole genome mRNA transcriptomics analysis reveals different modes of action of the diarrheic shellfish poisons okadaic acid and dinophysis toxin-1 versus azaspiracid-1 in Caco-2 cells. Toxicol In Vitro. 2018 Feb;46:102-112.
844 Plasmatic concentration of organochlorine lindane acts as metabolic disruptors in HepG2 liver cell line by inducing mitochondrial disorder. Toxicol Appl Pharmacol. 2013 Oct 15;272(2):325-34.
845 Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-alpha, CH11 and CYC202. Endocr Relat Cancer. 2007 Jun;14(2):305-15. doi: 10.1677/ERC-06-0003.
846 Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies. Leuk Res. 2008 Feb;32(2):275-85. doi: 10.1016/j.leukres.2007.05.024. Epub 2007 Jul 19.
847 Steroid signalling in the ovarian surface epithelium. Trends Endocrinol Metab. 2005 Sep;16(7):327-33.
848 A comparative proteomic analysis for capsaicin-induced apoptosis between human hepatocarcinoma (HepG2) and human neuroblastoma (SK-N-SH) cells. Proteomics. 2008 Nov;8(22):4748-67. doi: 10.1002/pmic.200800094.
849 Differentiation-associated alteration in gene expression of importins and exportins in human leukemia HL-60 cells. Biomed Res. 2008 Jun;29(3):141-5. doi: 10.2220/biomedres.29.141.
850 Effect of Ivermectin and Atorvastatin on Nuclear Localization of Importin Alpha and Drug Target Expression Profiling in Host Cells from Nasopharyngeal Swabs of SARS-CoV-2- Positive Patients. Viruses. 2021 Oct 15;13(10):2084. doi: 10.3390/v13102084.
851 Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells. Mol Cancer Ther. 2012 Oct;11(10):2138-48. doi: 10.1158/1535-7163.MCT-12-0562. Epub 2012 Aug 6.
852 Effects of antiepileptic drugs on lipogenic gene regulation and hyperlipidemia risk in Taiwan: a nationwide population-based cohort study and supporting in vitro studies. Arch Toxicol. 2018 Sep;92(9):2829-2844. doi: 10.1007/s00204-018-2263-3. Epub 2018 Jul 13.
853 Prenatal caffeine exposure increases the susceptibility to non-alcoholic fatty liver disease in female offspring rats via activation of GR-C/EBP-SIRT1 pathway. Toxicology. 2019 Apr 1;417:23-34. doi: 10.1016/j.tox.2019.02.008. Epub 2019 Feb 15.
854 Brexpiprazole suppresses cell proliferation and de novo lipogenesis through AMPK/SREBP1 pathway in colorectal cancer. Environ Toxicol. 2023 Oct;38(10):2352-2360. doi: 10.1002/tox.23871. Epub 2023 Jun 22.
855 Effect of cyclophosphamide on gene expression of cytochromes p450 and beta-actin in the HL-60 cell line. Eur J Pharmacol. 2002 Aug 9;449(3):197-205.
856 Role of HER-2/neu signaling in sensitivity to tumor necrosis factor-related apoptosis-inducing ligand: enhancement of TRAIL-mediated apoptosis by amiloride. J Cell Biochem. 2005 Oct 1;96(2):376-89. doi: 10.1002/jcb.20512.
857 Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse. Pharmacogenomics J. 2003;3(1):27-40.
858 Proteasome inhibition creates a chromatin landscape favorable to RNA Pol II processivity. J Biol Chem. 2020 Jan 31;295(5):1271-1287. doi: 10.1074/jbc.RA119.011174. Epub 2019 Dec 5.
859 A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):904-12. doi: 10.1016/j.ijrobp.2008.10.032.
860 Inhibition of beta-globin gene expression by 3'-azido-3'-deoxythymidine in human erythroid progenitor cells. Antiviral Res. 1999 Dec 31;44(3):167-77. doi: 10.1016/s0166-3542(99)00065-0.
861 Changes in DNA methylation of erythroid-specific genes in K562 cells exposed to phenol and hydroquinone. Toxicology. 2013 Oct 4;312:108-14. doi: 10.1016/j.tox.2013.08.007. Epub 2013 Aug 20.
862 Voxelotor for the treatment of sickle cell disease. Expert Rev Hematol. 2021 Mar;14(3):253-262. doi: 10.1080/17474086.2021.1893688. Epub 2021 Mar 4.
863 Label-Free Bottom-Up Proteomic Workflow for Simultaneously Assessing the Target Specificity of Covalent Drug Candidates and Their Off-Target Reactivity to Selected Proteins. Chem Res Toxicol. 2016 Jan 19;29(1):109-16. doi: 10.1021/acs.chemrestox.5b00460. Epub 2015 Dec 29.
864 Identification of flucloxacillin-modified hepatocellular proteins: implications in flucloxacillin-induced liver injury. Toxicol Sci. 2023 Mar 20;192(1):106-116. doi: 10.1093/toxsci/kfad015.
865 Gene expression responses reflecting 5-FU-induced toxicity: Comparison between patient colon tissue and 3D human colon organoids. Toxicol Lett. 2022 Dec 1;371:17-24. doi: 10.1016/j.toxlet.2022.09.013. Epub 2022 Sep 29.
866 Incorporation of 5-fluorouracil into U2 snRNA blocks pseudouridylation and pre-mRNA splicing in vivo. Nucleic Acids Res. 2007;35(2):550-8. doi: 10.1093/nar/gkl1084. Epub 2006 Dec 14.
867 Alpha4-overexpressing HL7702 cells can counteract microcystin-LR effects on cytoskeletal structure. Environ Toxicol. 2018 Sep;33(9):978-987. doi: 10.1002/tox.22585. Epub 2018 Jul 9.
868 Gene expression in benzene-exposed workers by microarray analysis of peripheral mononuclear blood cells: induction and silencing of CYP4F3A and regulation of DNA-dependent protein kinase catalytic subunit in DNA double strand break repair. Chem Biol Interact. 2010 Mar 19;184(1-2):207-11.
869 Arsenic exposure from drinking water is associated with decreased gene expression and increased DNA methylation in peripheral blood. Toxicol Appl Pharmacol. 2017 Apr 15;321:57-66. doi: 10.1016/j.taap.2017.02.019. Epub 2017 Feb 24.
870 Comprehensive analysis of transcriptomic changes induced by low and high doses of bisphenol A in HepG2 spheroids in vitro and rat liver in vivo. Environ Res. 2019 Jun;173:124-134. doi: 10.1016/j.envres.2019.03.035. Epub 2019 Mar 18.
871 Morphological and molecular course of mitochondrial pathology in cultured human cells exposed long-term to Zidovudine. Environ Mol Mutagen. 2007 Apr-May;48(3-4):179-89. doi: 10.1002/em.20245.
872 Vitamin D Counteracts an IL-23-Dependent IL-17A(+)IFN-(+) Response Driven by Urban Particulate Matter. Am J Respir Cell Mol Biol. 2017 Sep;57(3):355-366. doi: 10.1165/rcmb.2016-0409OC.
873 Effects of aromatase inhibitors on human osteoblast and osteoblast-like cells: a possible androgenic bone protective effects induced by exemestane. Bone. 2007 Apr;40(4):876-87. doi: 10.1016/j.bone.2006.11.029. Epub 2006 Dec 28.
874 HU-331 and Oxidized Cannabidiol Act as Inhibitors of Human Topoisomerase II and . Chem Res Toxicol. 2018 Feb 19;31(2):137-144. doi: 10.1021/acs.chemrestox.7b00302. Epub 2018 Jan 8.
875 Chlorpyrifos Induces MLL Translocations Through Caspase 3-Dependent Genomic Instability and Topoisomerase II Inhibition in Human Fetal Liver Hematopoietic Stem Cells. Toxicol Sci. 2015 Oct;147(2):588-606. doi: 10.1093/toxsci/kfv153. Epub 2015 Jul 20.
876 Curcumin prevents DNA damage and enhances the repair potential in a chronically arsenic-exposed human population in West Bengal, India. Eur J Cancer Prev. 2011 Mar;20(2):123-31. doi: 10.1097/cej.0b013e328341017a.
877 New insights into the mechanisms underlying 5-fluorouracil-induced intestinal toxicity based on transcriptomic and metabolomic responses in human intestinal organoids. Arch Toxicol. 2021 Aug;95(8):2691-2718. doi: 10.1007/s00204-021-03092-2. Epub 2021 Jun 20.
878 Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells. Cancer Med. 2017 Nov;6(11):2646-2659. doi: 10.1002/cam4.1179. Epub 2017 Sep 27.
879 Characterization of DNA reactive and non-DNA reactive anticancer drugs by gene expression profiling. Mutat Res. 2007 Jun 1;619(1-2):16-29. doi: 10.1016/j.mrfmmm.2006.12.007. Epub 2007 Feb 8.
880 -Carotene Induces Apoptosis in Human Esophageal Squamous Cell Carcinoma Cell Lines via the Cav-1/AKT/NF-B Signaling Pathway. J Biochem Mol Toxicol. 2016 Mar;30(3):148-57. doi: 10.1002/jbt.21773. Epub 2016 Jan 6.
881 Differential gene expression of sulindac-treated human breast epithelial cells. Int J Oncol. 2005 Dec;27(6):1727-36.
882 Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells. Immunology. 2007 May;121(1):71-81. doi: 10.1111/j.1365-2567.2006.02539.x.
883 Glucosamine regulation of LPS-mediated inflammation in human bronchial epithelial cells. Eur J Pharmacol. 2010 Jun 10;635(1-3):219-26. doi: 10.1016/j.ejphar.2010.02.044. Epub 2010 Mar 20.
884 Analysis of telomerase activity and RNA expression in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid. Pediatr Blood Cancer. 2006 Apr;46(4):506-11. doi: 10.1002/pbc.20392.
885 Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2. Clin Cancer Res. 2005 Sep 1;11(17):6325-32. doi: 10.1158/1078-0432.CCR-05-0182.
886 Arsenic trioxide initiates ER stress responses, perturbs calcium signalling and promotes apoptosis in human lens epithelial cells. Exp Eye Res. 2007 Dec;85(6):825-35. doi: 10.1016/j.exer.2007.08.018. Epub 2007 Aug 29.
887 Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance. Breast Cancer Res Treat. 2007 Apr;102(2):157-72.
888 Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 2018;14(8):1435-1455. doi: 10.1080/15548627.2018.1474314. Epub 2018 Jul 20.
889 Effects of acute ethanol treatment on NCCIT cells and NCCIT cell-derived embryoid bodies (EBs). Toxicol In Vitro. 2010 Sep;24(6):1696-704. doi: 10.1016/j.tiv.2010.05.017. Epub 2010 May 26.
890 Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis. Oncogene. 2010 Mar 4;29(9):1329-38. doi: 10.1038/onc.2009.425. Epub 2009 Nov 30.
891 Differential DNA methylation profile of key genes in malignant prostate epithelial cells transformed by inorganic arsenic or cadmium. Toxicol Appl Pharmacol. 2015 Aug 1;286(3):159-67.
892 Identification of potential biomarkers of hepatitis B-induced acute liver failure using hepatic cells derived from human skin precursors. Toxicol In Vitro. 2015 Sep;29(6):1231-9. doi: 10.1016/j.tiv.2014.10.012. Epub 2014 Oct 24.
893 Unique transcriptome, pathways, and networks in the human endometrial fibroblast response to progesterone in endometriosis. Biol Reprod. 2011 Apr;84(4):801-15.
894 Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer. Cancer Res. 2006 Mar 1;66(5):2765-77.
895 Involvement of Asp-Glu-Val-Asp-directed, caspase-mediated mitogen-activated protein kinase kinase 1 Cleavage, c-Jun N-terminal kinase activation, and subsequent Bcl-2 phosphorylation for paclitaxel-induced apoptosis in HL-60 cells. Mol Pharmacol. 2001 Feb;59(2):254-62. doi: 10.1124/mol.59.2.254.
896 Arsenic and the epigenome: interindividual differences in arsenic metabolism related to distinct patterns of DNA methylation. J Biochem Mol Toxicol. 2013 Feb;27(2):106-15. doi: 10.1002/jbt.21462. Epub 2013 Jan 11.
897 Comparison of protective effect of ascorbic acid on redox and endocannabinoid systems interactions in in vitro cultured human skin fibroblasts exposed to UV radiation and hydrogen peroxide. Arch Dermatol Res. 2017 May;309(4):285-303. doi: 10.1007/s00403-017-1729-0. Epub 2017 Mar 11.
898 PP2A-B56? complex is involved in dephosphorylation of -H2AX in the repair process of CPT-induced DNA double-strand breaks. Toxicology. 2015 May 4;331:57-65. doi: 10.1016/j.tox.2015.03.007. Epub 2015 Mar 12.
899 Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen. Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2730-5. doi: 10.1073/pnas.1018872108. Epub 2011 Apr 11.
900 Effects of aspirin on metastasis-associated gene expression detected by cDNA microarray. Acta Pharmacol Sin. 2004 Oct;25(10):1327-33.
901 Induction of heme oxygenase-1 by cobalt protoporphyrin enhances the antitumour effect of bortezomib in adult T-cell leukaemia cells. Br J Cancer. 2007 Oct 22;97(8):1099-105. doi: 10.1038/sj.bjc.6604003. Epub 2007 Sep 25.
902 AS3MT facilitates NLRP3 inflammasome activation by m(6)A modification during arsenic-induced hepatic insulin resistance. Cell Biol Toxicol. 2023 Oct;39(5):2165-2181. doi: 10.1007/s10565-022-09703-7. Epub 2022 Feb 28.
903 Cimetidine induces interleukin-18 production through H2-agonist activity in monocytes. Mol Pharmacol. 2006 Aug;70(2):450-3. doi: 10.1124/mol.106.025890. Epub 2006 May 24.
904 The differential cancer growth associated with anaesthetics in a cancer xenograft model of mice: mechanisms and implications of postoperative cancer recurrence. Cell Biol Toxicol. 2023 Aug;39(4):1561-1575. doi: 10.1007/s10565-022-09747-9. Epub 2022 Aug 12.
905 Dihydroartemisinin induces pyroptosis by promoting the AIM2/caspase-3/DFNA5 axis in breast cancer cells. Chem Biol Interact. 2021 May 1;340:109434. doi: 10.1016/j.cbi.2021.109434. Epub 2021 Mar 6.
906 Effects of metformin and pioglitazone combination on apoptosis and AMPK/mTOR signaling pathway in human anaplastic thyroid cancer cells. J Biochem Mol Toxicol. 2020 Oct;34(10):e22547. doi: 10.1002/jbt.22547. Epub 2020 Jun 26.
907 Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells. BMC Med Genomics. 2009 Aug 20;2:55. doi: 10.1186/1755-8794-2-55.
908 Inhibition of fatty acid synthase expression by 1alpha,25-dihydroxyvitamin D3 in prostate cancer cells. J Steroid Biochem Mol Biol. 2003 May;85(1):1-8. doi: 10.1016/s0960-0760(03)00142-0.
909 DNA methylation inhibits p53-mediated survivin repression. Oncogene. 2009 May 14;28(19):2046-50. doi: 10.1038/onc.2009.62. Epub 2009 Apr 13.
910 Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells. Oncol Rep. 2008 Jun;19(6):1627-34.
911 Identification of molecular signatures predicting the carcinogenicity of polycyclic aromatic hydrocarbons (PAHs). Toxicol Lett. 2012 Jul 7;212(1):18-28. doi: 10.1016/j.toxlet.2012.04.013. Epub 2012 May 1.
912 Effects of SIDT2 on the miR-25/NOX4/HuR axis and SIRT3 mRNA stability lead to ROS-mediated TNF- expression in hydroquinone-treated leukemia cells. Cell Biol Toxicol. 2023 Oct;39(5):2207-2225. doi: 10.1007/s10565-022-09705-5. Epub 2022 Mar 18.
913 The p38 MAPK pathway mediates aryl propionic acid induced messenger rna stability of p75 NTR in prostate cancer cells. Cancer Res. 2007 Dec 1;67(23):11402-10. doi: 10.1158/0008-5472.CAN-07-1792.
914 Tyrosine phosphorylation of HuR by JAK3 triggers dissociation and degradation of HuR target mRNAs. Nucleic Acids Res. 2014 Jan;42(2):1196-208. doi: 10.1093/nar/gkt903. Epub 2013 Oct 7.
915 Amsacrine downregulates BCL2L1 expression and triggers apoptosis in human chronic myeloid leukemia cells through the SIDT2/NOX4/ERK/HuR pathway. Toxicol Appl Pharmacol. 2023 Sep 1;474:116625. doi: 10.1016/j.taap.2023.116625. Epub 2023 Jul 13.
916 Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. Cancer Res. 2006 Jul 15;66(14):7334-40.
917 Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease. J Neurosci. 2016 Jun 8;36(23):6332-51. doi: 10.1523/JNEUROSCI.0426-16.2016.
918 P21(Waf1/Cip1) plays a critical role in furazolidone-induced apoptosis in HepG2 cells through influencing the caspase-3 activation and ROS generation. Food Chem Toxicol. 2016 Feb;88:1-12. doi: 10.1016/j.fct.2015.12.004. Epub 2015 Dec 11.
919 Madecassoside ameliorates cisplatin-induced nephrotoxicity by inhibiting activation of the mitogen activated protein kinase pathway. Environ Toxicol. 2023 Jul;38(7):1473-1483. doi: 10.1002/tox.23777. Epub 2023 Apr 23.
920 Arsenic trioxide promotes ERK1/2-mediated phosphorylation and degradation of BIM(EL) to attenuate apoptosis in BEAS-2B cells. Chem Biol Interact. 2023 Jan 5;369:110304. doi: 10.1016/j.cbi.2022.110304. Epub 2022 Dec 10.
921 Aspirin-mediated COX-2 transcript stabilization via sustained p38 activation in human intestinal myofibroblasts. Mol Pharmacol. 2004 Feb;65(2):470-8.
922 All-trans-retinoic acid inhibits collapsin response mediator protein-2 transcriptional activity during SH-SY5Y neuroblastoma cell differentiation. FEBS J. 2007 Jan;274(2):498-511. doi: 10.1111/j.1742-4658.2006.05597.x.
923 Proteomic identification of differentially expressed proteins associated with the multiple drug resistance in methotrexate-resistant human breast cancer cells. Int J Oncol. 2014 Jul;45(1):448-58.
924 Effect of mood stabilizers on gene expression in lymphoblastoid cells. J Neural Transm (Vienna). 2010 Feb;117(2):155-64.
925 FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res. 2003 Nov 1;63(21):7436-42.
926 Oxyresveratrol stimulates mucin production in an NAD+-dependent manner in human intestinal goblet cells. Food Chem Toxicol. 2018 Aug;118:880-888.
927 Gene expression profile and cytotoxicity of human bronchial epithelial cells exposed to crotonaldehyde. Toxicol Lett. 2010 Aug 16;197(2):113-22.
928 Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod. 2011 Jul;26(7):1813-25.
929 Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: results from a crossover study. Atherosclerosis. 2011 Jul;217(1):165-70. doi: 10.1016/j.atherosclerosis.2011.02.012. Epub 2011 Feb 22.
930 Peroxisome Proliferator-activated receptor activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression. J Biol Chem. 2012 Jul 6;287(28):23667-77. doi: 10.1074/jbc.M112.350181. Epub 2012 May 16.
931 Transient Receptor Potential Melastatin 4 (TRPM4) Contributes to High Salt Diet-Mediated Early-Stage Endothelial Injury. Cell Physiol Biochem. 2017;41(2):835-848. doi: 10.1159/000459695. Epub 2017 Feb 16.
932 Depletion of 14-3-3 reduces the surface expression of Transient Receptor Potential Melastatin 4b (TRPM4b) channels and attenuates TRPM4b-mediated glutamate-induced neuronal cell death. Mol Brain. 2014 Jul 22;7:52. doi: 10.1186/s13041-014-0052-3.
933 Transient receptor potential melastatin 4 contributes to early-stage endothelial injury induced by arsenic trioxide. Toxicol Lett. 2019 Sep 15;312:98-108. doi: 10.1016/j.toxlet.2019.04.035. Epub 2019 May 1.
934 Transcriptome profile analysis of saturated aliphatic aldehydes reveals carbon number-specific molecules involved in pulmonary toxicity. Chem Res Toxicol. 2014 Aug 18;27(8):1362-70.
935 The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel. BMC Med Genomics. 2010 Aug 13;3:37. doi: 10.1186/1755-8794-3-37.
936 Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status. Environ Health Perspect. 2007 Nov;115(11):1646-53. doi: 10.1289/ehp.10283.
937 Dermal hyaluronan is rapidly reduced by topical treatment with glucocorticoids. J Invest Dermatol. 2010 Jan;130(1):141-9. doi: 10.1038/jid.2009.210.
938 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
939 Examining the genomic influence of skin antioxidants in vitro. Mediators Inflamm. 2010;2010.
940 Effects of methyl paraben on skin keratinocytes. J Appl Toxicol. 2007 Jan-Feb;27(1):1-9. doi: 10.1002/jat.1176.
941 Imatinib-induced hepatotoxicity via oxidative stress and activation of NLRP3 inflammasome: an in vitro and in vivo study. Arch Toxicol. 2022 Apr;96(4):1075-1087. doi: 10.1007/s00204-022-03245-x. Epub 2022 Feb 22.
942 Pterostilbene attenuates RIPK3-dependent hepatocyte necroptosis in alcoholic liver disease via SIRT2-mediated NFATc4 deacetylation. Toxicology. 2021 Sep;461:152923. doi: 10.1016/j.tox.2021.152923. Epub 2021 Aug 30.
943 Prediction of drug-induced liver injury using keratinocytes. J Appl Toxicol. 2017 Jul;37(7):863-872. doi: 10.1002/jat.3435. Epub 2017 Jan 31.
944 Marked regression of liver metastasis by combined therapy of ultrasound-mediated NF kappaB-decoy transfer and transportal injection of paclitaxel, in mouse. Int J Cancer. 2008 Apr 1;122(7):1645-56. doi: 10.1002/ijc.23280.
945 Interindividual variation in gene expression responses and metabolite formation in acetaminophen-exposed primary human hepatocytes. Arch Toxicol. 2016 May;90(5):1103-15. doi: 10.1007/s00204-015-1545-2. Epub 2015 Jun 24.
946 Bisphenol-A and estradiol exert novel gene regulation in human MCF-7 derived breast cancer cells. Mol Cell Endocrinol. 2004 Jun 30;221(1-2):47-55. doi: 10.1016/j.mce.2004.04.010.
947 Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs. BMC Neurosci. 2006 Oct 20;7:69.
948 Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood. 2006 Apr 15;107(8):3221-8. doi: 10.1182/blood-2005-07-2843. Epub 2005 Dec 15.
949 Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer. Cancer Res. 2007 May 15;67(10):5033-41.
950 Long-term estrogen exposure promotes carcinogen bioactivation, induces persistent changes in gene expression, and enhances the tumorigenicity of MCF-7 human breast cancer cells. Toxicol Appl Pharmacol. 2009 Nov 1;240(3):355-66.
951 Gene-expression profiling during curcumin-induced apoptosis reveals downregulation of CXCR4. Exp Hematol. 2007 Jan;35(1):84-95.
952 Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells. Biol Pharm Bull. 2006 Apr;29(4):655-69.
953 Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells. Chem Res Toxicol. 2014 Mar 17;27(3):408-20.
954 Human Mincle Binds to Cholesterol Crystals and Triggers Innate Immune Responses. J Biol Chem. 2015 Oct 16;290(42):25322-32. doi: 10.1074/jbc.M115.645234. Epub 2015 Aug 20.
955 CRK7 modifies the MAPK pathway and influences the response to endocrine therapy. Carcinogenesis. 2009 Oct;30(10):1696-701. doi: 10.1093/carcin/bgp187. Epub 2009 Aug 3.
956 Oxidative stress modulates expression of immune checkpoint genes via activation of AhR signaling. Toxicol Appl Pharmacol. 2022 Dec 15;457:116314. doi: 10.1016/j.taap.2022.116314. Epub 2022 Nov 9.
957 Essential role of HDAC6 in the regulation of PD-L1 in?melanoma. Mol Oncol. 2016 May;10(5):735-750. doi: 10.1016/j.molonc.2015.12.012. Epub 2016 Jan 6.
958 CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124/PD-L1 axis. Cell Biol Toxicol. 2022 Oct;38(5):825-845. doi: 10.1007/s10565-021-09613-0. Epub 2021 May 20.
959 [Arsenic trioxide induced p15INK4B gene expression in myelodysplastic syndrome cell line MUTZ-1]. Zhonghua Xue Ye Xue Za Zhi. 2002 Dec;23(12):638-41.
960 Alcohol triggered bile acid disequilibrium by suppressing BSEP to sustain hepatocellular carcinoma progression. Chem Biol Interact. 2022 Apr 1;356:109847. doi: 10.1016/j.cbi.2022.109847. Epub 2022 Feb 9.
961 Differential gene expression profiles may differentiate responder and nonresponder patients with rheumatoid arthritis for methotrexate (MTX) monotherapy and MTX plus tumor necrosis factor inhibitor combined therapy. J Rheumatol. 2012 Aug;39(8):1524-32. doi: 10.3899/jrheum.120092. Epub 2012 Jul 1.
962 Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein. Neoplasia. 2004 Jul-Aug;6(4):354-63. doi: 10.1593/neo.03478.
963 Arginine methylation provides epigenetic transcription memory for retinoid-induced differentiation in myeloid cells. Mol Cell Biol. 2005 Jul;25(13):5648-63.
964 Citrullination of RGG Motifs in FET Proteins by PAD4 Regulates Protein Aggregation and ALS Susceptibility. Cell Rep. 2018 Feb 6;22(6):1473-1483. doi: 10.1016/j.celrep.2018.01.031.
965 Sulforaphane-induced apoptosis in human leukemia HL-60 cells through extrinsic and intrinsic signal pathways and altering associated genes expression assayed by cDNA microarray. Environ Toxicol. 2017 Jan;32(1):311-328.
966 CD34+ derived macrophage and dendritic cells display differential responses to paraquat. Toxicol In Vitro. 2021 Sep;75:105198. doi: 10.1016/j.tiv.2021.105198. Epub 2021 Jun 9.
967 Expression and DNA methylation changes in human breast epithelial cells after bisphenol A exposure. Int J Oncol. 2012 Jul;41(1):369-77.
968 Identification by functional cloning from a retroviral cDNA library of cDNAs for ribosomal protein L36 and the 10-kDa heat shock protein that confer cisplatin resistance. Mol Pharmacol. 2006 Apr;69(4):1383-8. doi: 10.1124/mol.105.017525. Epub 2006 Jan 4.
969 The contact allergen nickel triggers a unique inflammatory and proangiogenic gene expression pattern via activation of NF-kappaB and hypoxia-inducible factor-1alpha. J Immunol. 2007 Mar 1;178(5):3198-207.
970 Differential protein expression of peroxiredoxin I and II by benzo(a)pyrene and quercetin treatment in 22Rv1 and PrEC prostate cell lines. Toxicol Appl Pharmacol. 2007 Apr 15;220(2):197-210. doi: 10.1016/j.taap.2006.12.030. Epub 2007 Jan 9.
971 Inhibition of glutathione S-transferases by antimalarial drugs possible implications for circumventing anticancer drug resistance. Int J Cancer. 2002 Feb 10;97(5):700-5.
972 Human glutathione S-transferase A (GSTA) family genes are regulated by steroidogenic factor 1 (SF-1) and are involved in steroidogenesis. FASEB J. 2013 Aug;27(8):3198-208. doi: 10.1096/fj.12-222745. Epub 2013 May 6.
973 Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa. Br J Clin Pharmacol. 2009 Jan;67(1):50-60. doi: 10.1111/j.1365-2125.2008.03321.x. Epub 2008 Nov 17.
974 Effects of phenytoin on glutathione status and oxidative stress biomarker gene mRNA levels in cultured precision human liver slices. Toxicol Sci. 2001 Jan;59(1):118-26.
975 Acetaminophen-induced hepatocyte injury: C2-ceramide and oltipraz intervention, hepatocyte nuclear factor 1 and glutathione S-transferase A1 changes. J Appl Toxicol. 2019 Dec;39(12):1640-1650. doi: 10.1002/jat.3881. Epub 2019 Aug 6.
976 Antineoplastic drug sensitivity of human MCF-7 breast cancer cells stably transfected with a human alpha class glutathione S-transferase gene. Cancer Res. 1991 Jan 15;51(2):587-94.
977 Establishment of cisplatin-resistant ovarian yolk sac tumor cells and investigation of the mechanism of cisplatin resistance using this cell line. Gynecol Obstet Invest. 2011;71(2):104-11. doi: 10.1159/000320744. Epub 2010 Dec 9.
978 Overexpression of glutathione S-transferase A1-1 in ECV 304 cells protects against busulfan mediated G2-arrest and induces tissue factor expression. Br J Pharmacol. 2002 Dec;137(7):1100-6. doi: 10.1038/sj.bjp.0704972.
979 Astaxanthin and omega-3 fatty acids individually and in combination protect against oxidative stress via the Nrf2-ARE pathway. Food Chem Toxicol. 2013 Dec;62:869-75.
980 Simulation of interindividual differences in inactivation of reactive para-benzoquinone imine metabolites of diclofenac by glutathione S-transferases in human liver cytosol. Toxicol Lett. 2016 Jul 25;255:52-62.
981 Expression of glutathione S-transferase M2 in stage I/II non-small cell lung cancer and alleviation of DNA damage exposure to benzo[a]pyrene. Toxicol Lett. 2010 Feb 15;192(3):316-23. doi: 10.1016/j.toxlet.2009.11.003. Epub 2009 Nov 10.
982 Functional defect caused by the 4544G>A SNP in ABCC2: potential impact for drug cellular disposition. Pharmacogenet Genomics. 2011 Dec;21(12):884-93. doi: 10.1097/FPC.0b013e32834d672b.
983 Role of multidrug resistance protein 2 (MRP2, ABCC2) in alkylating agent detoxification: MRP2 potentiates glutathione S-transferase A1-1-mediated resistance to chlorambucil cytotoxicity. J Pharmacol Exp Ther. 2004 Jan;308(1):260-7. doi: 10.1124/jpet.103.057729. Epub 2003 Oct 20.
984 MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid. Int J Cancer. 2005 Sep 20;116(5):824-9. doi: 10.1002/ijc.21013.
985 Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia. Cancer Sci. 2008 May;99(5):967-72.
986 In vitro study of transporters involved in intestinal absorption of inorganic arsenic. Chem Res Toxicol. 2012 Feb 20;25(2):446-53. doi: 10.1021/tx200491f. Epub 2012 Jan 26.
987 Potency of individual bile acids to regulate bile acid synthesis and transport genes in primary human hepatocyte cultures. Toxicol Sci. 2014 Oct;141(2):538-46. doi: 10.1093/toxsci/kfu151. Epub 2014 Jul 23.
988 Co-encapsulation of chrysophsin-1 and epirubicin in PEGylated liposomes circumvents multidrug resistance in HeLa cells. Chem Biol Interact. 2015 Dec 5;242:13-23. doi: 10.1016/j.cbi.2015.08.023. Epub 2015 Sep 1.
989 Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma. Head Neck. 2011 Jul;33(7):959-68. doi: 10.1002/hed.21559. Epub 2010 Aug 24.
990 Oestrogenic potencies of Zeranol, oestradiol, diethylstilboestrol, Bisphenol-A and genistein: implications for exposure assessment of potential endocrine disrupters. Hum Reprod. 2001 May;16(5):1037-45.
991 The redox state of cytochrome c modulates resistance to methotrexate in human MCF7 breast cancer cells. PLoS One. 2013 May 13;8(5):e63276. doi: 10.1371/journal.pone.0063276. Print 2013.
992 Crystal structure of maleylacetoacetate isomerase/glutathione transferase zeta reveals the molecular basis for its remarkable catalytic promiscuity. Biochemistry. 2001 Feb 13;40(6):1567-76. doi: 10.1021/bi002249z.
993 Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease. Inflamm Bowel Dis. 2007 Jan;13(1):57-64. doi: 10.1002/ibd.20004.
994 Association of polymorphism in alcohol dehydrogenase and interaction with other genetic risk factors with alcoholic liver cirrhosis. Drug Alcohol Depend. 2010 Jun 1;109(1-3):190-7. doi: 10.1016/j.drugalcdep.2010.01.010. Epub 2010 Feb 18.
995 Inhibition of human glutathione S-transferases by dopamine, alpha-methyldopa and their 5-S-glutathionyl conjugates. Chem Biol Interact. 1994 Jan;90(1):87-99.
996 Differences among allelic variants of human glutathione transferase A2-2 in the activation of azathioprine. Chem Biol Interact. 2010 Jul 30;186(2):110-7. doi: 10.1016/j.cbi.2010.04.028. Epub 2010 Apr 29.
997 Overexpression of GSTA2 protects against cell cycle arrest and apoptosis induced by the DNA inter-strand crosslinking nitrogen mustard, mechlorethamine. J Cell Biochem. 2005 May 15;95(2):339-51. doi: 10.1002/jcb.20440.
998 Capturing time-dependent activation of genes and stress-response pathways using transcriptomics in iPSC-derived renal proximal tubule cells. Cell Biol Toxicol. 2023 Aug;39(4):1773-1793. doi: 10.1007/s10565-022-09783-5. Epub 2022 Dec 31.
999 Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. Toxicol Appl Pharmacol. 2009 Feb 1;234(3):345-60.
1000 Cytochrome P450-mediated bioactivation of mefenamic acid to quinoneimine intermediates and inactivation by human glutathione S-transferases. Chem Res Toxicol. 2014 Dec 15;27(12):2071-81.